10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2022

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number 0-16244

VEECO INSTRUMENTS INC.

(Exact Name of Registrant as Specified in Its Charter)

Delaware	11-2989601
(State or Other Jurisdiction of Incorporation or Organization)	(I.R.S. Employer Identification No.)
Terminal Drive Plainview, New York	11803
(Address of Principal Executive Offices)	(Zip Code)

Registrant’s telephone number, including area code:

(516) 677-0200

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.01 per share	VECO	The NASDAQ Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒  No ◻

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).Yes ☒  No ◻

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☒	Accelerated filer ☐
Non-accelerated filer ☐	Smaller reporting company ☐
	Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes ☐  No ☒

As of November 2, 2022, there were 51,425,150 shares of the registrant’s common stock outstanding.

VEECO INSTRUMENTS INC.

INDEX

Safe Harbor Statement	1
PART I—FINANCIAL INFORMATION	4
Item 1. Financial Statements	4
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	30
Item 3. Quantitative and Qualitative Disclosures about Market Risk	40
Item 4. Controls and Procedures	40
PART II—OTHER INFORMATION	41
Item 1. Legal Proceedings	41
Item 1A. Risk Factors	41
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	42
Item 3. Defaults Upon Senior Securities	42
Item 4. Mine Safety Disclosures	42
Item 5. Other Information	43
Item 6. Exhibits	43
SIGNATURES	44

Safe Harbor Statement

This quarterly report on Form 10-Q (the “Report”) contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Discussions containing such forward-looking statements may be found in Part I - Items 1, 2, and 3 hereof, as well as within this Report generally. In addition, when used in this Report, the words “believes,” “anticipates,” “expects,” “estimates,” “targets,” “plans,” “intends,” “will,” and similar expressions related to the future are intended to identify forward-looking statements. All forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from projected results.

In addition, the preparation of financial statements in conformity with U.S. Generally Accepted Accounting Principles (“U.S. GAAP”) requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Although these estimates and assumptions are based on knowledge of current events, including the potential impact of the COVID-19 pandemic on our business, and planned actions to be undertaken in the future, they may ultimately differ from actual results. Operating results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022. All estimates and assumptions are subject to a number of risks and uncertainties that could cause actual results to differ materially from these estimates and assumptions.

The risks and uncertainties of Veeco Instruments Inc. (together with its consolidated subsidiaries, “Veeco,” the “Company,” “we,” “us,” and “our,” unless the context indicates otherwise) include, without limitation, those set forth under the heading “Risk Factors” in Part 1, Item 1A of our 2021 Form 10-K, those included within Item 1A of our quarterly reports on Form 10-Q for the quarters ending March 31, 2022 and June 30, 2022, and the following:

Risks Related to Our Business, Finance and Operations

● The effects of the COVID-19 pandemic have strained and have negatively impacted our business and operations, and the duration and extent to which COVID-19 may impact our future results of operations and overall financial performance remains uncertain;

● Unfavorable market conditions, coupled with ongoing supply chain challenges and inflationary pressures, have adversely affected, and may continue to adversely affect, our operating results;

● The timing of our orders, shipments, and revenue recognition may cause our quarterly operating results to fluctuate significantly;

● Our sales cycle is long and unpredictable;

● Our backlog is subject to customer cancellation or modification which could result in decreased sales, increased inventory obsolescence, and liabilities to our suppliers for products no longer needed;

● We may be required to take impairment charges on assets;

● We are exposed to risks associated with business combinations, acquisitions, strategic investments and divestitures;

● We have adopted certain measures that may have anti-takeover effects which may make an acquisition of our Company by another company more difficult;

● Our current debt facilities, including our 2.70% Convertible Senior Notes due 2023 (the “2023 Notes”), our 3.50% Convertible Senior Notes due 2025 (the “2025 Notes”), or our 3.75% Convertible Senior Notes due 2027 (the “2027 Notes”) (the 2023 Notes, 2025 Notes, and 2027 Notes, together, the “Notes”), and our revolving credit facility (the “Credit Facility”), may contain certain restrictions, covenants and repurchase provisions that

1

may limit our ability to raise the funds necessary to meet our working capital needs, which may include the cash conversion of the Notes or repurchase of the Notes for cash upon a fundamental change;

● The conditional conversion features of the 2023 Notes, 2025 Notes, and 2027 Notes, if triggered, may materially and adversely affect our financial condition and operating results;

● The accounting method for convertible debt securities that may be settled in cash, such as the Notes, could have a material effect on our reported financial results;

● Issuance of our common stock, if any, upon conversion of the Notes, as well as the capped call transactions and the hedging activities of the option counterparties, may impair or reduce our ability to utilize our net operating loss carryforwards or our research and development credits carryforwards in the future;

● The capped call transactions may affect the value of the 2027 Notes and our common stock;

Risks Associated with Operating a Global Business

● We are exposed to risks of operating businesses outside the United States;

● Changes in U.S. trade policy and export controls and ongoing trade disputes between the U.S. and China have adversely affected, and may continue to adversely affect, our business, results of operations, and financial condition;

● We may be unable to obtain required export licenses for the sale of our products;

● We are exposed to various risks associated with global regulatory requirements;

● We may be exposed to liabilities under the Foreign Corrupt Practices Act and other similar laws;

● Our operating results may be adversely affected by tightening credit markets;

● We are subject to foreign currency exchange risks;

Risks Related to Intellectual Property and Cybersecurity

● Disruptions in our information technology systems or data security incidents could result in significant financial, legal, regulatory, business, and reputational harm to us;

● We may be unable to effectively enforce and protect our intellectual property rights;

● We may be subject to claims of intellectual property infringement by others;

Risks Associated with Our Industry

● We face significant competition;

● We operate in industries characterized by rapid technological change;

● Certain of our sales are dependent on the demand for consumer electronic products and automobiles, which can experience significant volatility;

● We have a concentrated customer base, located primarily in a limited number of regions, which operates in highly concentrated industries;

2

● The cyclicality of the industries we serve directly affects our business;

● Our failure to estimate customer demand accurately could result in inventory obsolescence, liabilities to our suppliers for products no longer needed, and manufacturing interruptions or delays which could affect our ability to meet customer demand;

● We rely on a limited number of suppliers, some of whom are our sole source for particular components;

● Our failure to successfully manage our outsourcing activities or failure of our outsourcing partners to perform as anticipated could adversely affect our results of operations;

General Risk Factors

● The price of our common shares is volatile and could decrease;

● We are subject to risks of non-compliance with environmental, health, and safety regulations and sustainability requirements;

● Our inability to attract, retain, and motivate employees could have a material adverse effect on our business; and

● Changes in accounting pronouncements or taxation rules, practices, or rates may adversely affect our financial results.

Consequently, such forward looking statements and estimates should be regarded solely as the current plans and beliefs of Veeco. We do not undertake any obligation to update any forward looking statements to reflect future events or circumstances after the date of such statements.

3

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements

Veeco Instruments Inc. and Subsidiaries

Consolidated Balance Sheets

(in thousands, except share amounts)

	September 30,		December 31,
	2022		2021
Assets	(unaudited)
Current assets:
Cash and cash equivalents	$	169,111	$	119,747
Restricted cash		557		725
Short-term investments		101,862		104,181
Accounts receivable, net		142,985		109,609
Contract assets		29,865		18,293
Inventories		187,737		170,858
Prepaid expenses and other current assets		17,586		25,974
Total current assets		649,703		549,387
Property, plant, and equipment, net		108,416		99,743
Operating lease right-of-use assets		25,119		28,813
Intangible assets, net		26,391		33,905
Goodwill		181,943		181,943
Deferred income taxes		1,639		1,639
Other assets		3,406		3,546
Total assets	$	996,617	$	898,976
Liabilities and stockholders' equity
Current liabilities:
Accounts payable	$	51,129	$	44,456
Accrued expenses and other current liabilities		65,062		79,752
Customer deposits and deferred revenue		122,285		63,136
Income taxes payable		1,565		1,860
Current portion of long-term debt		20,144		—
Total current liabilities		260,185		189,204
Deferred income taxes		4,748		4,792
Long-term debt		254,272		229,438
Long-term operating lease liabilities		31,266		32,834
Other liabilities		5,031		5,080
Total liabilities		555,502		461,348
Stockholders' equity:
Preferred stock, $0.01 par value; 500,000 shares authorized; no shares issued and outstanding.		—		—
Common stock, $0.01 par value; 120,000,000 shares authorized; 51,420,150 shares issued and outstanding at September 30, 2022 and 50,652,864 shares issued and outstanding at December 31, 2021		515		507
Additional paid-in capital		1,071,097		1,116,921
Accumulated deficit		(630,716)		(681,283)
Accumulated other comprehensive income		219		1,483
Total stockholders' equity		441,115		437,628
Total liabilities and stockholders' equity	$	996,617	$	898,976

See accompanying Notes to the Consolidated Financial Statements.

4

Veeco Instruments Inc. and Subsidiaries

Consolidated Statements of Operations

(in thousands, except per share amounts)

(unaudited)

	Three months ended September 30,				Nine months ended September 30,
	2022		2021		2022		2021
Net sales	$	171,913	$	150,246	$	492,338	$	430,305
Cost of sales		101,962		87,077		292,109		252,055
Gross profit		69,951		63,169		200,229		178,250
Operating expenses, net:
Research and development		27,104		21,999		77,237		66,397
Selling, general, and administrative		22,144		21,603		67,987		63,325
Amortization of intangible assets		2,505		2,976		7,514		9,305
Other operating expense (income), net		634		175		587		138
Total operating expenses, net		52,387		46,753		153,325		139,165
Operating income		17,564		16,416		46,904		39,085
Interest income		571		95		873		464
Interest expense		(2,886)		(7,107)		(8,626)		(20,685)
Income before income taxes		15,249		9,404		39,151		18,864
Income tax expense (benefit)		208		411		1,125		1,029
Net income	$	15,041	$	8,993	$	38,026	$	17,835
Income per common share:
Basic	$	0.30	$	0.18	$	0.76	$	0.36
Diluted	$	0.27	$	0.17	$	0.70	$	0.33
Weighted average number of shares:
Basic		49,887		49,021		49,831		48,968
Diluted		65,151		53,849		65,090		53,606

See accompanying Notes to the Consolidated Financial Statements.

5

Veeco Instruments Inc. and Subsidiaries

Consolidated Statements of Comprehensive Income

(in thousands)

(unaudited)

	Three months ended September 30,				Nine months ended September 30,
	2022		2021		2022		2021
Net income	$	15,041	$	8,993	$	38,026	$	17,835
Other comprehensive income (loss), net of tax:
Unrealized gain (loss) on available-for-sale securities		(113)		(12)		(1,156)		(16)
Change in currency translation adjustments		(57)		(21)		(108)		(60)
Total other comprehensive income (loss), net of tax		(170)		(33)		(1,264)		(76)
Total comprehensive income	$	14,871	$	8,960	$	36,762	$	17,759

See accompanying Notes to the Consolidated Financial Statements.

6

Veeco Instruments Inc. and Subsidiaries

Consolidated Statements of Cash Flows

(in thousands)

(unaudited)

	Nine months ended September 30,
	2022		2021
Cash Flows from Operating Activities
Net income	$	38,026	$	17,835
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization		19,100		19,634
Non-cash interest expense		719		10,762
Deferred income taxes		(43)		(12)
Share-based compensation expense		16,969		11,735
Changes in operating assets and liabilities:
Accounts receivable and contract assets		(44,948)		(12,987)
Inventories		(18,117)		(24,879)
Prepaid expenses and other current assets		8,388		9,829
Accounts payable and accrued expenses		(6,072)		21,786
Customer deposits and deferred revenue		59,149		(6,532)
Income taxes receivable and payable, net		(296)		823
Other, net		2,499		2,655
Net cash provided by (used in) operating activities		75,374		50,649
Cash Flows from Investing Activities
Capital expenditures		(21,771)		(31,453)
Proceeds from the sale of investments		44,592		199,475
Payments for purchases of investments		(43,982)		(225,112)
Net cash provided by (used in) investing activities		(21,161)		(57,090)
Cash Flows from Financing Activities
Proceeds (net of tax withholdings) from option exercises and employee stock purchase plan		2,909		2,709
Restricted stock tax withholdings		(7,818)		(4,260)
Net cash provided by (used in) financing activities		(4,909)		(1,551)
Effect of exchange rate changes on cash and cash equivalents		(108)		(60)
Net increase (decrease) in cash, cash equivalents, and restricted cash		49,196		(8,052)
Cash, cash equivalents, and restricted cash - beginning of period		120,472		130,283
Cash, cash equivalents, and restricted cash - end of period	$	169,668	$	122,231
Supplemental Disclosure of Cash Flow Information
Interest paid	$	7,760	$	9,039
Income taxes paid (refunds received)		1,349		(130)
Non-cash activities
Capital expenditures included in accounts payable and accrued expenses		6,709		9,133
Net transfer of inventory to property, plant and equipment		1,235		(253)
Right-of-use assets obtained in exchange for lease obligations		375		20,353

See accompanying Notes to the Consolidated Financial Statements.

7

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements

(unaudited)

Note 1 — Basis of Presentation

The accompanying unaudited Consolidated Financial Statements of Veeco have been prepared in accordance with U.S. GAAP as defined in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification 270 for interim financial information and with the instructions to Rule 10-01 of Securities and Exchange Commission Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements as the interim information is an update of the information that was presented in Veeco’s most recent annual financial statements. For further information, refer to Veeco’s Consolidated Financial Statements and Notes thereto included in the Annual Report on Form 10-K for the year ended December 31, 2021 (“2021 Form 10-K”). In the opinion of management, all adjustments considered necessary for a fair presentation have been included. All such adjustments are of a normal, recurring nature.

Veeco reports interim quarters on a 13-week basis ending on the last Sunday of each quarter. The fourth quarter always ends on the last day of the calendar year, December 31. The 2022 interim quarters end on April 3, July 3, and October 2, and the 2021 interim quarters ended on April 4, July 4, and October 3. These interim quarters are reported as March 31, June 30, and September 30 in Veeco’s interim consolidated financial statements.

The preparation of financial statements in conformity with U.S GAAP requires the Company’s management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Although these estimates are based on management’s knowledge of current events and actions it may undertake in the future, actual results may differ from these estimates. In particular, the COVID-19 pandemic has adversely impacted and is likely to further adversely impact the Company’s business and markets, including the Company’s workforce and operations and the operations of the Company’s customers, suppliers, and business partners. The full extent to which the pandemic will directly or indirectly impact the Company's business, results of operations and financial condition, including sales, expenses, manufacturing, research and development costs, reserves and allowances, fair value measurements, and asset impairment charges, will depend on future developments that are highly uncertain and difficult to predict. These developments include, but are not limited to, the duration and spread of the outbreak, its severity, the actions to contain the virus or address its impact, governmental actions to contain the spread of the pandemic and respond to the reduction in global economic activity, and how quickly and to what extent normal economic and operating conditions can resume.

Revenue Recognition

Revenue is recognized upon the transfer of control of the promised product or service to the customer in an amount that reflects the consideration the Company expects to receive in exchange for such product or service. The Company’s contracts with customers generally do not contain variable consideration. In the rare instances where variable consideration is included, the Company estimates the amount of variable consideration and determines what portion of that, if any, has a high probability of significant subsequent revenue reversal, and if so, that amount is excluded from the transaction price. The Company’s contracts with customers frequently contain multiple deliverables, such as systems, upgrades, components, spare parts, installation, maintenance, and service plans. Judgment is required to properly identify the performance obligations within a contract and to determine how the revenue should be allocated among the performance obligations. The Company also evaluates whether multiple transactions with the same customer or related parties should be considered part of a single contract based on an assessment of whether the contracts or agreements are negotiated or executed within a short time frame of each other or if there are indicators that the contracts are negotiated in contemplation of one another.

When there are separate units of accounting, the Company allocates revenue to each performance obligation on a relative stand-alone selling price basis. The stand-alone selling prices are determined based on the prices at which the Company separately sells the systems, upgrades, components, spare parts, installation, maintenance, and service plans. For items

8

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

that are not sold separately, the Company estimates stand-alone selling prices generally using an expected cost plus margin approach.

Most of the Company’s revenue is recognized at a point in time when the performance obligation is satisfied. The Company considers many facts when evaluating each of its sales arrangements to determine the timing of revenue recognition, including its contractual obligations and the nature of the customer’s post-delivery acceptance provisions. The Company’s system sales arrangements, including certain upgrades, generally include field acceptance provisions that may include functional or mechanical test procedures. For many of these arrangements, a customer source inspection of the system is performed in the Company’s facility, test data is sent to the customer documenting that the system is functioning to the agreed upon specifications prior to delivery, or other quality assurance testing is performed internally to ensure system functionality prior to shipment. Historically, such source inspection or test data replicates the field acceptance provisions that are performed at the customer’s site prior to final acceptance of the system. When the Company objectively demonstrates that the criteria specified in the contractual acceptance provisions are achieved prior to delivery either through customer testing or the Company’s historical experience of its tools meeting specifications, transfer of control of the product to the customer is considered to have occurred and revenue is recognized upon system delivery since there is no substantive contingency remaining related to the acceptance provisions at that date. For new products, new applications of existing products, or for products with substantive customer acceptance provisions where the Company cannot objectively demonstrate that the criteria specified in the contractual acceptance provisions have been achieved prior to delivery, revenue and the associated costs are deferred. The Company recognizes such revenue and costs upon obtaining objective evidence that the acceptance provisions can be achieved, assuming all other revenue recognition criteria have been met.

In certain cases the Company’s contracts with customers contain a billing retention, which is billed by the Company and payable by the customer when field acceptance provisions are completed. Revenue recognized in advance of the amount that has been billed is recorded as a contract asset on the Consolidated Balance Sheets.

The Company recognizes revenue related to maintenance and service contracts over time based upon the respective contract term. Installation revenue is recognized over time as the installation services are performed. The Company recognizes revenue from the sales of components, spare parts, and specified service engagements at a point in time, which is typically consistent with the time of delivery in accordance with the terms of the applicable sales arrangement.

The Company may receive customer deposits on system transactions. The timing of the transfer of goods or services related to the deposits is either at the discretion of the customer or generally expected to be within one year from the deposit receipt. As such, the Company does not adjust transaction prices for the time value of money. Incremental direct costs incurred related to the acquisition of a customer contract, such as sales commissions, are expensed as incurred since the expected amortization period is one year or less.

The Company has elected to treat shipping and handling costs as a fulfillment activity, and the Company includes such costs in cost of sales when the Company recognizes revenue for the related goods. Taxes assessed by governmental authorities that are collected by the Company from a customer are excluded from revenue.

Inventories

Inventories are stated at the lower of cost or net realizable value, with cost determined on a first-in, first-out basis. Each quarter the Company assesses the valuation and recoverability of all inventories: materials (raw materials, spare parts, and service inventory); work-in-process; and finished goods. Obsolete inventory or inventory in excess of management’s estimated usage requirement is written down to its estimated net realizable value if less than cost. The Company evaluates usage requirements by analyzing historical usage, anticipated demand, alternative uses of materials, and other qualitative factors. Unanticipated changes in demand for the Company’s products may require a write down of

9

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

inventory, which would be reflected in cost of sales in the period the revision is made. Inventory acquired as part of a business combination is recorded at fair value on the date of acquisition.

Recently Adopted Accounting Standards

The Company adopted ASU 2020-06: Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity on January 1, 2022, using the modified retrospective method for all financial instruments that are outstanding as of the adoption date. This standard simplifies the accounting for convertible debt instruments by removing the separation models for convertible debt with a cash conversion feature, as well as convertible instruments with a beneficial conversion feature. As a result, entities will account for a convertible debt instrument wholly as debt, unless certain other conditions are met. The elimination of these models will reduce non-cash interest expense for entities that have issued a convertible instrument that was within the scope of those models before the adoption of ASU 2020-06, such as the Company’s 2023 Notes, 2025 Notes, and 2027 Notes. Additionally, ASU 2020-06 requires the application of the if-converted method for calculating diluted earnings per share, and precludes the use of the treasury stock method for certain debt instruments, such as the Company’s 2023 Notes, 2025 Notes, and 2027 Notes.

The adoption of ASU 2020-06 resulted in the following adjustments to the Consolidated Balance Sheets:

	December 31, 2021		Adoption of ASU 2020-06		January 1, 2022
	(in thousands)
Balance Sheet line item:
Long-term debt	$	229,438	$	44,260	$	273,698
Additional paid-in capital		1,116,921		(56,801)		1,060,120
Accumulated deficit		(681,283)		12,541		(668,742)

The adoption of ASU 2020-06 resulted in the following adjustments to the Company’s calculations of basic and diluted income per share for the three and nine months ended September 30, 2022:

	Three months ended September 30, 2022						Nine months ended September 30, 2022
	Under		Under				Under		Under
	ASU 2020-06		legacy accounting		Difference		ASU 2020-06		legacy accounting		Difference
Income per common share:
Basic income per common share	$	0.30	$	0.25	$	0.05	$	0.76	$	0.62	$	0.14
Diluted income per common share		0.27		0.24		0.03		0.70		0.57		0.13

The adoption of ASU 2020-06 did not materially impact the Company’s cash flows or compliance with debt covenants.

i

10

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

Note 2 — Income Per Common Share

Basic income per share is calculated by dividing net income by the weighted average number of shares outstanding during the period. Diluted income per share is calculated by dividing net income available to common shareholders by the weighted average number of shares used to calculate basic income per share plus the weighted average number of common share equivalents outstanding during the period. The dilutive effect of outstanding options to purchase common stock and share-based awards is considered in diluted income per share by application of the treasury stock method. The dilutive effect of performance share units is included in diluted income per common share if the performance targets have been achieved, or would have been achieved if the reporting date was the end of the contingency period. Upon the adoption of ASU 2020-06 on January 1, 2022, the Company includes the dilutive effect of shares issuable upon conversion of its Notes in the calculation of diluted income per share using the if-converted method. Prior to the adoption of ASU 2020-06, based on the Company’s ability and intent to settle the principal amount of its convertible senior notes in cash, and the excess of the principal portion in shares of its common stock, the Company accounted for the conversion spread using the treasury stock method, and the shares issuable upon conversion of the Notes were not included in the calculation of diluted earnings per share except to the extent that the conversion value of the Notes exceeds their principal amount and if the effect would be dilutive. The computations of basic and diluted income per share for the three months and nine months ended September 30, 2022 and 2021 are as follows:

	Three months ended September 30,				Nine months ended September 30,
	2022		2021		2022		2021
	(in thousands, except per share amounts)
Numerator:
Net income	$	15,041	$	8,993	$	38,026	$	17,835
Interest expense associated with convertible notes		2,549		—		7,639		—
Net income available to common shareholders	$	17,590	$	8,993	$	45,665	$	17,835
Denominator:
Basic weighted average shares outstanding		49,887		49,021		49,831		48,968
Effect of potentially dilutive share-based awards		801		1,507		796		1,377
Dilutive effect of convertible notes		14,463		3,321		14,463		3,261
Diluted weighted average shares outstanding		65,151		53,849		65,090		53,606
Net income per common share:
Basic	$	0.30	$	0.18	$	0.76	$	0.36
Diluted	$	0.27	$	0.17	$	0.70	$	0.33
Potentially dilutive shares excluded from the diluted calculation as their effect would be antidilutive		1,016		451		751		447
Maximum potential shares to be issued for settlement of the convertible notes excluded from the diluted calculation as their effect would be antidilutive		504		8,811		504		8,811

Note 3 — Assets

Investments

Short-term investments are generally classified as available-for-sale and reported at fair value, with unrealized gains and losses, net of tax, presented as a separate component of stockholders’ equity under the caption “Accumulated other comprehensive income” in the Consolidated Balance Sheets. These securities may include U.S. treasuries, government agency securities, corporate debt, and commercial paper, all with maturities of greater than three months when

11

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

purchased. All realized gains and losses and unrealized losses resulting from declines in fair value that are other than temporary are included in “Other operating expense (income), net” in the Consolidated Statements of Operations.

Fair value is the price that would be received for an asset or the amount paid to transfer a liability in an orderly transaction between market participants. Veeco classifies certain assets based on the following fair value hierarchy:

Level 1: Quoted prices in active markets that are unadjusted and accessible at the measurement date for identical, unrestricted assets or liabilities;

Level 2: Quoted prices for identical assets and liabilities in markets that are not active, quoted prices for similar assets and liabilities in active markets or financial instruments for which significant inputs are observable, either directly or indirectly; and

Level 3: Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable.

A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Veeco has evaluated the estimated fair value of financial instruments using available market information and valuations as provided by third-party sources. The use of different market assumptions or estimation methodologies could have a significant effect on the estimated fair value amounts.

12

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

The following table presents the portion of Veeco’s assets that were measured at fair value on a recurring basis at September 30, 2022 and December 31, 2021:

	Level 1		Level 2		Level 3		Total
	(in thousands)
September 30, 2022
Cash equivalents
Certificate of deposits and time deposits	$	63,527	$	—	$	—	$	63,527
Commercial paper		—		4,959		—		4,959
Money market cash		15,066		—		—		15,066
Total	$	78,593	$	4,959	$	—	$	83,552
Short-term investments
U.S. treasuries	$	46,353	$	—	$	—	$	46,353
Government agency securities		—		12,879		—		12,879
Corporate debt		—		36,745		—		36,745
Commercial paper		—		5,885		—		5,885
Total	$	46,353	$	55,509	$	—	$	101,862
December 31, 2021
Cash equivalents
Certificate of deposits and time deposits	$	41,544	$	—	$	—	$	41,544
Money market cash		121		—		—		121
Total	$	41,665	$	—	$	—	$	41,665
Short-term investments
U.S. treasuries	$	51,095	$	—	$	—	$	51,095
Government agency securities		—		12,052		—		12,052
Corporate debt		—		40,035		—		40,035
Commercial paper		—		999		—		999
Total	$	51,095	$	53,086	$	—	$	104,181

There were no transfers between fair value measurement levels during the three months and nine months ended September 30, 2022.

13

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

At September 30, 2022 and December 31, 2021, the amortized cost and fair value of available-for-sale securities consist of:

			Gross		Gross
	Amortized		Unrealized		Unrealized		Estimated
	Cost		Gains		Losses		Fair Value
	(in thousands)
September 30, 2022
U.S. treasuries	$	47,084	$	—	$	(732)	$	46,352
Government agency securities		12,991		—		(112)		12,879
Corporate debt		37,389		—		(643)		36,746
Commercial paper		5,885		—		—		5,885
Total	$	103,349	$	—	$	(1,487)	$	101,862
December 31, 2021
U.S. treasuries	$	51,269	$	—	$	(174)	$	51,095
Government agency securities		12,075		—		(23)		12,052
Corporate debt		40,169		—		(134)		40,035
Commercial paper		999		—		—		999
Total	$	104,512	$	—	$	(331)	$	104,181

Available-for-sale securities in a loss position at September 30, 2022 and December 31, 2021 consist of:

	September 30, 2022								December 31, 2021
	Continuous Loss Position				Continuous Loss Position				Continuous Loss Position
	for Less than 12 Months				for 12 Months or More				for Less than 12 Months
			Gross				Gross				Gross
	Estimated		Unrealized		Estimated		Unrealized		Estimated		Unrealized
	Fair Value		Losses		Fair Value		Losses		Fair Value		Losses
		(in thousands)
U.S. treasuries	$	16,973	$	(122)	$	29,379	$	(610)	$	51,095	$	(174)
Government agency securities		8,082		(59)		4,797		(53)		12,052		(23)
Corporate debt		25,980		(423)		10,766		(220)		40,035		(134)
Total	$	51,035	$	(604)	$	44,942	$	(883)	$	103,182	$	(331)

At December 31, 2021, there were no short-term investments that had been in a continuous loss position for more than 12 months.

The contractual maturities of securities classified as available-for-sale at September 30, 2022 were as follows:

	September 30, 2022
	Amortized		Estimated
	Cost		Fair Value
		(in thousands)
Due in one year or less	$	97,762	$	96,468
Due after one year through two years		5,587		5,394
Total	$	103,349	$	101,862

Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. There were no realized gains or losses, or unrealized losses from declines in fair value that are other than temporary, for the nine months ended September 30, 2022 and 2021.

14

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

Accounts Receivable

Accounts receivable is presented net of an allowance for doubtful accounts of $0.7 million at September 30, 2022 and December 31, 2021. The Company considered its current expectations of future economic conditions, including the impact of COVID-19, when estimating its allowance for doubtful accounts.

Inventories

Inventories at September 30, 2022 and December 31, 2021 consist of the following:

	September 30,		December 31,
	2022		2021
	(in thousands)
Materials	$	120,021	$	96,027
Work-in-process		61,052		54,128
Finished goods		6,664		20,703
Total	$	187,737	$	170,858

Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets primarily consist of supplier deposits, prepaid value-added tax, lease deposits, prepaid insurance, prepaid licenses, and other receivables. In addition, Veeco had deposits with its suppliers of $7.1 million and $3.9 million at September 30, 2022 and December 31, 2021, respectively.

Property, Plant, and Equipment

Property, plant, and equipment at September 30, 2022 and December 31, 2021 consist of the following:

	September 30,		December 31,
	2022		2021
	(in thousands)
Land	$	5,061	$	5,061
Building and improvements		64,198		63,946
Machinery and equipment (1)		160,365		145,656
Leasehold improvements		50,404		45,979
Gross property, plant, and equipment		280,028		260,642
Less: accumulated depreciation and amortization		171,612		160,899
Net property, plant, and equipment	$	108,416	$	99,743

(1) Machinery and equipment also includes software, furniture and fixtures

For the three and nine months ended September 30, 2022, depreciation expense was $3.8 million and $11.6 million, respectively, and $3.5 million and $10.3 million, respectively, for the comparable 2021 periods.

Goodwill

Goodwill represents the future economic benefits arising from assets acquired in a business combination that are not individually identified and separately recognized. The Company continues to assess potential triggering events related to the value of its goodwill and concluded that there were no indicators of impairment during the nine months ended September 30, 2022.

15

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

Intangible Assets

Intangible assets consist of purchased technology, customer relationships, patents, trademarks and tradenames, licenses, and backlog, and are initially recorded at fair value. Long-lived intangible assets are amortized over their estimated useful lives in a method reflecting the pattern in which the economic benefits are consumed or amortized on a straight-line basis if such pattern cannot be reliably determined. The Company continues to assess potential triggering events related to the value of its intangible assets and concluded that there were no indicators of impairment during the three and nine months ended September 30, 2022.

The components of purchased intangible assets were as follows:

	September 30, 2022						December 31, 2021
			Accumulated						Accumulated
	Gross		Amortization				Gross		Amortization
	Carrying		and		Net		Carrying		and		Net
	Amount		Impairment		Amount		Amount		Impairment		Amount
	(in thousands)
Technology	$	327,908	$	315,327	$	12,581	$	327,908	$	310,551	$	17,357
Customer relationships		146,465		134,803		11,662		146,465		132,970		13,495
Trademarks and tradenames		30,910		28,762		2,148		30,910		27,857		3,053
Other		3,686		3,686		—		3,686		3,686		—
Total	$	508,969	$	482,578	$	26,391	$	508,969	$	475,064	$	33,905

Other intangible assets primarily consist of patents, licenses, and backlog.

Note 4 — Liabilities

Accrued Expenses and Other Current Liabilities

The components of accrued expenses and other current liabilities at September 30, 2022 and December 31, 2021 consist of:

	September 30,		December 31,
	2022		2021
	(in thousands)
Payroll and related benefits	$	33,920	$	35,712
Warranty		8,716		7,878
Operating lease liabilities		3,802		4,437
Interest		2,732		2,757
Professional fees		1,865		1,467
Legal settlement		300		15,000
Sales, use, and other taxes		5,317		4,889
Other		8,410		7,612
Total	$	65,062	$	79,752

Warranty

Warranties are typically valid for one year from the date of system final acceptance. The Company estimates the costs that may be incurred under the warranty which are determined by analyzing specific product and historical configuration statistics and regional warranty support costs and are affected by product failure rates, material usage, and labor costs incurred in correcting product failures during the warranty period. Unforeseen component failures or exceptional

16

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

component performance can also result in changes to warranty costs. Changes in product warranty reserves for the nine months ended September 30, 2022 include:

		(in thousands)
Balance - December 31, 2021	$	7,878
Warranties issued		6,195
Consumption of reserves		(5,734)
Changes in estimate		377
Balance - September 30, 2022	$	8,716

Customer Deposits and Deferred Revenue

Customer deposits totaled $108.9 million and $46.9 million at September 30, 2022 and December 31, 2021, respectively. Deferred revenue represents amounts billed, other than deposits, in excess of the revenue that can be recognized on a particular contract at the balance sheet date. Changes in deferred revenue were as follows:

	(in thousands)
Balance - December 31, 2021	$	16,276
Deferral of revenue		2,908
Recognition of unearned revenue		(5,836)
Balance - September 30, 2022	$	13,348

As of September 30, 2022, the Company has approximately $142.5 million of remaining performance obligations on contracts with an original estimated duration of one year or more, of which approximately 24% is expected to be recognized within one year, with the remaining amounts expected to be recognized between one to three years. The Company has elected to exclude disclosures regarding remaining performance obligations that have an original expected duration of one year or less.

Convertible Senior Notes

2023 Notes

On January 10, 2017, the Company issued $345.0 million of 2.70% convertible senior unsecured notes due 2023 (the “2023 Notes”). The Company received net proceeds, after deducting underwriting discounts and fees and expenses payable by the Company, of approximately $335.8 million. The 2023 Notes bear interest at a rate of 2.70% per year, payable semiannually in arrears on January 15 and July 15 of each year, commencing on July 15, 2017. The 2023 Notes mature on January 15, 2023, unless earlier purchased by the Company, redeemed, or converted.

On May 18, 2020, in connection with the completion of a private offering of $125.0 million aggregate principal amount of 3.75% convertible senior notes due 2027 described below, the Company repurchased and retired approximately $88.3 million in aggregate principal amount of its outstanding 2023 Notes, with a carrying amount of $78.1 million, for approximately $81.2 million of cash.

Additionally, on November 11, 2020, the Company entered into a privately negotiated exchange agreement with a holder of its outstanding 2023 Notes, under which the Company agreed to retire $125.0 million in aggregate original principal amount of the 2023 Notes, with a carrying amount of $113.1 million, in exchange for the issuance of $132.5 million in

17

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

aggregate principal amount of new 3.50% convertible senior notes due 2025 described below, which had a fair value that approximated the principal amount of notes issued.

Finally, on November 5, 2021, the Company entered into a privately negotiated note purchase agreement with a holder of its outstanding 2023 Notes, under which the Company agreed to repurchase and retire approximately $111.5 million in aggregate original principal amount of the 2023 Notes, with a carrying amount of $105.5 million, for cash consideration of approximately $115.6 million, and approximately $1.0 million of accrued and unpaid interest.

2025 Notes

On November 17, 2020, as part of the privately negotiated exchange agreement described above, the Company issued $132.5 million of 3.50% convertible senior notes due 2025 (the “2025 Notes”). The 2025 Notes bear interest at a rate of 3.50% per year, payable semiannually in arrears on January 15 and July 15 of each year, commencing on July 15, 2021. The 2025 Notes mature on January 15, 2025, unless earlier purchased by the Company, redeemed, or converted.

2027 Notes

On May 18, 2020, the Company completed a private offering of $125.0 million of 3.75% convertible senior notes due 2027 (the “2027 Notes”). The Company received net proceeds of approximately $121.9 million, after deducting underwriting discounts and fees and expenses payable by the Company. Additionally, the Company used approximately $10.3 million of cash to purchase capped calls, discussed below. The 2027 Notes bear interest at a rate of 3.75% per year, payable semiannually in arrears on June 1 and December 1 of each year, commencing on December 1, 2020. The 2027 Notes mature on June 1, 2027, unless earlier purchased by the Company, redeemed, or converted.

The 2023 Notes, 2025 Notes, and 2027 Notes (collectively, the “Notes”) are unsecured obligations of Veeco and rank senior in right of payment to any of Veeco’s subordinated indebtedness; equal in right of payment to all of Veeco’s unsecured indebtedness that is not subordinated; effectively subordinated in right of payment to any of Veeco’s secured indebtedness to the extent of the value of the assets securing such indebtedness; and structurally subordinated to all indebtedness and other liabilities (including trade payables) of Veeco’s subsidiaries.

The Notes are convertible at the option of the holders upon the satisfaction of specified conditions and during certain periods as described below. The initial conversion rates are 24.9800, 41.6667, and 71.5372 shares of the Company’s common stock per $1,000 principal amount of the 2023 Notes, 2025 Notes, and 2027 Notes, respectively, representing initial effective conversion prices of $40.03, $24.00, and $13.98 per share of common stock, respectively. The conversion rates may be subject to adjustment upon the occurrence of certain specified events.

Holders may convert all or any portion of their notes, in multiples of one thousand dollar principal amount, at their option at any time prior to the close of business on the business day immediately preceding October 15, 2022 with respect to the 2023 Notes, October 15, 2024 with respect to the 2025 Notes, and October 1, 2026 with respect to the 2027 Notes, only under the following circumstances:

(i) During any calendar quarter (and only during such calendar quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day;

(ii) During the five consecutive business day period after any five consecutive trading day period (the “measurement period”) in which the trading price per one thousand dollar principal amount of Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of Veeco’s common stock and the conversion rate on each such trading day;

18

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

(iii) If the Company calls any or all of applicable series of the Notes for redemption at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or

(iv) Upon the occurrence of specified corporate events.

For the calendar quarter ended September 30, 2022, the last reported sales price of common stock during the 30 consecutive trading days, based on the criteria outlined in (i) above, was greater than 130% of the conversion price of the 2027 Notes, and as such the 2027 Notes are convertible by the holders until December 31, 2022.

Holders may convert their notes at any time, regardless of the foregoing circumstances, on or after October 15, 2022 with respect to the 2023 Notes, October 15, 2024 with respect to the 2025 Notes, and October 1, 2026 with respect to the 2027 Notes, until the close of business on the business day immediately preceding the respective maturity date.

Accounting for the Notes after the adoption of ASU 2020-06

The Company adopted ASU 2020-06 on January 1, 2022 as further described in Note 1, “Basis of Presentation”. Following the adoption of ASU 2020-06, the Notes are recorded as a single unit within liabilities in the consolidated balance sheets as the conversion features within the Notes are not derivatives that require bifurcation and the Notes do not involve a substantial premium. Transaction costs of $9.2 million, $1.9 million, and $3.1 million incurred in connection with the issuance of the 2023 Notes, 2025 Notes, and 2027 Notes, respectively, were recorded as direct deductions from the related debt liabilities and recognized as non-cash interest expense using the effective interest method over the expected terms of the Notes.

Accounting for the Notes prior to the adoption of ASU 2020-06

Upon conversion by the holders, the Company may elect to settle such conversion in shares of its common stock, cash, or a combination thereof. As a result of its cash conversion options, prior to the adoption of ASU 2020-06, the Company segregated the liability component of the instruments from the equity components. The liability components were measured by estimating the fair value of a non-convertible debt instrument that is similar in its terms to the Notes. The calculation of the fair value of the debt components required the use of Level 3 inputs, including utilization of convertible investors’ credit assumptions and high yield bond indices. Fair value was estimated through discounting future interest and principal payments, an income approach, due under the Notes at a discount rate equal to the estimated borrowing rate for similar non-convertible debt, or 7.0%, 8.0%, and 9.1% with respect to the 2023 Notes, 2025 Notes, and 2027 Notes, respectively. The excess of the aggregate face values of the Notes over the estimated fair values of the liability components of $72.5 million, $21.0 million, and $34.2 million with respect to the 2023 Notes, 2025 Notes, and 2027 Notes, respectively, were recognized as debt discounts and recorded as an increase to additional paid-in capital and were to be amortized over the expected lives of the Notes using the effective interest rate method. Amortization of the debt discounts were recognized as non-cash interest expense.

The transaction costs of $9.2 million, $1.9 million, and $3.1 million incurred in connection with the issuance of the 2023 Notes, 2025 Notes, and 2027 Notes, respectively, were allocated to the liability and equity components based on their relative values. Transaction costs allocated to the liability component were being amortized using the effective interest rate method and recognized as non-cash interest expense over the expected terms of the Notes. Transaction costs allocated to the equity component of $1.9 million, $0.3 million, and $0.8 million with respect to the 2023 Notes, 2025 Notes, and 2027 Notes, respectively, reduced the value of the equity components recognized in stockholders' equity.

19

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

The carrying value of the 2023 Notes, 2025 Notes and 2027 Notes are as follows:

		September 30, 2022						December 31, 2021
		Principal Amount		Unamortized transaction costs		Net carrying value		Principal Amount		Unamortized debt discount/ transaction costs		Net carrying value
		(in thousands)
2023 Notes	$	20,173	$	(29)	$	20,144	$	20,173	$	(967)	$	19,206
2025 Notes		132,500		(1,105)		131,395		132,500		(17,302)		115,198
2027 Notes		125,000		(2,123)		122,877		125,000		(29,966)		95,034
Net carrying value	$	277,673	$	(3,257)	$	274,416	$	277,673	$	(48,235)	$	229,438

Total interest expense related to the 2023 Notes, 2025 Notes and 2027 Notes is as follows:

	Three months ended September 30,				Nine months ended September 30,
	2022		2021		2022		2021
	(in thousands)
Cash Interest Expense
Coupon interest expense - 2023 Notes	$	136	$	889	$	409	$	2,667
Coupon interest expense - 2025 Notes		1,159		1,159		3,478		3,478
Coupon interest expense - 2027 Notes		1,172		1,172		3,516		3,516
Non-cash Interest Expense
Amortization of debt discount/transaction costs- 2023 Notes		24		1,417		73		4,171
Amortization of debt discount/transaction costs- 2025 Notes		115		1,211		341		3,558
Amortization of debt discount/transaction costs- 2027 Notes		103		1,035		305		3,033
Total Interest Expense	$	2,709	$	6,883	$	8,122	$	20,423

The Company determined the 2023 Notes, 2025 notes, and 2027 Notes are Level 2 liabilities in the fair value hierarchy and had an estimated fair value at September 30, 2022 of $19.5 million, $144.3, and $191.9 million, respectively.

Capped Call Transactions

In connection with the offering of the 2027 Notes, on May 13, 2020, the Company entered into privately negotiated capped call transactions (the “Capped Call Transactions”), pursuant to capped call confirmations, covering the total principal amount of the 2027 Notes for an aggregate premium of $10.3 million. The Capped Call Transactions are expected generally to reduce the potential dilution to the Company’s common stock upon any conversion of the 2027 Notes and/or offset any cash payments the Company is required to make in excess of the aggregate principal amount of converted 2027 Notes, as the case may be, with such reduction and/or offset subject to a cap based on the capped price of the Capped Call Transactions. The Capped Call Transactions exercise price is equal to the initial conversion price of the 2027 Notes, and the capped price of the Capped Call Transactions is approximately $18.46 per share and is subject to certain adjustments under the terms of the capped call confirmations.

The Capped Call Transactions are separate transactions entered into by the Company with the capped call counterparties, are not part of the terms of the 2027 Notes and do not change the holders’ rights under the 2027 Notes. Holders of the 2027 Notes do not have any rights with respect to the Capped Call Transactions. The cost of the Capped Call Transactions is not expected to be tax-deductible as the Company did not elect to integrate the Capped Call Transactions into the 2027 Notes for tax purposes. The Company used a portion of the net proceeds from the offering of the 2027

20

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

Notes to pay for the Capped Call Transactions, and the cost of the Capped Call Transactions was recorded as a reduction of the Company’s additional paid-in capital in the accompanying consolidated financial statements.

Revolving Credit Facility

On December 16, 2021, the Company entered into a loan and security agreement providing for a senior secured revolving credit facility in an aggregate principal amount of $150 million (the “Credit Facility”), including a $15 million letter of credit sublimit. The Credit Facility is guaranteed by the Company’s direct material U.S. subsidiaries, subject to customary exceptions. Borrowings under the Credit Facility are secured by a first-priority lien on substantially all of the assets of the Company, subject to customary exceptions. The Credit Facility has a term of five years, maturing on December 16, 2026, or earlier if certain liquidity measures are not met prior to the 2025 Notes maturing. Subject to certain conditions and the receipt of commitments from the lenders, the Loan and Security Agreement allows for revolving commitments under the Credit Facility to be increased by up to $75 million. The existing lenders under the Credit Facility are entitled, but not obligated, to provide such incremental commitments.

Borrowings will bear interest at a floating rate which can be, at the Company’s option, either (a) an alternate base rate plus an applicable rate ranging from 0.50% to 1.25% or (b) a Secured Overnight Financing Rate (“SOFR”) (with a floor of 0.00%) for the specified interest period plus an applicable rate ranging from 1.50% to 2.25%, in each case, depending on the Company’s Secured Net Leverage Ratio (as defined in the Loan and Security Agreement). The Company will pay an unused commitment fee ranging from 0.25% to 0.35% based on unused capacity under the Credit Facility and the Company’s Secured Net Leverage Ratio. The Company may use the proceeds of borrowings under the Credit Facility to pay transaction fees and expenses, provide for its working capital needs and reimburse drawings under letters of credit and for other general corporate purposes.

The Loan and Security Agreement contains customary affirmative covenants for transactions of this type, including, among others, the provision of financial and other information to the administrative agent, notice to the administrative agent upon the occurrence of certain material events, preservation of existence, maintenance of properties and insurance, compliance with laws, including environmental laws, the provision of additional guarantees, and an affiliate transactions covenant, subject to certain exceptions. The Loan and Security Agreement contains customary negative covenants, including, among others, restrictions on the ability to merge and consolidate with other companies, incur indebtedness, refinance our existing convertible notes, grant liens or security interests on assets, make investments, acquisitions, loans, or advances, pay dividends, and sell or otherwise transfer assets.

The Loan and Security Agreement contains financial maintenance covenants that require the Borrower to maintain an Interest Coverage Ratio (as defined in the Loan and Security Agreement) of not less than 3.00 to 1.00, a Total Net Leverage Ratio (as defined in the Loan and Security Agreement) of not more than 4.50 to 1.00, and a Secured Net Leverage Ratio (as defined in the Loan and Security Agreement) of not more than 2.50 to 1.00, in each case, tested at the end of each fiscal quarter commencing with the fiscal quarter ending June 30, 2022. The Loan and Security Agreement also provides for a number of customary events of default, including, among others: payment defaults to the lenders; voluntary and involuntary bankruptcy proceedings; covenant defaults; material inaccuracies of representations and warranties; certain change of control events; material money judgments; and other customary events of default. The occurrence of an event of default could result in the acceleration of obligations and the termination of lending commitments under the Loan and Security Agreement.

No amounts were outstanding under the Credit Facility as of September 30, 2022 or December 31, 2021.

Other Liabilities

Other liabilities at September 30, 2022 and December 31, 2021 included (i) medical and dental benefits for former executives of $1.8 million; (ii) asset retirement obligations of $2.8 million; and (iii) income tax payables of $0.4 million.

21

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

Note 5 — Commitments and Contingencies

Leases

The Company’s operating leases primarily include real estate leases for properties used for manufacturing, R&D activities, sales and service, and administration, as well as certain equipment leases. Some leases may include options to renew for a period of up to 5 years, while others may include options to terminate the lease. The weighted average remaining lease term of the Company’s operating leases as of September 30, 2022 was 12 years, and the weighted average discount rate used in determining the present value of future lease payments was 5.6%.

The following table provides the maturities of lease liabilities at September 30, 2022:

	Operating
	Leases
	(in thousands)
Payments due by period:
2022	$	952
2023		4,097
2024		3,877
2025		3,292
2026		3,480
Thereafter		35,961
Total future minimum lease payments		51,659
Less: Imputed interest		(16,591)
Total	$	35,068
Reported as of September 30, 2022
Accrued expenses and other current liabilities	$	3,802
Long-term operating lease liabilities		31,266
Total	$	35,068

Operating lease cost for the three and nine months ended September 30, 2022 were $1.8 million and $5.5 million, respectively, and $1.8 million and $4.8 million, respectively, for the comparable 2021 periods. Variable lease cost for the three and nine months ended September 30, 2022 were $0.5 million and $1.5 million, respectively, and $0.4 million and $1.3 million, respectively, for the comparable 2021 periods. Additionally, the Company has an immaterial amount of short-term leases. Operating cash outflows from operating leases for the nine months ended September 30, 2022 and 2021 were $5.7 million and $4.9 million, respectively.

Receivable Purchase Agreement

In December 2020, the Company entered into a receivable purchase agreement with a financial institution to sell certain of its trade receivables from customers without recourse, up to $15.0 million at any point in time. Pursuant to this agreement, the Company sold $7.8 million of receivables during the three months ended September 30, 2022, all of which was outstanding at September 30, 2022 as defined in the receivable purchase agreement, and $7.2 million was available under the agreement for additional sales of receivables. The Company did not sell any receivables under this agreement for the nine months ended September 30, 2021. The net sale of accounts receivable under the agreement is reflected as a reduction of accounts receivable in the Company’s Consolidated Balance Sheet at the time of sale and any fees for the sale of trade receivables were not material for the periods presented.

22

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

Purchase Commitments

Veeco has purchase commitments of $299.4 million at September 30, 2022, substantially all of which become due within one year.

Bank Guarantees

Veeco has bank guarantees and letters of credit issued by a financial institution on its behalf as needed. At September 30, 2022, outstanding bank guarantees and standby letters of credit totaled $7.0 million, and unused bank guarantees and letters of credit of $14.7 million were available to be drawn upon.

Legal Proceedings

On June 8, 2018, an Ultratech shareholder who received Veeco stock as part of the consideration for the Ultratech acquisition filed a purported class action complaint in the Superior Court of the State of California, County of Santa Clara, captioned Wolther v. Maheshwari et al., Case No. 18CV329690, on behalf of himself and others who purchased or acquired shares of Veeco pursuant to the registration statement and prospectus which Veeco filed with the SEC in connection with the Ultratech acquisition (the “Wolther Action”). On August 2 and August 8, 2018, two purported class action complaints substantially similar to the Wolther Action were filed on behalf of different plaintiffs in the same court as the Wolther Action. These cases have been consolidated with the Wolther Action, and a consolidated complaint was filed on December 11, 2018. The consolidated complaint seeks to recover damages and fees under Sections 11, 12, and 15 of the Securities Act of 1933 for, among other things, alleged false/misleading statements in the registration statement and prospectus relating to the Ultratech acquisition, relating primarily to the alleged failure to disclose delays in the advanced packaging business, increased metal organic chemical vapor deposition (“MOCVD”) competition in China, and an intellectual property dispute. In October 2021, Veeco and the court-appointed class representatives signed an agreement to settle the Wolther Action on a class-wide basis for $15.0 million, subject to court approval and class members’ opportunity to object and opt-out. On June 27, 2022, the court granted final approval to the class action settlement. The settlement amount has been funded by insurance carriers. The corresponding receivable and liability had been included within “Prepaid expenses and other current assets” and “Accrued expenses and other current liabilities”, respectively, in the Consolidated Balance Sheets as of December 31, 2021.

On December 21, 2018, a purported Veeco stockholder filed a derivative action in the Superior Court of the State of California, County of Santa Clara, captioned Vladimir Gusinsky Revocable Trust v. Peeler, et al., Case No. 18CV339925, on behalf of nominal defendant Veeco (the “Derivative Action”). The complaint seeks to assert claims for breach of fiduciary duty, waste of corporate assets, and unjust enrichment against current and former Veeco directors premised on purported misstatements and omissions in the registration statement relating to the Ultratech acquisition. On January 25, 2021, the court granted the defendants’ demurrer without leave to amend effecting the dismissal of the case. On March 26, 2021, plaintiff filed its notice of appeal of the trial court’s order granting defendants’ demurrer without leave to amend. In April 2022, Veeco and plaintiff reached an agreement to settle the Derivative Action subject to court approval. As part of the settlement and subject to court approval, Veeco will make certain revisions to its internal Disclosure Committee Charter and its director education program. The agreement also provides that, subject to court approval, plaintiff will receive $0.3 million for fees and expenses. This amount will be funded by insurance that Veeco maintains in the normal course of its business. On September 12, 2022, the court issued an order granting preliminary approval of the proposed settlement (the “Preliminary Approval Order”). The Preliminary Approval Order set the final settlement approval hearing for November 17, 2022.

The Company is involved in various other legal proceedings arising in the normal course of business. The Company does not believe that the ultimate resolution of these matters will have a material adverse effect on its consolidated financial position, results of operations, or cash flows.

23

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

Note 6 — Derivative Financial Instruments

The Company is exposed to financial market risks arising from changes in currency exchange rates. Changes in currency exchange rates could affect the Company’s foreign currency denominated monetary assets and liabilities and forecasted cash flows. The Company enters into monthly forward derivative contracts from time to time with the intent of mitigating a portion of this risk. The Company only uses derivative financial instruments in the context of hedging and not for speculative purposes and had not designated its foreign exchange derivatives as hedges. Accordingly, changes in fair value from these contracts are recorded as “Other operating expense (income), net” in the Company’s Consolidated Statements of Operations. The Company executes derivative transactions with highly rated financial institutions to mitigate counterparty risk.

The Company did not have any outstanding derivative contracts at September 30, 2022 or December 31, 2021. Additionally, the Company did not have any gains or losses from currency exchange derivatives during the nine months ended September 30, 2022 and 2021.

24

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

Note 7 — Equity

Statement of Stockholders’ Equity

The following tables present the changes in Stockholders’ Equity:

								Accumulated
				Additional				Other
	Common Stock			Paid-in		Accumulated		Comprehensive
	Shares	Amount		Capital		Deficit		Income		Total
	(in thousands)
Balance at December 31, 2021	50,653	$	507	$	1,116,921	$	(681,283)	$	1,483	$	437,628
Cumulative effect of change in accounting principle - adoption of ASU 2020-06	—		—		(56,801)		12,541		—		(44,260)
Net income	—		—		—		13,330		—		13,330
Other comprehensive income (loss), net of tax	—		—		—		—		(822)		(822)
Share-based compensation expense	—		—		4,481		—		—		4,481
Net issuance under employee stock plans	590		6		(6,793)		—		—		(6,787)
Balance at March 31, 2022	51,243	$	513	$	1,057,808	$	(655,412)	$	661	$	403,570
Net income	—		—		—		9,655		—		9,655
Other comprehensive income (loss), net of tax	—		—		—		—		(272)		(272)
Share-based compensation expense	—		—		6,278		—		—		6,278
Net issuance under employee stock plans	182		2		1,504		—		—		1,506
Balance at June 30, 2022	51,425	$	515	$	1,065,590	$	(645,757)	$	389	$	420,737
Net income (loss)	—		—		—		15,041		—		15,041
Other comprehensive income (loss), net of tax	—		—		—		—		(170)		(170)
Share-based compensation expense	—		—		6,210		—		—		6,210
Net issuance under employee stock plans	(5)		—		(703)		—		—		(703)
Balance at September 30, 2022	51,420	$	515	$	1,071,097	$	(630,716)	$	219	$	441,115

								Accumulated
				Additional				Other
	Common Stock			Paid-in		Accumulated		Comprehensive
	Shares	Amount		Capital		Deficit		Income		Total
	(in thousands)
Balance at December 31, 2020	49,724	$	497	$	1,113,352	$	(707,321)	$	1,846	$	408,374
Net income	—		—		—		2,494		—		2,494
Other comprehensive income (loss), net of tax	—		—		—		—		(19)		(19)
Share-based compensation expense	—		—		3,237		—		—		3,237
Net issuance under employee stock plans	459		5		(1,630)		—		—		(1,625)
Balance at March 31, 2021	50,183	$	502	$	1,114,959	$	(704,827)	$	1,827	$	412,461
Net income	—		—		—		6,348		—		6,348
Other comprehensive income (loss), net of tax	—		—		—		—		(24)		(24)
Share-based compensation expense	—		—		4,367		—		—		4,367
Net issuance under employee stock plans	166		1		582		—		—		583
Balance at June 30, 2021	50,349	$	503	$	1,119,908	$	(698,479)	$	1,803	$	423,735
Net income (loss)	—		—		—		8,993		—		8,993
Other comprehensive income (loss), net of tax	—		—		—		—		(33)		(33)
Share-based compensation expense	—		—		4,131		—		—		4,131
Net issuance under employee stock plans	(28)		—		(1,513)		—		—		(1,513)
Balance at September 30, 2021	50,321	$	503	$	1,122,526	$	(689,486)	$	1,770	$	435,313

25

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

Accumulated Other Comprehensive Income (“AOCI”)

The following table presents the changes in the balances of each component of AOCI, net of tax:

			Unrealized
			Gains (Losses)
	Foreign		on Available
	Currency		for Sale
	Translation		Securities		Total
	(in thousands)
Balance - December 31, 2021	$	1,814	$	(331)	$	1,483
Other comprehensive income (loss)		(108)		(1,156)		(1,264)
Balance - September 30, 2022	$	1,706	$	(1,487)	$	219

There were minimal reclassifications from AOCI into net income for the three and nine months ended September 30, 2022 and 2021.

Note 8 — Share-based Compensation

Restricted share awards are issued to employees and board of directors that are subject to specified restrictions and a risk of forfeiture. The restrictions typically lapse over one to four years and may entitle holders to dividends and voting rights. Other types of share-based compensation include performance share awards, performance share units, and restricted share units (collectively with restricted share awards, “restricted shares”), as well as options to purchase common stock.

Share-based compensation expense was recognized in the following line items in the Consolidated Statements of Operations for the three and nine months ended September 30, 2022 and 2021:

	Three months ended September 30,				Nine months ended September 30,
	2022		2021		2022		2021
	(in thousands)
Cost of sales	$	1,195	$	620	$	3,384	$	1,765
Research and development		1,819		1,007		4,939		2,957
Selling, general, and administrative		3,196		2,504		8,646		7,013
Total	$	6,210	$	4,131	$	16,969	$	11,735

For the nine months ended September 30, 2022, equity activity related to stock options was as follows:

		Weighted
	Number of	Average
	Shares	Exercise Price
	(in thousands)
Balance - December 31, 2021	443	$	32.15
Expired	(266)		32.95
Balance - September 30, 2022	177		30.94

26

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

For the nine months ended September 30, 2022, equity activity related to non-vested restricted shares and performance shares was as follows:

		Weighted
		Average
	Number of	Grant Date
	Shares	Fair Value
	(in thousands)
Balance - December 31, 2021	2,083	$	17.33
Granted	1,060		30.84
Performance award adjustments	85		14.03
Vested	(787)		15.21
Forfeited	(73)		19.85
Balance - September 30, 2022	2,368		23.88

Note 9 — Income Taxes

Income taxes are estimated for each of the jurisdictions in which the Company operates. Deferred income taxes reflect the net tax effect of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes, as well as the tax effect of carryforwards. Realization of net deferred tax assets is dependent on future taxable income. At September 30, 2022, the Company’s U.S. deferred tax assets are fully offset by a valuation allowance since the Company cannot conclude that it is more likely than not that these future benefits will be realized. The Company will maintain this valuation allowance until there is sufficient positive evidence to support its reversal. The Company believes there is a reasonable possibility within the next twelve months that sufficient positive evidence may become available to allow management to reach a conclusion that a significant portion of the valuation allowance will no longer be needed. Release of the valuation allowance would result in the recognition of certain deferred tax assets with a corresponding decrease to income tax expense for the period the release is recorded. Additionally, if the valuation allowance is released and the Company continues to earn profits, the Company’s effective tax rate would likely increase in future periods compared to its current rates.

At the end of each interim reporting period, the effective tax rate is aligned with expectations for the full year. This estimate is used to determine the income tax provision on a year-to-date basis and may change in subsequent interim periods.

Income before income taxes and income tax expense (benefit) for the three and nine months ended September 30, 2022 and 2021 were as follows:

	Three months ended September 30,				Nine months ended September 30,
	2022		2021		2022		2021
	(in thousands)
Income before income taxes	$	15,249	$	9,404	$	39,151	$	18,864
Income tax expense (benefit)	$	208	$	411	$	1,125	$	1,029

The Company’s tax expense for the three months ended September 30, 2022 was $0.2 million, compared to $0.4 million for the comparable prior period. The 2022 tax expense included an expense of $0.1 million related to the Company’s non-U.S. operations and $0.1 million related to the Company’s domestic operations. The 2021 tax expense included an expense of $0.4 million related to the Company’s non-U.S. operations and minimal expense related to the Company’s domestic operations. For the three months ended September 30, 2022 and 2021, the Company’s U.S. deferred tax assets are fully offset by a valuation allowance since the Company cannot conclude that it is more likely than not that these future benefits will be realized. The domestic tax expense for both periods is primarily attributable to state income taxes and the tax amortization of indefinite lived intangible assets that is not available to offset U.S. deferred tax assets. The

27

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

foreign tax expense for both periods is primarily attributable to non-US operations profits and foreign withholding taxes on unremitted earnings, offset by the amortization of intangible assets.

The Company’s tax expense for the nine months ended September 30, 2022 was $1.1 million, compared to $1.0 million for the comparable prior period. The 2022 tax expense included an expense of $0.8 million related to the Company’s non-U.S. operations and $0.3 million related to the Company’s domestic operations. The 2021 tax expense included an expense of $0.8 million related to the Company’s non-U.S. operations and $0.2 million related to the Company’s domestic operations. For the nine months ended September 30, 2022 and 2021, the Company’s U.S. deferred tax assets are fully offset by a valuation allowance since the Company cannot conclude that it is more likely than not that these future benefits will be realized. The domestic tax expense for both periods is primarily attributable to state income taxes and the tax amortization of indefinite lived intangible assets that is not available to offset U.S. deferred tax assets. The foreign tax expense for both periods is primarily attributable to non-US operations profits and foreign withholding taxes on unremitted earnings, offset by the amortization of intangible assets.

Inflation Reduction Act and CHIP Act

The Inflation Reduction Act of 2022 (the “IRA Act”) was signed into U.S. law on August 16, 2022. The Act includes various tax provisions, including an excise tax on stock repurchases, expanded tax credits for clean energy incentives, and a corporate alternative minimum tax that generally applies to U.S. corporations with average adjusted financial statement income over a three year period in excess of $1 billion. The Company does not expect the IRA Act to materially impact its financial statements.

The CHIPS and Science Act of 2022 (the “CHIP Act”) was signed into U.S. law on August 9, 2022. The Act includes a 25% advanced investment tax credit for certain investments in semiconductor manufacturing. While the Company is still evaluating the impact of this act, the CHIP Act may benefit the Company for qualified investments placed in service after December 31, 2022.

Note 10 — Segment Reporting and Geographic Information

Veeco operates and measures its results in one operating segment and therefore has one reportable segment: the development, manufacture, sales, and support of semiconductor and thin film process equipment primarily sold to make electronic devices.

Veeco serves the following four end-markets:

Semiconductor

The Semiconductor market refers to early process steps in logic and memory applications where silicon wafers are processed. There are many different process steps in forming patterned wafers, such as deposition, etching, masking, and doping, where the microchips are created but remain on the silicon wafer. This market includes mask blank production for extreme ultraviolet (“EUV”) lithography. This market also includes Advanced Packaging which refers to a portfolio of wafer-level assembly technologies that enable improved performance of electronic products, such as smartphones, high-end servers, and graphical processors.

Compound Semiconductor

The Compound Semiconductor market includes Photonics, Power Electronics, RF Filters and Amplifiers, and Solar applications. Photonics refers to light source technologies and laser-based solutions for 3D sensing, datacom and telecom applications. This includes micro-LED, laser diodes, edge emitting lasers and vertical cavity surface emitting lasers (“VCSELs”). Power Electronics refers to semiconductor devices such as rectifiers, inverters and converters for the

28

Veeco Instruments Inc. and Subsidiaries

Notes to the Consolidated Financial Statements - continued

(unaudited)

control and conversion of electric power in applications such as fast or wireless charging of consumer electronics and automotive applications. RF power amplifiers and filters (including surface acoustic wave (“SAW”) and bulk acoustic wave (“BAW”) filters) are used in 5G communications infrastructure, smartphones, tablets, and mobile devices. They make use of radio waves for wireless broadcasting and/or communications. Solar refers to power obtained by harnessing the energy of the sun through the use of compound semiconductor devices such as photovoltaics.

Data Storage

Data Storage refers to the Hard Disk Drive (“HDD”) market, for which our systems enable customers to manufacture thin film magnetic heads for hard disk drives as part of large capacity storage applications.

Scientific & Other

Scientific & Other refers to advanced materials research and a range of manufacturing applications including optical coatings (laser mirrors, optical filters, and anti-reflective coatings).

Sales by end-market and geographic region for the three and nine months ended September 30, 2022 and 2021 were as follows:

	Three months ended September 30,				Nine months ended September 30,
	2022		2021		2022		2021
	(in thousands)
Sales by end-market
Semiconductor	$	100,387	$	76,320	$	275,528	$	181,641
Compound Semiconductor		28,094		23,273		96,325		72,255
Data Storage		27,702		39,256		70,845		132,261
Scientific & Other		15,730		11,397		49,640		44,148
Total	$	171,913	$	150,246	$	492,338	$	430,305
Sales by geographic region
United States	$	53,747	$	48,776	$	159,157	$	160,908
EMEA(1)		17,562		13,564		66,221		36,128
China		36,193		27,261		95,071		68,148
Rest of APAC		64,259		60,589		170,526		164,926
Rest of World		152		56		1,363		195
Total	$	171,913	$	150,246	$	492,338	$	430,305

(1) EMEA consists of Europe, the Middle East, and Africa

For geographic reporting, sales are attributed to the location in which the customer facility is located.

29

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Cautionary Statement Regarding Forward Looking Statements

Our discussion below constitutes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. When used in this Report, the words “believes,” “anticipates,” “expects,” “estimates,” “targets,” “plans,” “intends,” “will,” and similar expressions related to the future are intended to identify forward-looking statements. All forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from projected results. You should not place undue reliance on any forward-looking statements, which speak only as of the dates they are made.

Executive Summary

We are an innovative manufacturer of semiconductor process equipment. Our proven ion beam, laser annealing, lithography, MOCVD and single wafer etch & clean technologies play an integral role in the fabrication and packaging of advanced semiconductor devices. With equipment designed to optimize performance, yield and cost of ownership, Veeco holds leading technology positions in the markets we serve. To learn more about Veeco’s systems and service offerings, visit www.veeco.com.

COVID-19 Update and Attendant Challenges

As a result of the continued COVID-19 pandemic, governmental authorities and businesses continue to implement numerous and constantly evolving measures to limit the spread of the virus, such as travel bans and restrictions, limits on gatherings, quarantines, shelter-in-place orders, vaccine mandates, and business shutdowns. We have important sales, manufacturing, and support operations in the U.S. and Singapore, and sales and support operations in China, Germany, Japan, Malaysia, Philippines, Singapore, South Korea, Thailand, Taiwan and the United Kingdom, all of which continue to be affected by the COVID-19 pandemic.

Our operations are considered part of the critical and essential infrastructure defined by applicable government authorities, and, although governmental measures to contain the pandemic may be modified or extended, our manufacturing facilities remain open. We believe our diverse product offerings and the critical nature of certain of our products for infrastructure continue to insulate us, to some extent, from the ongoing adverse effects of the pandemic; however, a prolonged economic downturn will adversely affect our customers, which could have a material adverse effect on our revenues, particularly if customers from whom we derive a significant amount of revenue reduce or delay purchases to mitigate the impacts of the pandemic or fail to make payments to us on time or at all.

We serve a global and highly interconnected customer base across the Asia-Pacific region, Europe, and North America. Our net sales to customers located outside of the United States represented approximately 68% of our total net sales for the nine months ended September 30, 2022, and 62% and 68% for the years ended December 31, 2021 and 2020, respectively, and we expect that net sales to customers outside the United States will continue to represent a significant percentage of our total net sales. As a result, our business will be adversely impacted by further deterioration in global economic conditions, particularly in markets in Asia and Europe.

We are also seeing the effects of the macroeconomic inflationary cost environment and supply chain disruptions due to strained transportation capacity, labor shortages, high global demand and other factors. These effects include longer lead times and increased costs. We are taking proactive steps to manage the impact on our business, including buying in advance and re-sourcing components on a more frequent basis. We continue to monitor our global supply chain and may experience additional disruptions in future periods, which could cause continued challenges in our ability to obtain raw materials or components required to manufacture our products.

Like many in our industry, we are managing through the effects of the COVID-19 pandemic. Although the full extent of the COVID-19 pandemic’s impact on our business, results of operations, supply chain, and growth is not yet known, we proactively identified potential challenges to our business and have been executing business continuity activities to manage disruptions in our business and continue to provide critical infrastructure to our customers. In response to the

30

pandemic, we have taken the following steps, among others, to keep our employees safe, minimize the spread of the virus, and serve our customers:

● maintain flexible health and safety protocols in response to local circumstances at our manufacturing facilities, including extensively and frequently disinfecting our facilities and providing protective equipment;

● continue remote working arrangements for employees that do not need to be physically present on the manufacturing floor or at customer facilities;

● implement virtual meetings, customer demos, and factory acceptances where feasible to enable customers to review data and performance of their system in our factory remotely via live video;

● perform service and support activities remotely where feasible to resolve customer issues and enable our customers to maintain their operations;

● proactively identify gaps in our supply chain and re-source components in order to maintain our customer shipment commitments and mitigate single points of failure;

● monitor our IT systems and implementing contingency and disaster recovery plans to support our IT infrastructure to ensure that our systems remain continuously operative; and

● continue to monitor and, if necessary, reduce our operating expenses and capital expenditures to maintain financial flexibility and profit margins.

While these steps have been effective so far, there could be additional challenges ahead that may impact either our operations or those of our customers, which could have a negative effect on our financial performance, including productivity and capacity impacts as a result of the ongoing pandemic. We expect these measures to continue until we determine that the COVID-19 pandemic is adequately contained for the purposes of our business, and we may take further actions as government authorities require or recommend or as we determine to be in the best interests of our employees, customers and suppliers. As a result, we may incur additional expenses in future periods in response to the pandemic, which could adversely affect our financial position, results of operations, or cash flows. In addition, we may revise our approach to these initiatives or take additional actions to meet the needs of our employees and customers, and mitigate the impact of the pandemic on our business.

Business Update

Macroeconomic challenges across the industry have been well publicized, including supply chain constraints, an inflationary environment with a potential recession ahead, and new China-export regulations, all of which are contributing to a difficult environment with increased uncertainty.

Longer lead times and parts shortages and allocations have required that we plan further ahead than usual, and we have undertaken efforts to increase our purchase commitments to secure critical components in a timely manner. While we have been able to meet our financial targets and fulfill our customers’ most critical demands, material lead times continue to be a challenge with respect to our supply chain, limiting our ability to fulfill some of our customers’ demands in a timely manner, as many of our peers have also been experiencing. We are also experiencing increasing labor, logistics, and material costs, creating additional gross margin pressures. We expect supply shortages and related challenges to persist throughout the remainder of the year and into 2023, and we continue to monitor our supply chain and work with our suppliers to identify and mitigate potential gaps in an effort to ensure continuity of supply. Additionally, we have seen a slow down in our book and turn business, as well as instances where customers have requested order cancellations, delayed shipments, or delayed payments. Consequently, we are monitoring the situation very closely and balancing the risk associated with macro-economic uncertainty and the investments we are making to maintain our growth trajectory. 

31

Furthermore, the US Department of Commerce, Bureau of Industry and Security (“BIS”), recently issued new China-export regulations which have broadened the requirements under which export licenses will be required. Notably, semiconductor equipment sold to factories in China manufacturing logic devices at or below 16/14nm, DRAM at or below 18nm ½ pitch, or NAND at or above 128 layers, will require export licenses, as will US persons supporting these operations, with a presumption of denial. In addition, a new export classification code – 3B090 – has been created for certain deposition equipment, for which licenses will now be required for sale into China (again with a presumption of denial). Furthermore, certain China-based companies have been added to the BIS Unverified List, and changes have been made to the BIS Entity List, further restricting sales to the named entities. Recent order activity has led to significant backlog in China, which may be subject to these regulations. While the export regulation landscape is fluid and evolving, we believe at this time that the substantial majority of this backlog will not be negatively affected by the new regulations.

While we work to overcome these macroeconomic challenges, we continue to serve our customers in the following four end-markets: Semiconductor; Compound Semiconductor; Data Storage; and Scientific & Other. We are seeing the following trends in each of these markets as follows:

Sales in the Semiconductor market grew both from the prior quarter and from the year ago quarter, driven by our laser annealing systems for logic devices, lithography systems for Advanced Packaging, and our ion beam deposition system for EUV mask blank production. We continue to build momentum for our laser annealing solutions with advanced node logic customers. We are innovating and have been working with DRAM manufacturers and existing logic customers on their next manufacturing nodes. Demand for our laser annealing systems is increasingly coming from trailing node customers primarily in China, in addition to advanced node customers. Our lithography systems for Advanced Packaging are aligned with longer-term growth of FOWLP and other Advanced Packaging applications. Order activity has slowed in the third quarter; however, we continue to view our Advanced Packaging lithography product line as a key enabler for our customers as they seek to improve device performance. Additionally, the ongoing adoption of EUV Lithography for advanced node, semiconductor manufacturing continues to drive demand for our mask blank systems. Overall, our technology and market strategy are well aligned with trends such as artificial intelligence, mobile connectivity and high-performance computing that drive the Semiconductor market.

We address the Compound Semiconductor market with a broad portfolio of technologies including Wet Processing and MOCVD, along with MBE and Ion Beam, all of which have been developed to support emerging applications such as 5G driven RF device/filter manufacturing, Gallium Nitride power electronics, and photonics applications including edge-emitting lasers and micro-LEDs. Sales in the Compound Semiconductor market decreased from the prior quarter but increased from the year ago quarter, as we shipped systems for photonics and RF Device applications.

After a multi-year period of growth, and based on reduced order activity in 2021, Data Storage performance in 2022 is playing out as we expected as customers slow the pace of capacity additions. In the Data Storage market, the mix of hard disk drive shipments for PCs, servers and cloud datacenters has been transitioning for some time. Overall number of drives shipping has been declining in the consumer markets, but in the growing enterprise markets, the capacity and number of magnetic heads per hard drive has been increasing, in response to a 30% growth rate in data stored each year in cloud and datacenter applications. In fact, the absolute number of heads shipped has been steadily increasing for years and is forecasted to continue to increase. In addition, complexity of heads has been increasing and is expected to continue to increase as disk drive makers advance their technology roadmaps. Veeco’s ion beam equipment is used to manufacture our customers magnetic heads and based on the aforementioned industry dynamics, we believe the Data Storage market will provide growth over the long term. In fact, based on strong order activity with customers today, absent a shift in market dynamics including customer cancellations or delays, we expect 2023 Data Storage revenue to meaningfully grow over 2022.

Sales in the Scientific & Other market are largely driven by sales to governments, universities, and research institutions. Revenue increased both from the prior quarter and the year ago quarter, consistent with near term strength we are seeing from pent-up demand in the research market. We expect long-term growth to be in line with GDP.

Finally, our growth strategy includes placing evaluation systems with select customers in the Semiconductor and Compound Semiconductor markets. These customer evaluations have been performing well, and this evaluation program

32

will continue to be a focus as we execute on our growth strategy. In the near term, given our backlog, along with our customer engagements and order activity, we continue to expect revenue growth in 2022, despite the ongoing macroeconomic challenges.

Results of Operations

For the three months ended September 30, 2022 and 2021

The following table presents revenue and expense line items reported in our Consolidated Statements of Operations for the indicated periods in 2022 and 2021 and the period-over-period dollar and percentage changes for those line items. Our results of operations are reported as one business segment, represented by our single operating segment.

	Three Months Ended September 30,						Change
	2022			2021			Period to Period
	(dollars in thousands)
Net sales	$	171,913	100%	$	150,246	100%	$	21,667	14%
Cost of sales		101,962	59%		87,077	58%		14,885	17%
Gross profit		69,951	41%		63,169	42%		6,782	11%
Operating expenses, net:
Research and development		27,104	16%		21,999	15%		5,105	23%
Selling, general, and administrative		22,144	13%		21,603	14%		541	3%
Amortization of intangible assets		2,505	1%		2,976	2%		(471)	(16)%
Other operating expense (income), net		634	-		175	-		459	*
Total operating expenses, net		52,387	30%		46,753	31%		5,634	12%
Operating income		17,564	10%		16,416	11%		1,148	7%
Interest income (expense), net		(2,315)	(1)%		(7,012)	(5)%		4,697	(67)%
Income before income taxes		15,249	9%		9,404	6%		5,845	62%
Income tax expense (benefit)		208	-		411	-		(203)	(49)%
Net income	$	15,041	9%	$	8,993	6%	$	6,048	67%

* Not meaningful

Net Sales

The following is an analysis of sales by market and by region:

	Three Months Ended September 30,						Change
	2022			2021			Period to Period
	(dollars in thousands)
Sales by end-market
Semiconductor	$	100,387	59%	$	76,320	51%	$	24,067	32%
Compound Semiconductor		28,094	16%		23,273	15%		4,821	21%
Data Storage		27,702	16%		39,256	26%		(11,554)	(29)%
Scientific & Other		15,730	9%		11,397	8%		4,333	38%
Total	$	171,913	100%	$	150,246	100%	$	21,667	14%
Sales by geographic region
United States	$	53,747	31%	$	48,776	33%	$	4,971	10%
EMEA		17,562	10%		13,564	9%		3,998	29%
China		36,193	21%		27,261	18%		8,932	33%
Rest of APAC		64,259	38%		60,589	40%		3,670	6%
Rest of World		152	-		56	-		96	*
Total	$	171,913	100%	$	150,246	100%	$	21,667	14%

* Not meaningful

33

Sales increased for the three months ended September 30, 2022 against the comparable prior year period in the Semiconductor, Compound Semiconductor, and Scientific & Other markets, partially offset by a decline in the Data Storage market. By geography, sales increased across all regions. Sales in the Rest of APAC region for the three months ended September 30, 2022 included sales in Taiwan, Japan, and Singapore of $34.0 million, $12.3 million, and $8.9 million, respectively. Sales in the Rest of APAC region for the three months ended September 30, 2021 included sales in Taiwan, South Korea, and Japan of $19.2 million, $14.3 million, and $13.7 million, respectively. We expect there will continue to be year-to-year variations in our future sales distribution across markets and geographies. In light of the global nature of our business, we are impacted by conditions in the various countries in which we and our customers operate.

Gross Profit

For the three months ended September 30, 2022, gross profit increased against the comparable prior period primarily due to an increase in sales volume, partially offset by a decrease in gross margins. Gross margins decreased principally due to increased logistics costs, as well as an increase in spending as we invested in service infrastructure and capacity expansion to meet the growing demands for our semiconductor product lines. We expect our gross margins to fluctuate each period due to product mix and other factors.

Research and Development

The markets we serve are characterized by continuous technological development and product innovation, and we invest in various research and development initiatives to maintain our competitive advantage and achieve our growth objectives. Research and development expenses increased for the three months ended September 30, 2022 against the comparable prior period primarily due to personnel-related expenses as we invest in new research and development and additional applications for our technology in order to be well-positioned to capitalize on emerging global megatrends and support longer term growth in Semiconductor and Compound Semiconductor markets.

Selling, General, and Administrative

Selling, general, and administrative expenses increased for the three months ended September 30, 2022 against the comparable prior period primarily due to higher variable expenses associated with the increase in revenue, profitability, and order in-take. However, expenses as a percentage of revenue have decreased when compared to the prior year period. Given the uncertainty regarding the impacts on our business resulting from the COVID-19 pandemic, we are focused on the proactive management of expenses. In future periods, we may incur additional selling, general and administrative expenses to support our responses to the COVID-19 pandemic. In addition, we are currently experiencing duplicate operating expenses for the transition from our existing facility in San Jose, California to our new leased facility, and will continue to do so until this transition is completed.

Amortization Expense

Amortization expense decreased compared to the comparable prior year period primarily due to changes in amortization expense to reflect expected cash flows of certain intangible assets, as well as certain other intangible assets becoming fully amortized in 2021.

Interest Income (Expense)

We recorded net interest expense of $2.3 million for the three months ended September 30, 2022, compared to $7.0 million for the comparable prior year period. The decrease in interest expense was primarily related to the adoption of ASU 2020-06, as non-cash charges related to the amortization of debt discount and transaction costs of the 2023 Notes, 2025 Notes, and 2027 Notes decreased approximately $3.4 million for the three months ended September 30, 2022 against the comparable prior period. Additionally, cash interest expense on the Notes decreased approximately $0.8 million from the comparable prior period due to the partial repurchase of the 2023 Notes in November 2021.

34

Income Taxes

At the end of each interim reporting period, we estimate the effective income tax rate expected to be applicable for the full year. This estimate is used to determine the income tax provision or benefit on a year-to-date basis and may change in subsequent interim periods.

Our tax expense for the three months ended September 30, 2022 was $0.2 million, compared to $0.4 million for the comparable prior year period. The 2022 tax expense included an expense of $0.1 million related to our non-U.S. operations and $0.1 million related to our domestic operations, compared to the comparable period in 2021 when the expense included a $0.4 million expense related to our non-U.S. operations and minimal expense related to our domestic operations.

The domestic tax expense for both periods is primarily attributable to state income taxes and the tax amortization of indefinite-lived intangible assets that is not available to offset U.S. deferred tax assets. The foreign tax expense for both periods is primarily attributable to non-U.S operations profits and foreign withholding taxes on unremitted earnings, offset by the amortization of intangible assets. For the three months ended September 30, 2022 and 2021, the Company’s U.S. deferred tax assets are fully offset by a valuation allowance since the Company cannot conclude that it is more likely than not that these future benefits will be realized. We will maintain this valuation allowance until there is sufficient positive evidence to support its reversal. We believe there is a reasonable possibility within the next twelve months that sufficient positive evidence may become available to allow us to reach a conclusion that a significant portion of the valuation allowance will no longer be needed. Release of the valuation allowance would result in the recognition of certain deferred tax assets with a corresponding decrease to income tax expense for the period the release is recorded. Additionally, if the valuation allowance is released and we continue to earn profits, our effective tax rate would likely increase in future periods compared to our current rates.

For the nine months ended September 30, 2022 and 2021

The following table presents revenue and expense line items reported in our Consolidated Statements of Operations for the indicated periods in 2022 and 2021 and the period-over-period dollar and percentage changes for those line items. Our results of operations are reported as one business segment, represented by our single operating segment.

	Nine Months Ended September 30,						Change
	2022			2021			Period to Period
	(dollars in thousands)
Net sales	$	492,338	100%	$	430,305	100%	$	62,033	14%
Cost of sales		292,109	59%		252,055	59%		40,054	16%
Gross profit		200,229	41%		178,250	41%		21,979	12%
Operating expenses, net:
Research and development		77,237	16%		66,397	15%		10,840	16%
Selling, general, and administrative		67,987	14%		63,325	15%		4,662	7%
Amortization of intangible assets		7,514	2%		9,305	2%		(1,791)	(19)%
Other operating expense (income), net		587	-		138	-		449	*
Total operating expenses, net		153,325	31%		139,165	32%		14,160	10%
Operating income (loss)		46,904	10%		39,085	9%		7,819	20%
Interest income (expense), net		(7,753)	(2)%		(20,221)	(5)%		12,468	(62)%
Income (loss) before income taxes		39,151	8%		18,864	4%		20,287	108%
Income tax expense (benefit)		1,125	-		1,029	-		96	9%
Net income (loss)	$	38,026	8%	$	17,835	4%	$	20,191	113%

* Not meaningful

35

Net Sales

The following is an analysis of sales by market and by region:

	Nine Months Ended September 30,						Change
	2022			2021			Period to Period
	(dollars in thousands)
Sales by end-market
Semiconductor	$	275,528	56%	$	181,641	42%	$	93,887	52%
Compound Semiconductor		96,325	20%		72,255	17%		24,070	33%
Data Storage		70,845	14%		132,261	31%		(61,416)	(46)%
Scientific & Other		49,640	10%		44,148	10%		5,492	12%
Total	$	492,338	100%	$	430,305	100%	$	62,033	14%
Sales by geographic region
United States	$	159,157	32%	$	160,908	38%	$	(1,751)	(1)%
EMEA		66,221	13%		36,128	8%		30,093	83%
China		95,071	20%		68,148	16%		26,923	40%
Rest of APAC		170,526	35%		164,926	38%		5,600	3%
Rest of World		1,363	-		195	-		1,168	*
Total	$	492,338	100%	$	430,305	100%	$	62,033	14%

* Not meaningful

Sales increased for the nine months ended September 30, 2022 against the comparable prior year period, primarily in the Semiconductor and Compound Semiconductor markets, partially offset by a decline in the Data Storage market. By geography, sales increased in the EMEA and China regions, partially offset by a decline in the United States. Sales in the Rest of APAC region for the nine months ended September 30, 2022 included sales in Taiwan, Singapore and Japan of $79.1 million, $34.8 million, and $27.6 million, respectively. Sales in the Rest of APAC region for the nine months ended September 30, 2021 included sales in Taiwan and South Korea of $53.0 million and $39.9 million, respectively. We expect there will continue to be year-to-year variations in our future sales distribution across markets and geographies. In light of the global nature of our business, we are impacted by conditions in the various countries in which we and our customers operate.

Gross Profit

For the nine months ended September 30, 2022, gross profit increased against the comparable prior period primarily due to an increase in sales volume. Gross margins remained relatively flat, as increases in margins due to product and region mix of sales in the period were offset by increased logistics costs, as well as an increase in spending as we invested in service infrastructure and capacity expansion to meet the growing demands for our semiconductor product lines. We expect our gross margins to fluctuate each period due to product mix and other factors.

Research and Development

The markets we serve are characterized by continuous technological development and product innovation, and we invest in various research and development initiatives to maintain our competitive advantage and achieve our growth objectives. Research and development expenses increased for the nine months ended September 30, 2022 against the comparable prior period primarily due to personnel-related expenses as we invest in new research and development and additional applications for our technology in order to be well-positioned to capitalize on emerging global megatrends and support longer term growth in Semiconductor and Compound Semiconductor markets.

Selling, General, and Administrative

Selling, general, and administrative expenses increased for the nine months ended September 30, 2022 against the comparable prior period primarily due to higher variable expenses associated with the increase in revenue, profitability,

36

and order in-take. However, expenses as a percentage of revenue have decreased when compared to the prior year period. Given the uncertainty regarding the impacts on our business resulting from the COVID-19 pandemic, we are focused on the proactive management of expenses. In future periods, we may incur additional selling, general and administrative expenses to support our responses to the COVID-19 pandemic. In addition, we are currently experiencing duplicate operating expenses for the transition from our existing facility in San Jose, California to our new leased facility, and will continue to do so until this transition is completed.

Amortization Expense

Amortization expense decreased compared to the comparable prior year period primarily due to changes in amortization expense to reflect expected cash flows of certain intangible assets, as well as certain other intangible assets becoming fully amortized in 2021.

Interest Income (Expense)

We recorded net interest expense of $7.8 million for the nine months ended September 30, 2022, compared to $20.2 million for the comparable prior year period. The decrease in interest expense was primarily related to the adoption of ASU 2020-06, as non-cash charges related to the amortization of debt discount and transaction costs of the 2023 Notes, 2025 Notes, and 2027 Notes decreased approximately $10.0 million for the nine months ended September 30, 2022 against the comparable prior period. Additionally, cash interest expense on the Notes decreased approximately $2.3 million from the comparable prior period due to the partial repurchase of the 2023 Notes in November 2021.

Income Taxes

At the end of each interim reporting period, we estimate the effective income tax rate expected to be applicable for the full year. This estimate is used to determine the income tax provision or benefit on a year-to-date basis and may change in subsequent interim periods.

Our tax expense for the nine months ended September 30, 2022 was $1.1 million, compared to $1.0 million for the comparable prior year period. The 2022 tax expense included an expense of $0.8 million related to our non-U.S. operations and $0.3 million related to our domestic operations, compared to the comparable period in 2021 when the expense included a $0.8 million expense related to our non-U.S. operations and $0.2 million related to our domestic operations.

The domestic tax expense for both periods is primarily attributable to state income taxes and the tax amortization of indefinite-lived intangible assets that is not available to offset U.S. deferred tax assets. The foreign tax expense for both periods is primarily attributable to non-U.S operations profits and foreign withholding taxes on unremitted earnings, offset by the amortization of intangible assets. For the nine months ended September 30, 2022 and 2021, the Company’s U.S. deferred tax assets are fully offset by a valuation allowance since the Company cannot conclude that it is more likely than not that these future benefits will be realized. We will maintain this valuation allowance until there is sufficient positive evidence to support its reversal. We believe there is a reasonable possibility within the next twelve months that sufficient positive evidence may become available to allow us to reach a conclusion that a significant portion of the valuation allowance will no longer be needed. Release of the valuation allowance would result in the recognition of certain deferred tax assets with a corresponding decrease to income tax expense for the period the release is recorded. Additionally, if the valuation allowance is released and we continue to earn profits, our effective tax rate would likely increase in future periods compared to our current rates.

37

Liquidity and Capital Resources

Our cash and cash equivalents, restricted cash, and short-term investments are as follows:

	September 30,		December 31,
	2022		2021
	(in thousands)
Cash and cash equivalents	$	169,111	$	119,747
Restricted cash		557		725
Short-term investments		101,862		104,181
Total	$	271,530	$	224,653

At September 30, 2022 and December 31, 2021, cash and cash equivalents of $47.4 million and $38.3 million, respectively, were held outside the United States. As of September 30, 2022, we had $16.8 million of accumulated undistributed earnings generated by our non-U.S. subsidiaries for which the U.S. repatriation tax has been provided and did not require the use of cash due to the use of net operating loss carryforwards. Approximately $6.8 million of undistributed earnings will be subject to foreign withholding taxes if distributed back to the United States.

We believe that our projected cash flow from operations, combined with our cash and short-term investments, will be sufficient to meet our projected working capital requirements, contractual obligations, and other cash flow needs for the next twelve months, including scheduled interest payments on our convertible senior notes, purchase commitments, and payments in respect of operating leases. Although there is uncertainty related to the anticipated impact of the COVID-19 outbreak on our future results, we believe our business model, our current cash and short-term investments, and our proactive management of expenses, leave us well-positioned to manage our business through this crisis as it continues to unfold.

A summary of the cash flow activity for the nine months ended September 30, 2022 and 2021 is as follows:

Cash Flows from Operating Activities

	Nine Months Ended September 30,
	2022		2021
	(in thousands)
Net income	$	38,026	$	17,835
Non-cash items:
Depreciation and amortization		19,100		19,634
Non-cash interest expense		719		10,762
Deferred income taxes		(43)		(12)
Share-based compensation expense		16,969		11,735
Changes in operating assets and liabilities		603		(9,305)
Net cash provided by (used in) operating activities	$	75,374	$	50,649

Net cash provided by operating activities was $75.4 million for the nine months ended September 30, 2022 and was due to net income of $38.0 million, adjustments for non-cash items of $36.7 million, and an increase in cash flow from changes in operating assets and liabilities of $0.6 million. The changes in operating assets and liabilities were largely attributable to 1) increases in accounts receivable and inventories; 2) decreases in accrued expenses; partially offset by 3) increases in customer deposits; and 4) decreases in prepaid expenses and other current assets.

38

Cash Flows from Investing Activities

	Nine Months Ended September 30,
	2022		2021
	(in thousands)
Capital expenditures	$	(21,771)	$	(31,453)
Changes in investments, net		610		(25,637)
Net cash provided by (used in) investing activities	$	(21,161)	$	(57,090)

The cash used in investing activities during the nine months ended September 30, 2022 and 2021 was primarily attributable capital expenditures. We experienced a high level of capital expenditures in both 2022 and 2021 as we build-out our newly leased facility in San Jose, California. We expect a period of some duplicate operating expenses until the transition from our pre-existing facility to our new facility is completed. 

Cash Flows from Financing Activities

	Nine Months Ended September 30,
	2022		2021
	(in thousands)
Settlement of equity awards, net of withholding taxes	$	(4,909)	$	(1,551)
Net cash provided by (used in) financing activities	$	(4,909)	$	(1,551)

The cash used in financing activities for the nine months ended September 30, 2022 and 2021 was related to cash used to settle taxes related to employee equity programs, partially offset by cash received under the Employee Stock Purchase Plan.

Convertible Senior Notes

We have $20.2 million outstanding principal balance of 2.70% convertible senior notes that bear interest at a rate of 2.70% per year, payable semiannually in arrears on January 15 and July 15 of each year, and mature on January 15, 2023, unless earlier purchased by the Company, redeemed, or converted. In addition, we have $132.5 million outstanding principal balance of 3.50% convertible senior notes that bear interest at a rate of 3.50% per year, payable semiannually in arrears on January 15 and July 15 of each year, and mature on January 15, 2025, unless earlier purchased by the Company, redeemed, or converted. Finally, we have $125.0 million outstanding principal balance of 3.75% convertible senior notes that bear interest at a rate of 3.75% per year, payable semiannually in arrears on June 1 and December 1 of each year, and mature on June 1, 2027, unless earlier purchased by the Company, redeemed, or converted. The 2027 Notes are currently convertible by shareholders until September 30, 2022.

We believe that we have sufficient capital resources and cash flows from operations to support scheduled interest payments on these debts. In addition, we have access to a $150.0 million revolving credit facility (including an ability to request an additional $75.0 million, for a total commitment of no more than $225.0 million) to provide for our working capital needs and reimburse drawings under letters of credit and for other general corporate purposes. The Company has no immediate plans to draw down on the facility, which expires in December of 2026. Interest under the facility is variable based on the Company’s secured net leverage ratio and is expected to bear interest based on SOFR plus a range of 150 to 225 basis points, if drawn. There is a yearly commitment fee of 25 to 35 basis points, based on the Company’s secured net leverage ratio, charged on the unused portion of the Facility.

Contractual Obligations and Commitments

We have commitments under certain contractual arrangements to make future payments for goods and services. These contractual arrangements secure the rights to various assets and services to be used in the future in the normal course of business. We expect to fund these contractual arrangements with cash generated from operations in the normal course of business.

39

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Interest Rate Risk

Our exposure to market rate risk for changes in interest rates primarily relates to our investment portfolio. We centrally manage our investment portfolios considering investment opportunities and risks, tax consequences, and overall financing strategies. Our investment portfolio includes fixed-income securities with a fair value of approximately $101.9 million at September 30, 2022. These securities are subject to interest rate risk and, based on our investment portfolio at September 30, 2022, a 100 basis point increase in interest rates would result in a decrease in the fair value of the portfolio of $0.6 million. While an increase in interest rates may reduce the fair value of the investment portfolio, we will not realize the losses in the Consolidated Statements of Operations unless the individual fixed-income securities are sold prior to recovery or the loss is determined to be other-than-temporary.

Currency Exchange Risk

We conduct business on a worldwide basis and, as such, a portion of our revenues, earnings, and net investments in foreign affiliates is exposed to changes in currency exchange rates. The economic impact of currency exchange rate movements is complex because such changes are often linked to variability in real growth, inflation, interest rates, governmental actions, and other factors. These changes, if material, could cause us to adjust our financing and operating strategies. Consequently, isolating the effect of changes in currency does not incorporate these other important economic factors.

Changes in currency exchange rates could affect our foreign currency denominated monetary assets and liabilities and forecasted cash flows. We may enter into monthly forward derivative contracts from time to time with the intent of mitigating a portion of this risk. We only use derivative financial instruments in the context of hedging and not for speculative purposes and have not historically designated our foreign exchange derivatives as hedges. Accordingly, changes in fair value from these contracts are recorded as “Other, net” in our Consolidated Statements of Operations. We execute derivative transactions with highly rated financial institutions to mitigate counterparty risk.

Our net sales to customers located outside of the United States represented approximately 69% and 68% of our total net sales for the three and nine months ended September 30, 2022, respectively, and 67% and 62% for the comparable 2021 periods. We expect that net sales to customers outside the United States will continue to represent a large percentage of our total net sales. Our sales denominated in currencies other than the U.S. dollar represented approximately 3% of total net sales for both the three and nine months ended September 30, 2022 and 2021.

A 10% change in foreign exchange rates would have an immaterial impact on the consolidated results of operations since most of our sales outside the United States are denominated in U.S. dollars.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our principal executive and financial officers have evaluated and concluded that our disclosure controls and procedures are effective as of September 30, 2022. The disclosure controls and procedures are designed to ensure that the information required to be disclosed in this report filed under the Securities Exchange Act of 1934 is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and is accumulated and communicated to our principal executive and financial officers as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

During the quarter ended September 30, 2022, there were no changes in internal control that have materially affected or are reasonably likely to materially affect internal control over financial reporting.

40

PART II—OTHER INFORMATION

Item 1. Legal Proceedings

On June 8, 2018, an Ultratech shareholder who received Veeco stock as part of the consideration for the Ultratech acquisition filed a purported class action complaint in the Superior Court of the State of California, County of Santa Clara, captioned Wolther v. Maheshwari et al., Case No. 18CV329690, on behalf of himself and others who purchased or acquired shares of Veeco pursuant to the registration statement and prospectus which Veeco filed with the SEC in connection with the Ultratech acquisition (the “Wolther Action”). On August 2 and August 8, 2018, two purported class action complaints substantially similar to the Wolther Action were filed on behalf of different plaintiffs in the same court as the Wolther Action. These cases have been consolidated with the Wolther Action, and a consolidated complaint was filed on December 11, 2018. The consolidated complaint seeks to recover damages and fees under Sections 11, 12, and 15 of the Securities Act of 1933 for, among other things, alleged false/misleading statements in the registration statement and prospectus relating to the Ultratech acquisition, relating primarily to the alleged failure to disclose delays in the advanced packaging business, increased MOCVD competition in China, and an intellectual property dispute. In October 2021, Veeco and the court-appointed class representatives signed an agreement to settle the Wolther Action on a class-wide basis for $15.0 million, subject to court approval and class members’ opportunity to object and opt-out. The settlement amount has been funded by insurance carriers. On June 27, 2022, the court granted final approval to the class action settlement.

On December 21, 2018, a purported Veeco stockholder filed a derivative action in the Superior Court of the State of California, County of Santa Clara, captioned Vladimir Gusinsky Revocable Trust v. Peeler, et al., Case No. 18CV339925, on behalf of nominal defendant Veeco (the “Derivative Action”). The complaint seeks to assert claims for breach of fiduciary duty, waste of corporate assets, and unjust enrichment against current and former Veeco directors premised on purported misstatements and omissions in the registration statement relating to the Ultratech acquisition. On January 25, 2021, the court granted the defendants’ demurrer without leave to amend effecting the dismissal of the case. On March 26, 2021, plaintiff filed its notice of appeal of the trial court’s order granting defendants’ demurrer without leave to amend. In April 2022, Veeco and plaintiff reached an agreement to settle the Derivative Action subject to court approval. As part of the settlement and subject to court approval, Veeco will make certain revisions to its internal Disclosure Committee Charter and its director education program. The agreement also provides that, subject to court approval, plaintiff will receive $0.3 million for fees and expenses. This amount will be funded by insurance that Veeco maintains in the normal course of its business. On September 12, 2022, the court issued an order granting preliminary approval of the proposed settlement (the “Preliminary Approval Order”). The Preliminary Approval Order set the final settlement approval hearing for November 17, 2022.

The Company is involved in various other legal proceedings arising in the normal course of business. The Company does not believe that the ultimate resolution of these matters will have a material adverse effect on its consolidated financial position, results of operations, or cash flows.

Item 1A. Risk Factors

Information regarding risk factors appears in the Safe Harbor Statement at the beginning of this quarterly report on Form 10-Q, in Part I — Item 1A of our 2021 Form 10-K, and in Part 2, Item 1A of our quarterly reports on Form 10-Q for the quarters ending March 31, 2022 and June 30 2022. There have been no material changes from the risk factors previously disclosed, except as follows:

Changes in U.S. trade policy and export controls and ongoing trade disputes between the U.S. and China have adversely affected, and may continue to adversely affect, our business, results of operations, and financial condition.

The U.S. government has implemented, and may continue to implement, several changes in trade policy which have adversely affected and could continue to adversely affect the Company’s ability to sell and service its products to and for customers located in China and in certain other countries.

41

On October 7, 2022, the U.S. Commerce Department, Bureau of Industry and Security (“BIS”) announced new rules aimed in part at restricting China’s ability to obtain advanced computing chips and manufacture advanced semiconductors. These new rules include heightened restrictions on U.S. companies, and on defined “U.S. Persons”, who may facilitate semiconductor development and production at facilities in China which manufacture, or have the potential to manufacture, certain advanced integrated circuits. In addition, a new export classification code – 3B090 – has been created for certain deposition equipment, for which licenses will now be required for sale into China (with a presumption of denial). BIS explained that the new rules are designed to curtail China’s use of these items in the development of weapons of mass destruction, artificial intelligence and supercomputing-enhanced war fighting, and in technologies that enable human rights violations. Previous changes in trade policy by the U.S. government have included, without limitation, the elimination of license exception CIV, the implementation of new regulations governing the sale of equipment to defined “Military End Users” and for defined “Military End Uses”, and the addition of several companies to the U.S. Commerce Department’s Unverified List and Entity List (including Semiconductor Manufacturing International Corporation and certain related entities).

The effect of these changes, among others, is that U.S. companies are now required to obtain export licenses – now at times with a presumption of denial -- before providing commodities, software, and technology (which are subject to the regulations) to customers for whom licensing requirements did not previously apply. These changes have had, and will likely continue to have, a negative effect on our ability to sell and service certain equipment in China. The heightened export restrictions may also inhibit technical discussions with existing or prospective customers, negatively impacting our ability to pursue sales opportunities. The administrative processing, attendant delays and risk of ultimately not obtaining required export approvals pose a particular disadvantage to the Company relative to our non-U.S. competitors who are not required to comply with U.S. export controls. This difficulty and uncertainty has adversely affected our ability to compete for and win business from customers in China. Foreign customers affected by these and future U.S. government sanctions or threats of sanctions may respond by developing their own solutions to replace our products or by utilizing our foreign competitors’ products. This “trade war” with China, together with the prospect of additional governmental action related to export controls restrictions, international sanctions, and/or tariffs, has adversely affected, and is likely to continue to adversely affect, demand for our products and the results of our operations and financial condition.

The changes in U.S. trade policy and export controls, as well as sanctions imposed by the U.S. against certain Chinese companies, have triggered retaliatory action by China and could trigger further retaliation. In addition, China has provided, and is expected to continue to provide, significant assistance, financial and otherwise, to its domestic industries, including some of our competitors. We face increasing competition as a result of significant investment in the semiconductor industry by the Chinese government and various state-owned or affiliated entities that is intended to advance China's stated national policy objectives. In addition, the Chinese government may restrict us from participating in the China market or may prevent us from competing effectively with Chinese companies.

Further, we hold inventory of products that may be affected by the recent U.S. government actions, including potential order cancellations. While we continue to take steps to mitigate our exposure to this developing situation, if the sale of these products is delayed or we are unable to return or dispose of our inventory on favorable economic terms, we may incur additional carrying costs for the inventory or otherwise record charges associated with this inventory.  

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not Applicable.

42

Item 5. Other Information

None.

Item 6. Exhibits

Unless otherwise indicated, each of the following exhibits has been filed with the Securities and Exchange Commission by Veeco under File No. 0-16244.

Exhibit		Incorporated by Reference			Filed or Furnished
Number	Exhibit Description	Form	Exhibit	Filing Date	Herewith
31.1	Certification of Chief Executive Officer pursuant to Rule 13a—14(a) or Rule 15d—14(a) of the Securities and Exchange Act of 1934.				*
31.2	Certification of Chief Financial Officer pursuant to Rule 13a—14(a) or Rule 15d—14(a) of the Securities and Exchange Act of 1934.				*
32.1	Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes - Oxley Act of 2002.				*
32.2	Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes - Oxley Act of 2002.				*
101.INS	XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.				*
101.XSD	XBRL Schema.				**
101.PRE	XBRL Presentation.				**
101.CAL	XBRL Calculation.				**
101.DEF	XBRL Definition.				**
101.LAB	XBRL Label.				**
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).				**

*     Filed herewith

**   Filed herewith electronically

43

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on November 7, 2022.

Veeco Instruments Inc.
By:	/s/ WILLIAM J. MILLER, Ph.D.
	William J. Miller, Ph.D.
	Chief Executive Officer
By:	/s/ JOHN P. KIERNAN
	John P. Kiernan
	Senior Vice President and Chief Financial Officer

44

EX-31.1

Exhibit 31.1

CERTIFICATION PURSUANT TO

RULE 13a — 14(a) or RULE 15d — 14(a)

OF THE SECURITIES EXCHANGE ACT OF 1934

I, William J. Miller, Ph.D., certify that:

1. I have reviewed this quarterly report on Form 10-Q for the period ended September 30, 2022 of Veeco Instruments Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

By:	/s/ WILLIAM J. MILLER, Ph.D.
	William J. Miller, Ph.D.
	Chief Executive Officer
	Veeco Instruments Inc.
	November 7, 2022

EX-31.2

Exhibit 31.2

CERTIFICATION PURSUANT TO

RULE 13a — 14(a) or RULE 15d — 14(a)

OF THE SECURITIES EXCHANGE ACT OF 1934

I,  John P. Kiernan, certify that:

1.    I have reviewed this quarterly report on Form 10-Q for the period ended September 30, 2022 of Veeco Instruments Inc.;

2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.    The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)  designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)  designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)  evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)  disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.    The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)  all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)  any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

By:	/s/ JOHN P. KIERNAN
	John P. Kiernan
	Senior Vice President and Chief Financial Officer
	Veeco Instruments Inc.
	November 7, 2022

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Veeco Instruments Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, William J. Miller, Ph.D., Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

By:	/s/ WILLIAM J. MILLER Ph.D.
	William J. Miller, Ph.D.
	Chief Executive Officer
	Veeco Instruments Inc.
	November 7, 2022

A signed original of this written statement required by Section 906 has been provided to Veeco Instruments Inc. and will be retained by Veeco Instruments Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Veeco Instruments Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John P. Kiernan, Senior Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

By:	/s/ JOHN P. KIERNAN
	John P. Kiernan
	Senior Vice President and Chief Financial Officer
	Veeco Instruments Inc.
	November 7, 2022

A signed original of this written statement required by Section 906 has been provided to Veeco Instruments Inc. and will be retained by Veeco Instruments Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2022	Nov. 02, 2022
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2022
Document Transition Report	false
Entity File Number	0-16244
Entity Registrant Name	VEECO INSTRUMENTS INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	11-2989601
Entity Address, Address Line One	Terminal Drive
Entity Address, City or Town	Plainview
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	11803
City Area Code	516
Local Phone Number	677-0200
Title of 12(b) Security	Common Stock
Trading Symbol	VECO
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		51,425,150
Entity Central Index Key	0000103145
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Amendment Flag	false

XML

Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 169,111	$ 119,747
Restricted cash	557	725
Short-term investments	101,862	104,181
Accounts receivable, net	142,985	109,609
Contract assets	29,865	18,293
Inventories	187,737	170,858
Prepaid expenses and other current assets	17,586	25,974
Total current assets	649,703	549,387
Property, plant, and equipment, net	108,416	99,743
Operating lease right-of-use assets	25,119	28,813
Intangible assets, net	26,391	33,905
Goodwill	181,943	181,943
Deferred income taxes	1,639	1,639
Other assets	3,406	3,546
Total assets	996,617	898,976
Current liabilities:
Accounts payable	51,129	44,456
Accrued expenses and other current liabilities	65,062	79,752
Customer deposits and deferred revenue	122,285	63,136
Income taxes payable	1,565	1,860
Current portion of long-term debt	20,144
Total current liabilities	260,185	189,204
Deferred income taxes	4,748	4,792
Long-term debt	254,272	229,438
Long-term operating lease liabilities	31,266	32,834
Other liabilities	5,031	5,080
Total liabilities	555,502	461,348
Stockholders' equity:
Preferred stock, $0.01 par value; 500,000 shares authorized; no shares issued and outstanding.
Common stock, $0.01 par value; 120,000,000 shares authorized; 51,420,150 shares issued and outstanding at September 30, 2022 and 50,652,864 shares issued and outstanding at December 31, 2021	515	507
Additional paid-in capital	1,071,097	1,116,921
Accumulated deficit	(630,716)	(681,283)
Accumulated other comprehensive income	219	1,483
Total stockholders' equity	441,115	437,628
Total liabilities and stockholders' equity	$ 996,617	$ 898,976

XML

Consolidated Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2022	Dec. 31, 2021
Consolidated Balance Sheets
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized	500,000	500,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, authorized shares	120,000,000	120,000,000
Common stock, shares issued	51,420,150	50,652,864
Common stock, shares outstanding	51,420,150	50,652,864

XML

Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Consolidated Statements of Operations
Net sales	$ 171,913	$ 150,246	$ 492,338	$ 430,305
Cost of sales	101,962	87,077	292,109	252,055
Gross profit	69,951	63,169	200,229	178,250
Operating expenses, net:
Research and development	27,104	21,999	77,237	66,397
Selling, general, and administrative	22,144	21,603	67,987	63,325
Amortization of intangible assets	2,505	2,976	7,514	9,305
Other operating expense (income), net	634	175	587	138
Total operating expenses, net	52,387	46,753	153,325	139,165
Operating income	17,564	16,416	46,904	39,085
Interest income	571	95	873	464
Interest expense	(2,886)	(7,107)	(8,626)	(20,685)
Income before income taxes	15,249	9,404	39,151	18,864
Income tax expense (benefit)	208	411	1,125	1,029
Net income	$ 15,041	$ 8,993	$ 38,026	$ 17,835
Income per common share:
Basic (in dollars per share)	$ 0.30	$ 0.18	$ 0.76	$ 0.36
Diluted (in dollars per share)	$ 0.27	$ 0.17	$ 0.70	$ 0.33
Weighted average number of shares:
Basic (in shares)	49,887	49,021	49,831	48,968
Diluted (in shares)	65,151	53,849	65,090	53,606

XML

Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Consolidated Statements of Comprehensive Income
Net income	$ 15,041	$ 8,993	$ 38,026	$ 17,835
Other comprehensive income (loss), net of tax:
Unrealized gain (loss) on available-for-sale securities	(113)	(12)	(1,156)	(16)
Change in currency translation adjustments	(57)	(21)	(108)	(60)
Total other comprehensive income (loss), net of tax	(170)	(33)	(1,264)	(76)
Total comprehensive income	$ 14,871	$ 8,960	$ 36,762	$ 17,759

XML

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash Flows from Operating Activities
Net income	$ 38,026	$ 17,835
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	19,100	19,634
Non-cash interest expense	719	10,762
Deferred income taxes	(43)	(12)
Share-based compensation expense	16,969	11,735
Changes in operating assets and liabilities:
Accounts receivable and contract assets	(44,948)	(12,987)
Inventories	(18,117)	(24,879)
Prepaid expenses and other current assets	8,388	9,829
Accounts payable and accrued expenses	(6,072)	21,786
Customer deposits and deferred revenue	59,149	(6,532)
Income taxes receivable and payable, net	(296)	823
Other, net	2,499	2,655
Net cash provided by (used in) operating activities	75,374	50,649
Cash Flows from Investing Activities
Capital expenditures	(21,771)	(31,453)
Proceeds from the sale of investments	44,592	199,475
Payments for purchases of investments	(43,982)	(225,112)
Net cash provided by (used in) investing activities	(21,161)	(57,090)
Cash Flows from Financing Activities
Proceeds (net of tax withholdings) from option exercises and employee stock purchase plan	2,909	2,709
Restricted stock tax withholdings	(7,818)	(4,260)
Net cash provided by (used in) financing activities	(4,909)	(1,551)
Effect of exchange rate changes on cash and cash equivalents	(108)	(60)
Net increase (decrease) in cash, cash equivalents, and restricted cash	49,196	(8,052)
Cash, cash equivalents, and restricted cash - beginning of period	120,472	130,283
Cash, cash equivalents, and restricted cash - end of period	169,668	122,231
Supplemental Disclosure of Cash Flow Information
Interest paid	7,760	9,039
Income taxes paid (refunds received)	1,349	(130)
Non-cash activities
Capital expenditures included in accounts payable and accrued expenses	6,709	9,133
Net transfer of inventory to property, plant and equipment	1,235	(253)
Right-of-use assets obtained in exchange for lease obligations	$ 375	$ 20,353

XML

Basis of Presentation

9 Months Ended

Sep. 30, 2022

Significant Accounting Policies

Basis of Presentation

Note 1 — Basis of Presentation

The accompanying unaudited Consolidated Financial Statements of Veeco have been prepared in accordance with U.S. GAAP as defined in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification 270 for interim financial information and with the instructions to Rule 10-01 of Securities and Exchange Commission Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements as the interim information is an update of the information that was presented in Veeco’s most recent annual financial statements. For further information, refer to Veeco’s Consolidated Financial Statements and Notes thereto included in the Annual Report on Form 10-K for the year ended December 31, 2021 (“2021 Form 10-K”). In the opinion of management, all adjustments considered necessary for a fair presentation have been included. All such adjustments are of a normal, recurring nature.

Veeco reports interim quarters on a 13-week basis ending on the last Sunday of each quarter. The fourth quarter always ends on the last day of the calendar year, December 31. The 2022 interim quarters end on April 3, July 3, and October 2, and the 2021 interim quarters ended on April 4, July 4, and October 3. These interim quarters are reported as March 31, June 30, and September 30 in Veeco’s interim consolidated financial statements.

The preparation of financial statements in conformity with U.S GAAP requires the Company’s management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Although these estimates are based on management’s knowledge of current events and actions it may undertake in the future, actual results may differ from these estimates. In particular, the COVID-19 pandemic has adversely impacted and is likely to further adversely impact the Company’s business and markets, including the Company’s workforce and operations and the operations of the Company’s customers, suppliers, and business partners. The full extent to which the pandemic will directly or indirectly impact the Company's business, results of operations and financial condition, including sales, expenses, manufacturing, research and development costs, reserves and allowances, fair value measurements, and asset impairment charges, will depend on future developments that are highly uncertain and difficult to predict. These developments include, but are not limited to, the duration and spread of the outbreak, its severity, the actions to contain the virus or address its impact, governmental actions to contain the spread of the pandemic and respond to the reduction in global economic activity, and how quickly and to what extent normal economic and operating conditions can resume.

Revenue Recognition

Revenue is recognized upon the transfer of control of the promised product or service to the customer in an amount that reflects the consideration the Company expects to receive in exchange for such product or service. The Company’s contracts with customers generally do not contain variable consideration. In the rare instances where variable consideration is included, the Company estimates the amount of variable consideration and determines what portion of that, if any, has a high probability of significant subsequent revenue reversal, and if so, that amount is excluded from the transaction price. The Company’s contracts with customers frequently contain multiple deliverables, such as systems, upgrades, components, spare parts, installation, maintenance, and service plans. Judgment is required to properly identify the performance obligations within a contract and to determine how the revenue should be allocated among the performance obligations. The Company also evaluates whether multiple transactions with the same customer or related parties should be considered part of a single contract based on an assessment of whether the contracts or agreements are negotiated or executed within a short time frame of each other or if there are indicators that the contracts are negotiated in contemplation of one another.

When there are separate units of accounting, the Company allocates revenue to each performance obligation on a relative stand-alone selling price basis. The stand-alone selling prices are determined based on the prices at which the Company separately sells the systems, upgrades, components, spare parts, installation, maintenance, and service plans. For items

that are not sold separately, the Company estimates stand-alone selling prices generally using an expected cost plus margin approach.

Most of the Company’s revenue is recognized at a point in time when the performance obligation is satisfied. The Company considers many facts when evaluating each of its sales arrangements to determine the timing of revenue recognition, including its contractual obligations and the nature of the customer’s post-delivery acceptance provisions. The Company’s system sales arrangements, including certain upgrades, generally include field acceptance provisions that may include functional or mechanical test procedures. For many of these arrangements, a customer source inspection of the system is performed in the Company’s facility, test data is sent to the customer documenting that the system is functioning to the agreed upon specifications prior to delivery, or other quality assurance testing is performed internally to ensure system functionality prior to shipment. Historically, such source inspection or test data replicates the field acceptance provisions that are performed at the customer’s site prior to final acceptance of the system. When the Company objectively demonstrates that the criteria specified in the contractual acceptance provisions are achieved prior to delivery either through customer testing or the Company’s historical experience of its tools meeting specifications, transfer of control of the product to the customer is considered to have occurred and revenue is recognized upon system delivery since there is no substantive contingency remaining related to the acceptance provisions at that date. For new products, new applications of existing products, or for products with substantive customer acceptance provisions where the Company cannot objectively demonstrate that the criteria specified in the contractual acceptance provisions have been achieved prior to delivery, revenue and the associated costs are deferred. The Company recognizes such revenue and costs upon obtaining objective evidence that the acceptance provisions can be achieved, assuming all other revenue recognition criteria have been met.

In certain cases the Company’s contracts with customers contain a billing retention, which is billed by the Company and payable by the customer when field acceptance provisions are completed. Revenue recognized in advance of the amount that has been billed is recorded as a contract asset on the Consolidated Balance Sheets.

The Company recognizes revenue related to maintenance and service contracts over time based upon the respective contract term. Installation revenue is recognized over time as the installation services are performed. The Company recognizes revenue from the sales of components, spare parts, and specified service engagements at a point in time, which is typically consistent with the time of delivery in accordance with the terms of the applicable sales arrangement.

The Company may receive customer deposits on system transactions. The timing of the transfer of goods or services related to the deposits is either at the discretion of the customer or generally expected to be within one year from the deposit receipt. As such, the Company does not adjust transaction prices for the time value of money. Incremental direct costs incurred related to the acquisition of a customer contract, such as sales commissions, are expensed as incurred since the expected amortization period is one year or less.

The Company has elected to treat shipping and handling costs as a fulfillment activity, and the Company includes such costs in cost of sales when the Company recognizes revenue for the related goods. Taxes assessed by governmental authorities that are collected by the Company from a customer are excluded from revenue.

Inventories

Inventories are stated at the lower of cost or net realizable value, with cost determined on a first-in, first-out basis. Each quarter the Company assesses the valuation and recoverability of all inventories: materials (raw materials, spare parts, and service inventory); work-in-process; and finished goods. Obsolete inventory or inventory in excess of management’s estimated usage requirement is written down to its estimated net realizable value if less than cost. The Company evaluates usage requirements by analyzing historical usage, anticipated demand, alternative uses of materials, and other qualitative factors. Unanticipated changes in demand for the Company’s products may require a write down of

inventory, which would be reflected in cost of sales in the period the revision is made. Inventory acquired as part of a business combination is recorded at fair value on the date of acquisition.

Recently Adopted Accounting Standards

The Company adopted ASU 2020-06: Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity on January 1, 2022, using the modified retrospective method for all financial instruments that are outstanding as of the adoption date. This standard simplifies the accounting for convertible debt instruments by removing the separation models for convertible debt with a cash conversion feature, as well as convertible instruments with a beneficial conversion feature. As a result, entities will account for a convertible debt instrument wholly as debt, unless certain other conditions are met. The elimination of these models will reduce non-cash interest expense for entities that have issued a convertible instrument that was within the scope of those models before the adoption of ASU 2020-06, such as the Company’s 2023 Notes, 2025 Notes, and 2027 Notes. Additionally, ASU 2020-06 requires the application of the if-converted method for calculating diluted earnings per share, and precludes the use of the treasury stock method for certain debt instruments, such as the Company’s 2023 Notes, 2025 Notes, and 2027 Notes.

The adoption of ASU 2020-06 resulted in the following adjustments to the Consolidated Balance Sheets:

	December 31, 2021		Adoption of ASU 2020-06		January 1, 2022
	(in thousands)
Balance Sheet line item:
Long-term debt	$	229,438	$	44,260	$	273,698
Additional paid-in capital		1,116,921		(56,801)		1,060,120
Accumulated deficit		(681,283)		12,541		(668,742)

The adoption of ASU 2020-06 resulted in the following adjustments to the Company’s calculations of basic and diluted income per share for the three and nine months ended September 30, 2022:

	Three months ended September 30, 2022						Nine months ended September 30, 2022
	Under		Under				Under		Under
	ASU 2020-06		legacy accounting		Difference		ASU 2020-06		legacy accounting		Difference
Income per common share:
Basic income per common share	$	0.30	$	0.25	$	0.05	$	0.76	$	0.62	$	0.14
Diluted income per common share		0.27		0.24		0.03		0.70		0.57		0.13

The adoption of ASU 2020-06 did not materially impact the Company’s cash flows or compliance with debt covenants.

i

XML

Income Per Common Share

9 Months Ended

Sep. 30, 2022

Income Per Common Share

Income Per Common Share

Note 2 — Income Per Common Share

Basic income per share is calculated by dividing net income by the weighted average number of shares outstanding during the period. Diluted income per share is calculated by dividing net income available to common shareholders by the weighted average number of shares used to calculate basic income per share plus the weighted average number of common share equivalents outstanding during the period. The dilutive effect of outstanding options to purchase common stock and share-based awards is considered in diluted income per share by application of the treasury stock method. The dilutive effect of performance share units is included in diluted income per common share if the performance targets have been achieved, or would have been achieved if the reporting date was the end of the contingency period. Upon the adoption of ASU 2020-06 on January 1, 2022, the Company includes the dilutive effect of shares issuable upon conversion of its Notes in the calculation of diluted income per share using the if-converted method. Prior to the adoption of ASU 2020-06, based on the Company’s ability and intent to settle the principal amount of its convertible senior notes in cash, and the excess of the principal portion in shares of its common stock, the Company accounted for the conversion spread using the treasury stock method, and the shares issuable upon conversion of the Notes were not included in the calculation of diluted earnings per share except to the extent that the conversion value of the Notes exceeds their principal amount and if the effect would be dilutive. The computations of basic and diluted income per share for the three months and nine months ended September 30, 2022 and 2021 are as follows:

	Three months ended September 30,				Nine months ended September 30,
	2022		2021		2022		2021
	(in thousands, except per share amounts)
Numerator:
Net income	$	15,041	$	8,993	$	38,026	$	17,835
Interest expense associated with convertible notes		2,549		—		7,639		—
Net income available to common shareholders	$	17,590	$	8,993	$	45,665	$	17,835
Denominator:
Basic weighted average shares outstanding		49,887		49,021		49,831		48,968
Effect of potentially dilutive share-based awards		801		1,507		796		1,377
Dilutive effect of convertible notes		14,463		3,321		14,463		3,261
Diluted weighted average shares outstanding		65,151		53,849		65,090		53,606
Net income per common share:
Basic	$	0.30	$	0.18	$	0.76	$	0.36
Diluted	$	0.27	$	0.17	$	0.70	$	0.33
Potentially dilutive shares excluded from the diluted calculation as their effect would be antidilutive		1,016		451		751		447
Maximum potential shares to be issued for settlement of the convertible notes excluded from the diluted calculation as their effect would be antidilutive		504		8,811		504		8,811

XML

Assets

9 Months Ended

Sep. 30, 2022

Assets

Assets

Note 3 — Assets

Investments

Short-term investments are generally classified as available-for-sale and reported at fair value, with unrealized gains and losses, net of tax, presented as a separate component of stockholders’ equity under the caption “Accumulated other comprehensive income” in the Consolidated Balance Sheets. These securities may include U.S. treasuries, government agency securities, corporate debt, and commercial paper, all with maturities of greater than three months when

purchased. All realized gains and losses and unrealized losses resulting from declines in fair value that are other than temporary are included in “Other operating expense (income), net” in the Consolidated Statements of Operations.

Fair value is the price that would be received for an asset or the amount paid to transfer a liability in an orderly transaction between market participants. Veeco classifies certain assets based on the following fair value hierarchy:

Level 1: Quoted prices in active markets that are unadjusted and accessible at the measurement date for identical, unrestricted assets or liabilities;

Level 2: Quoted prices for identical assets and liabilities in markets that are not active, quoted prices for similar assets and liabilities in active markets or financial instruments for which significant inputs are observable, either directly or indirectly; and

Level 3: Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable.

A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Veeco has evaluated the estimated fair value of financial instruments using available market information and valuations as provided by third-party sources. The use of different market assumptions or estimation methodologies could have a significant effect on the estimated fair value amounts.

The following table presents the portion of Veeco’s assets that were measured at fair value on a recurring basis at September 30, 2022 and December 31, 2021:

	Level 1		Level 2		Level 3		Total
	(in thousands)
September 30, 2022
Cash equivalents
Certificate of deposits and time deposits	$	63,527	$	—	$	—	$	63,527
Commercial paper		—		4,959		—		4,959
Money market cash		15,066		—		—		15,066
Total	$	78,593	$	4,959	$	—	$	83,552
Short-term investments
U.S. treasuries	$	46,353	$	—	$	—	$	46,353
Government agency securities		—		12,879		—		12,879
Corporate debt		—		36,745		—		36,745
Commercial paper		—		5,885		—		5,885
Total	$	46,353	$	55,509	$	—	$	101,862
December 31, 2021
Cash equivalents
Certificate of deposits and time deposits	$	41,544	$	—	$	—	$	41,544
Money market cash		121		—		—		121
Total	$	41,665	$	—	$	—	$	41,665
Short-term investments
U.S. treasuries	$	51,095	$	—	$	—	$	51,095
Government agency securities		—		12,052		—		12,052
Corporate debt		—		40,035		—		40,035
Commercial paper		—		999		—		999
Total	$	51,095	$	53,086	$	—	$	104,181

There were no transfers between fair value measurement levels during the three months and nine months ended September 30, 2022.

At September 30, 2022 and December 31, 2021, the amortized cost and fair value of available-for-sale securities consist of:

			Gross		Gross
	Amortized		Unrealized		Unrealized		Estimated
	Cost		Gains		Losses		Fair Value
	(in thousands)
September 30, 2022
U.S. treasuries	$	47,084	$	—	$	(732)	$	46,352
Government agency securities		12,991		—		(112)		12,879
Corporate debt		37,389		—		(643)		36,746
Commercial paper		5,885		—		—		5,885
Total	$	103,349	$	—	$	(1,487)	$	101,862
December 31, 2021
U.S. treasuries	$	51,269	$	—	$	(174)	$	51,095
Government agency securities		12,075		—		(23)		12,052
Corporate debt		40,169		—		(134)		40,035
Commercial paper		999		—		—		999
Total	$	104,512	$	—	$	(331)	$	104,181

Available-for-sale securities in a loss position at September 30, 2022 and December 31, 2021 consist of:

	September 30, 2022								December 31, 2021
	Continuous Loss Position				Continuous Loss Position				Continuous Loss Position
	for Less than 12 Months				for 12 Months or More				for Less than 12 Months
			Gross				Gross				Gross
	Estimated		Unrealized		Estimated		Unrealized		Estimated		Unrealized
	Fair Value		Losses		Fair Value		Losses		Fair Value		Losses
		(in thousands)
U.S. treasuries	$	16,973	$	(122)	$	29,379	$	(610)	$	51,095	$	(174)
Government agency securities		8,082		(59)		4,797		(53)		12,052		(23)
Corporate debt		25,980		(423)		10,766		(220)		40,035		(134)
Total	$	51,035	$	(604)	$	44,942	$	(883)	$	103,182	$	(331)

At December 31, 2021, there were no short-term investments that had been in a continuous loss position for more than 12 months.

The contractual maturities of securities classified as available-for-sale at September 30, 2022 were as follows:

	September 30, 2022
	Amortized		Estimated
	Cost		Fair Value
		(in thousands)
Due in one year or less	$	97,762	$	96,468
Due after one year through two years		5,587		5,394
Total	$	103,349	$	101,862

Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. There were no realized gains or losses, or unrealized losses from declines in fair value that are other than temporary, for the nine months ended September 30, 2022 and 2021.

Accounts Receivable

Accounts receivable is presented net of an allowance for doubtful accounts of $0.7 million at September 30, 2022 and December 31, 2021. The Company considered its current expectations of future economic conditions, including the impact of COVID-19, when estimating its allowance for doubtful accounts.

Inventories

Inventories at September 30, 2022 and December 31, 2021 consist of the following:

	September 30,		December 31,
	2022		2021
	(in thousands)
Materials	$	120,021	$	96,027
Work-in-process		61,052		54,128
Finished goods		6,664		20,703
Total	$	187,737	$	170,858

Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets primarily consist of supplier deposits, prepaid value-added tax, lease deposits, prepaid insurance, prepaid licenses, and other receivables. In addition, Veeco had deposits with its suppliers of $7.1 million and $3.9 million at September 30, 2022 and December 31, 2021, respectively.

Property, Plant, and Equipment

Property, plant, and equipment at September 30, 2022 and December 31, 2021 consist of the following:

	September 30,		December 31,
	2022		2021
	(in thousands)
Land	$	5,061	$	5,061
Building and improvements		64,198		63,946
Machinery and equipment (1)		160,365		145,656
Leasehold improvements		50,404		45,979
Gross property, plant, and equipment		280,028		260,642
Less: accumulated depreciation and amortization		171,612		160,899
Net property, plant, and equipment	$	108,416	$	99,743

(1) Machinery and equipment also includes software, furniture and fixtures

For the three and nine months ended September 30, 2022, depreciation expense was $3.8 million and $11.6 million, respectively, and $3.5 million and $10.3 million, respectively, for the comparable 2021 periods.

Goodwill

Goodwill represents the future economic benefits arising from assets acquired in a business combination that are not individually identified and separately recognized. The Company continues to assess potential triggering events related to the value of its goodwill and concluded that there were no indicators of impairment during the nine months ended September 30, 2022.

Intangible Assets

Intangible assets consist of purchased technology, customer relationships, patents, trademarks and tradenames, licenses, and backlog, and are initially recorded at fair value. Long-lived intangible assets are amortized over their estimated useful lives in a method reflecting the pattern in which the economic benefits are consumed or amortized on a straight-line basis if such pattern cannot be reliably determined. The Company continues to assess potential triggering events related to the value of its intangible assets and concluded that there were no indicators of impairment during the three and nine months ended September 30, 2022.

The components of purchased intangible assets were as follows:

	September 30, 2022						December 31, 2021
			Accumulated						Accumulated
	Gross		Amortization				Gross		Amortization
	Carrying		and		Net		Carrying		and		Net
	Amount		Impairment		Amount		Amount		Impairment		Amount
	(in thousands)
Technology	$	327,908	$	315,327	$	12,581	$	327,908	$	310,551	$	17,357
Customer relationships		146,465		134,803		11,662		146,465		132,970		13,495
Trademarks and tradenames		30,910		28,762		2,148		30,910		27,857		3,053
Other		3,686		3,686		—		3,686		3,686		—
Total	$	508,969	$	482,578	$	26,391	$	508,969	$	475,064	$	33,905

Other intangible assets primarily consist of patents, licenses, and backlog.

XML

Liabilities

9 Months Ended

Sep. 30, 2022

Liabilities

Liabilities

Note 4 — Liabilities

Accrued Expenses and Other Current Liabilities

The components of accrued expenses and other current liabilities at September 30, 2022 and December 31, 2021 consist of:

	September 30,		December 31,
	2022		2021
	(in thousands)
Payroll and related benefits	$	33,920	$	35,712
Warranty		8,716		7,878
Operating lease liabilities		3,802		4,437
Interest		2,732		2,757
Professional fees		1,865		1,467
Legal settlement		300		15,000
Sales, use, and other taxes		5,317		4,889
Other		8,410		7,612
Total	$	65,062	$	79,752

Warranty

Warranties are typically valid for one year from the date of system final acceptance. The Company estimates the costs that may be incurred under the warranty which are determined by analyzing specific product and historical configuration statistics and regional warranty support costs and are affected by product failure rates, material usage, and labor costs incurred in correcting product failures during the warranty period. Unforeseen component failures or exceptional

component performance can also result in changes to warranty costs. Changes in product warranty reserves for the nine months ended September 30, 2022 include:

		(in thousands)
Balance - December 31, 2021	$	7,878
Warranties issued		6,195
Consumption of reserves		(5,734)
Changes in estimate		377
Balance - September 30, 2022	$	8,716

Customer Deposits and Deferred Revenue

Customer deposits totaled $108.9 million and $46.9 million at September 30, 2022 and December 31, 2021, respectively. Deferred revenue represents amounts billed, other than deposits, in excess of the revenue that can be recognized on a particular contract at the balance sheet date. Changes in deferred revenue were as follows:

	(in thousands)
Balance - December 31, 2021	$	16,276
Deferral of revenue		2,908
Recognition of unearned revenue		(5,836)
Balance - September 30, 2022	$	13,348

As of September 30, 2022, the Company has approximately $142.5 million of remaining performance obligations on contracts with an original estimated duration of one year or more, of which approximately 24% is expected to be recognized within one year, with the remaining amounts expected to be recognized between one to three years. The Company has elected to exclude disclosures regarding remaining performance obligations that have an original expected duration of one year or less.

Convertible Senior Notes

2023 Notes

On January 10, 2017, the Company issued $345.0 million of 2.70% convertible senior unsecured notes due 2023 (the “2023 Notes”). The Company received net proceeds, after deducting underwriting discounts and fees and expenses payable by the Company, of approximately $335.8 million. The 2023 Notes bear interest at a rate of 2.70% per year, payable semiannually in arrears on January 15 and July 15 of each year, commencing on July 15, 2017. The 2023 Notes mature on January 15, 2023, unless earlier purchased by the Company, redeemed, or converted.

On May 18, 2020, in connection with the completion of a private offering of $125.0 million aggregate principal amount of 3.75% convertible senior notes due 2027 described below, the Company repurchased and retired approximately $88.3 million in aggregate principal amount of its outstanding 2023 Notes, with a carrying amount of $78.1 million, for approximately $81.2 million of cash.

Additionally, on November 11, 2020, the Company entered into a privately negotiated exchange agreement with a holder of its outstanding 2023 Notes, under which the Company agreed to retire $125.0 million in aggregate original principal amount of the 2023 Notes, with a carrying amount of $113.1 million, in exchange for the issuance of $132.5 million in

aggregate principal amount of new 3.50% convertible senior notes due 2025 described below, which had a fair value that approximated the principal amount of notes issued.

Finally, on November 5, 2021, the Company entered into a privately negotiated note purchase agreement with a holder of its outstanding 2023 Notes, under which the Company agreed to repurchase and retire approximately $111.5 million in aggregate original principal amount of the 2023 Notes, with a carrying amount of $105.5 million, for cash consideration of approximately $115.6 million, and approximately $1.0 million of accrued and unpaid interest.

2025 Notes

On November 17, 2020, as part of the privately negotiated exchange agreement described above, the Company issued $132.5 million of 3.50% convertible senior notes due 2025 (the “2025 Notes”). The 2025 Notes bear interest at a rate of 3.50% per year, payable semiannually in arrears on January 15 and July 15 of each year, commencing on July 15, 2021. The 2025 Notes mature on January 15, 2025, unless earlier purchased by the Company, redeemed, or converted.

2027 Notes

On May 18, 2020, the Company completed a private offering of $125.0 million of 3.75% convertible senior notes due 2027 (the “2027 Notes”). The Company received net proceeds of approximately $121.9 million, after deducting underwriting discounts and fees and expenses payable by the Company. Additionally, the Company used approximately $10.3 million of cash to purchase capped calls, discussed below. The 2027 Notes bear interest at a rate of 3.75% per year, payable semiannually in arrears on June 1 and December 1 of each year, commencing on December 1, 2020. The 2027 Notes mature on June 1, 2027, unless earlier purchased by the Company, redeemed, or converted.

The 2023 Notes, 2025 Notes, and 2027 Notes (collectively, the “Notes”) are unsecured obligations of Veeco and rank senior in right of payment to any of Veeco’s subordinated indebtedness; equal in right of payment to all of Veeco’s unsecured indebtedness that is not subordinated; effectively subordinated in right of payment to any of Veeco’s secured indebtedness to the extent of the value of the assets securing such indebtedness; and structurally subordinated to all indebtedness and other liabilities (including trade payables) of Veeco’s subsidiaries.

The Notes are convertible at the option of the holders upon the satisfaction of specified conditions and during certain periods as described below. The initial conversion rates are 24.9800, 41.6667, and 71.5372 shares of the Company’s common stock per $1,000 principal amount of the 2023 Notes, 2025 Notes, and 2027 Notes, respectively, representing initial effective conversion prices of $40.03, $24.00, and $13.98 per share of common stock, respectively. The conversion rates may be subject to adjustment upon the occurrence of certain specified events.

Holders may convert all or any portion of their notes, in multiples of one thousand dollar principal amount, at their option at any time prior to the close of business on the business day immediately preceding October 15, 2022 with respect to the 2023 Notes, October 15, 2024 with respect to the 2025 Notes, and October 1, 2026 with respect to the 2027 Notes, only under the following circumstances:

(i) During any calendar quarter (and only during such calendar quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day;

(ii) During the five consecutive business day period after any five consecutive trading day period (the “measurement period”) in which the trading price per one thousand dollar principal amount of Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of Veeco’s common stock and the conversion rate on each such trading day;

(iii) If the Company calls any or all of applicable series of the Notes for redemption at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or

(iv) Upon the occurrence of specified corporate events.

For the calendar quarter ended September 30, 2022, the last reported sales price of common stock during the 30 consecutive trading days, based on the criteria outlined in (i) above, was greater than 130% of the conversion price of the 2027 Notes, and as such the 2027 Notes are convertible by the holders until December 31, 2022.

Holders may convert their notes at any time, regardless of the foregoing circumstances, on or after October 15, 2022 with respect to the 2023 Notes, October 15, 2024 with respect to the 2025 Notes, and October 1, 2026 with respect to the 2027 Notes, until the close of business on the business day immediately preceding the respective maturity date.

Accounting for the Notes after the adoption of ASU 2020-06

The Company adopted ASU 2020-06 on January 1, 2022 as further described in Note 1, “Basis of Presentation”. Following the adoption of ASU 2020-06, the Notes are recorded as a single unit within liabilities in the consolidated balance sheets as the conversion features within the Notes are not derivatives that require bifurcation and the Notes do not involve a substantial premium. Transaction costs of $9.2 million, $1.9 million, and $3.1 million incurred in connection with the issuance of the 2023 Notes, 2025 Notes, and 2027 Notes, respectively, were recorded as direct deductions from the related debt liabilities and recognized as non-cash interest expense using the effective interest method over the expected terms of the Notes.

Accounting for the Notes prior to the adoption of ASU 2020-06

Upon conversion by the holders, the Company may elect to settle such conversion in shares of its common stock, cash, or a combination thereof. As a result of its cash conversion options, prior to the adoption of ASU 2020-06, the Company segregated the liability component of the instruments from the equity components. The liability components were measured by estimating the fair value of a non-convertible debt instrument that is similar in its terms to the Notes. The calculation of the fair value of the debt components required the use of Level 3 inputs, including utilization of convertible investors’ credit assumptions and high yield bond indices. Fair value was estimated through discounting future interest and principal payments, an income approach, due under the Notes at a discount rate equal to the estimated borrowing rate for similar non-convertible debt, or 7.0%, 8.0%, and 9.1% with respect to the 2023 Notes, 2025 Notes, and 2027 Notes, respectively. The excess of the aggregate face values of the Notes over the estimated fair values of the liability components of $72.5 million, $21.0 million, and $34.2 million with respect to the 2023 Notes, 2025 Notes, and 2027 Notes, respectively, were recognized as debt discounts and recorded as an increase to additional paid-in capital and were to be amortized over the expected lives of the Notes using the effective interest rate method. Amortization of the debt discounts were recognized as non-cash interest expense.

The transaction costs of $9.2 million, $1.9 million, and $3.1 million incurred in connection with the issuance of the 2023 Notes, 2025 Notes, and 2027 Notes, respectively, were allocated to the liability and equity components based on their relative values. Transaction costs allocated to the liability component were being amortized using the effective interest rate method and recognized as non-cash interest expense over the expected terms of the Notes. Transaction costs allocated to the equity component of $1.9 million, $0.3 million, and $0.8 million with respect to the 2023 Notes, 2025 Notes, and 2027 Notes, respectively, reduced the value of the equity components recognized in stockholders' equity.

The carrying value of the 2023 Notes, 2025 Notes and 2027 Notes are as follows:

		September 30, 2022						December 31, 2021
		Principal Amount		Unamortized transaction costs		Net carrying value		Principal Amount		Unamortized debt discount/ transaction costs		Net carrying value
		(in thousands)
2023 Notes	$	20,173	$	(29)	$	20,144	$	20,173	$	(967)	$	19,206
2025 Notes		132,500		(1,105)		131,395		132,500		(17,302)		115,198
2027 Notes		125,000		(2,123)		122,877		125,000		(29,966)		95,034
Net carrying value	$	277,673	$	(3,257)	$	274,416	$	277,673	$	(48,235)	$	229,438

Total interest expense related to the 2023 Notes, 2025 Notes and 2027 Notes is as follows:

	Three months ended September 30,				Nine months ended September 30,
	2022		2021		2022		2021
	(in thousands)
Cash Interest Expense
Coupon interest expense - 2023 Notes	$	136	$	889	$	409	$	2,667
Coupon interest expense - 2025 Notes		1,159		1,159		3,478		3,478
Coupon interest expense - 2027 Notes		1,172		1,172		3,516		3,516
Non-cash Interest Expense
Amortization of debt discount/transaction costs- 2023 Notes		24		1,417		73		4,171
Amortization of debt discount/transaction costs- 2025 Notes		115		1,211		341		3,558
Amortization of debt discount/transaction costs- 2027 Notes		103		1,035		305		3,033
Total Interest Expense	$	2,709	$	6,883	$	8,122	$	20,423

The Company determined the 2023 Notes, 2025 notes, and 2027 Notes are Level 2 liabilities in the fair value hierarchy and had an estimated fair value at September 30, 2022 of $19.5 million, $144.3, and $191.9 million, respectively.

Capped Call Transactions

In connection with the offering of the 2027 Notes, on May 13, 2020, the Company entered into privately negotiated capped call transactions (the “Capped Call Transactions”), pursuant to capped call confirmations, covering the total principal amount of the 2027 Notes for an aggregate premium of $10.3 million. The Capped Call Transactions are expected generally to reduce the potential dilution to the Company’s common stock upon any conversion of the 2027 Notes and/or offset any cash payments the Company is required to make in excess of the aggregate principal amount of converted 2027 Notes, as the case may be, with such reduction and/or offset subject to a cap based on the capped price of the Capped Call Transactions. The Capped Call Transactions exercise price is equal to the initial conversion price of the 2027 Notes, and the capped price of the Capped Call Transactions is approximately $18.46 per share and is subject to certain adjustments under the terms of the capped call confirmations.

The Capped Call Transactions are separate transactions entered into by the Company with the capped call counterparties, are not part of the terms of the 2027 Notes and do not change the holders’ rights under the 2027 Notes. Holders of the 2027 Notes do not have any rights with respect to the Capped Call Transactions. The cost of the Capped Call Transactions is not expected to be tax-deductible as the Company did not elect to integrate the Capped Call Transactions into the 2027 Notes for tax purposes. The Company used a portion of the net proceeds from the offering of the 2027

Notes to pay for the Capped Call Transactions, and the cost of the Capped Call Transactions was recorded as a reduction of the Company’s additional paid-in capital in the accompanying consolidated financial statements.

Revolving Credit Facility

On December 16, 2021, the Company entered into a loan and security agreement providing for a senior secured revolving credit facility in an aggregate principal amount of $150 million (the “Credit Facility”), including a $15 million letter of credit sublimit. The Credit Facility is guaranteed by the Company’s direct material U.S. subsidiaries, subject to customary exceptions. Borrowings under the Credit Facility are secured by a first-priority lien on substantially all of the assets of the Company, subject to customary exceptions. The Credit Facility has a term of five years, maturing on December 16, 2026, or earlier if certain liquidity measures are not met prior to the 2025 Notes maturing. Subject to certain conditions and the receipt of commitments from the lenders, the Loan and Security Agreement allows for revolving commitments under the Credit Facility to be increased by up to $75 million. The existing lenders under the Credit Facility are entitled, but not obligated, to provide such incremental commitments.

Borrowings will bear interest at a floating rate which can be, at the Company’s option, either (a) an alternate base rate plus an applicable rate ranging from 0.50% to 1.25% or (b) a Secured Overnight Financing Rate (“SOFR”) (with a floor of 0.00%) for the specified interest period plus an applicable rate ranging from 1.50% to 2.25%, in each case, depending on the Company’s Secured Net Leverage Ratio (as defined in the Loan and Security Agreement). The Company will pay an unused commitment fee ranging from 0.25% to 0.35% based on unused capacity under the Credit Facility and the Company’s Secured Net Leverage Ratio. The Company may use the proceeds of borrowings under the Credit Facility to pay transaction fees and expenses, provide for its working capital needs and reimburse drawings under letters of credit and for other general corporate purposes.

The Loan and Security Agreement contains customary affirmative covenants for transactions of this type, including, among others, the provision of financial and other information to the administrative agent, notice to the administrative agent upon the occurrence of certain material events, preservation of existence, maintenance of properties and insurance, compliance with laws, including environmental laws, the provision of additional guarantees, and an affiliate transactions covenant, subject to certain exceptions. The Loan and Security Agreement contains customary negative covenants, including, among others, restrictions on the ability to merge and consolidate with other companies, incur indebtedness, refinance our existing convertible notes, grant liens or security interests on assets, make investments, acquisitions, loans, or advances, pay dividends, and sell or otherwise transfer assets.

The Loan and Security Agreement contains financial maintenance covenants that require the Borrower to maintain an Interest Coverage Ratio (as defined in the Loan and Security Agreement) of not less than 3.00 to 1.00, a Total Net Leverage Ratio (as defined in the Loan and Security Agreement) of not more than 4.50 to 1.00, and a Secured Net Leverage Ratio (as defined in the Loan and Security Agreement) of not more than 2.50 to 1.00, in each case, tested at the end of each fiscal quarter commencing with the fiscal quarter ending June 30, 2022. The Loan and Security Agreement also provides for a number of customary events of default, including, among others: payment defaults to the lenders; voluntary and involuntary bankruptcy proceedings; covenant defaults; material inaccuracies of representations and warranties; certain change of control events; material money judgments; and other customary events of default. The occurrence of an event of default could result in the acceleration of obligations and the termination of lending commitments under the Loan and Security Agreement.

No amounts were outstanding under the Credit Facility as of September 30, 2022 or December 31, 2021.

Other Liabilities

Other liabilities at September 30, 2022 and December 31, 2021 included (i) medical and dental benefits for former executives of $1.8 million; (ii) asset retirement obligations of $2.8 million; and (iii) income tax payables of $0.4 million.

XML

Commitments and Contingencies

9 Months Ended

Sep. 30, 2022

Commitments and Contingencies

Commitments and Contingencies

Note 5 — Commitments and Contingencies

Leases

The Company’s operating leases primarily include real estate leases for properties used for manufacturing, R&D activities, sales and service, and administration, as well as certain equipment leases. Some leases may include options to renew for a period of up to 5 years, while others may include options to terminate the lease. The weighted average remaining lease term of the Company’s operating leases as of September 30, 2022 was 12 years, and the weighted average discount rate used in determining the present value of future lease payments was 5.6%.

The following table provides the maturities of lease liabilities at September 30, 2022:

	Operating
	Leases
	(in thousands)
Payments due by period:
2022	$	952
2023		4,097
2024		3,877
2025		3,292
2026		3,480
Thereafter		35,961
Total future minimum lease payments		51,659
Less: Imputed interest		(16,591)
Total	$	35,068
Reported as of September 30, 2022
Accrued expenses and other current liabilities	$	3,802
Long-term operating lease liabilities		31,266
Total	$	35,068

Operating lease cost for the three and nine months ended September 30, 2022 were $1.8 million and $5.5 million, respectively, and $1.8 million and $4.8 million, respectively, for the comparable 2021 periods. Variable lease cost for the three and nine months ended September 30, 2022 were $0.5 million and $1.5 million, respectively, and $0.4 million and $1.3 million, respectively, for the comparable 2021 periods. Additionally, the Company has an immaterial amount of short-term leases. Operating cash outflows from operating leases for the nine months ended September 30, 2022 and 2021 were $5.7 million and $4.9 million, respectively.

Receivable Purchase Agreement

In December 2020, the Company entered into a receivable purchase agreement with a financial institution to sell certain of its trade receivables from customers without recourse, up to $15.0 million at any point in time. Pursuant to this agreement, the Company sold $7.8 million of receivables during the three months ended September 30, 2022, all of which was outstanding at September 30, 2022 as defined in the receivable purchase agreement, and $7.2 million was available under the agreement for additional sales of receivables. The Company did not sell any receivables under this agreement for the nine months ended September 30, 2021. The net sale of accounts receivable under the agreement is reflected as a reduction of accounts receivable in the Company’s Consolidated Balance Sheet at the time of sale and any fees for the sale of trade receivables were not material for the periods presented.

Purchase Commitments

Veeco has purchase commitments of $299.4 million at September 30, 2022, substantially all of which become due within one year.

Bank Guarantees

Veeco has bank guarantees and letters of credit issued by a financial institution on its behalf as needed. At September 30, 2022, outstanding bank guarantees and standby letters of credit totaled $7.0 million, and unused bank guarantees and letters of credit of $14.7 million were available to be drawn upon.

Legal Proceedings

On June 8, 2018, an Ultratech shareholder who received Veeco stock as part of the consideration for the Ultratech acquisition filed a purported class action complaint in the Superior Court of the State of California, County of Santa Clara, captioned Wolther v. Maheshwari et al., Case No. 18CV329690, on behalf of himself and others who purchased or acquired shares of Veeco pursuant to the registration statement and prospectus which Veeco filed with the SEC in connection with the Ultratech acquisition (the “Wolther Action”). On August 2 and August 8, 2018, two purported class action complaints substantially similar to the Wolther Action were filed on behalf of different plaintiffs in the same court as the Wolther Action. These cases have been consolidated with the Wolther Action, and a consolidated complaint was filed on December 11, 2018. The consolidated complaint seeks to recover damages and fees under Sections 11, 12, and 15 of the Securities Act of 1933 for, among other things, alleged false/misleading statements in the registration statement and prospectus relating to the Ultratech acquisition, relating primarily to the alleged failure to disclose delays in the advanced packaging business, increased metal organic chemical vapor deposition (“MOCVD”) competition in China, and an intellectual property dispute. In October 2021, Veeco and the court-appointed class representatives signed an agreement to settle the Wolther Action on a class-wide basis for $15.0 million, subject to court approval and class members’ opportunity to object and opt-out. On June 27, 2022, the court granted final approval to the class action settlement. The settlement amount has been funded by insurance carriers. The corresponding receivable and liability had been included within “Prepaid expenses and other current assets” and “Accrued expenses and other current liabilities”, respectively, in the Consolidated Balance Sheets as of December 31, 2021.

On December 21, 2018, a purported Veeco stockholder filed a derivative action in the Superior Court of the State of California, County of Santa Clara, captioned Vladimir Gusinsky Revocable Trust v. Peeler, et al., Case No. 18CV339925, on behalf of nominal defendant Veeco (the “Derivative Action”). The complaint seeks to assert claims for breach of fiduciary duty, waste of corporate assets, and unjust enrichment against current and former Veeco directors premised on purported misstatements and omissions in the registration statement relating to the Ultratech acquisition. On January 25, 2021, the court granted the defendants’ demurrer without leave to amend effecting the dismissal of the case. On March 26, 2021, plaintiff filed its notice of appeal of the trial court’s order granting defendants’ demurrer without leave to amend. In April 2022, Veeco and plaintiff reached an agreement to settle the Derivative Action subject to court approval. As part of the settlement and subject to court approval, Veeco will make certain revisions to its internal Disclosure Committee Charter and its director education program. The agreement also provides that, subject to court approval, plaintiff will receive $0.3 million for fees and expenses. This amount will be funded by insurance that Veeco maintains in the normal course of its business. On September 12, 2022, the court issued an order granting preliminary approval of the proposed settlement (the “Preliminary Approval Order”). The Preliminary Approval Order set the final settlement approval hearing for November 17, 2022.

The Company is involved in various other legal proceedings arising in the normal course of business. The Company does not believe that the ultimate resolution of these matters will have a material adverse effect on its consolidated financial position, results of operations, or cash flows.

XML

Derivative Financial Instruments

9 Months Ended

Sep. 30, 2022

Derivative Financial Instruments

Derivative Financial Instruments

Note 6 — Derivative Financial Instruments

The Company is exposed to financial market risks arising from changes in currency exchange rates. Changes in currency exchange rates could affect the Company’s foreign currency denominated monetary assets and liabilities and forecasted cash flows. The Company enters into monthly forward derivative contracts from time to time with the intent of mitigating a portion of this risk. The Company only uses derivative financial instruments in the context of hedging and not for speculative purposes and had not designated its foreign exchange derivatives as hedges. Accordingly, changes in fair value from these contracts are recorded as “Other operating expense (income), net” in the Company’s Consolidated Statements of Operations. The Company executes derivative transactions with highly rated financial institutions to mitigate counterparty risk.

The Company did not have any outstanding derivative contracts at September 30, 2022 or December 31, 2021. Additionally, the Company did not have any gains or losses from currency exchange derivatives during the nine months ended September 30, 2022 and 2021.

XML

Equity

9 Months Ended

Sep. 30, 2022

Stockholders' Equity

Stockholders' Equity

Note 7 — Equity

Statement of Stockholders’ Equity

The following tables present the changes in Stockholders’ Equity:

								Accumulated
				Additional				Other
	Common Stock			Paid-in		Accumulated		Comprehensive
	Shares	Amount		Capital		Deficit		Income		Total
	(in thousands)
Balance at December 31, 2021	50,653	$	507	$	1,116,921	$	(681,283)	$	1,483	$	437,628
Cumulative effect of change in accounting principle - adoption of ASU 2020-06	—		—		(56,801)		12,541		—		(44,260)
Net income	—		—		—		13,330		—		13,330
Other comprehensive income (loss), net of tax	—		—		—		—		(822)		(822)
Share-based compensation expense	—		—		4,481		—		—		4,481
Net issuance under employee stock plans	590		6		(6,793)		—		—		(6,787)
Balance at March 31, 2022	51,243	$	513	$	1,057,808	$	(655,412)	$	661	$	403,570
Net income	—		—		—		9,655		—		9,655
Other comprehensive income (loss), net of tax	—		—		—		—		(272)		(272)
Share-based compensation expense	—		—		6,278		—		—		6,278
Net issuance under employee stock plans	182		2		1,504		—		—		1,506
Balance at June 30, 2022	51,425	$	515	$	1,065,590	$	(645,757)	$	389	$	420,737
Net income (loss)	—		—		—		15,041		—		15,041
Other comprehensive income (loss), net of tax	—		—		—		—		(170)		(170)
Share-based compensation expense	—		—		6,210		—		—		6,210
Net issuance under employee stock plans	(5)		—		(703)		—		—		(703)
Balance at September 30, 2022	51,420	$	515	$	1,071,097	$	(630,716)	$	219	$	441,115

								Accumulated
				Additional				Other
	Common Stock			Paid-in		Accumulated		Comprehensive
	Shares	Amount		Capital		Deficit		Income		Total
	(in thousands)
Balance at December 31, 2020	49,724	$	497	$	1,113,352	$	(707,321)	$	1,846	$	408,374
Net income	—		—		—		2,494		—		2,494
Other comprehensive income (loss), net of tax	—		—		—		—		(19)		(19)
Share-based compensation expense	—		—		3,237		—		—		3,237
Net issuance under employee stock plans	459		5		(1,630)		—		—		(1,625)
Balance at March 31, 2021	50,183	$	502	$	1,114,959	$	(704,827)	$	1,827	$	412,461
Net income	—		—		—		6,348		—		6,348
Other comprehensive income (loss), net of tax	—		—		—		—		(24)		(24)
Share-based compensation expense	—		—		4,367		—		—		4,367
Net issuance under employee stock plans	166		1		582		—		—		583
Balance at June 30, 2021	50,349	$	503	$	1,119,908	$	(698,479)	$	1,803	$	423,735
Net income (loss)	—		—		—		8,993		—		8,993
Other comprehensive income (loss), net of tax	—		—		—		—		(33)		(33)
Share-based compensation expense	—		—		4,131		—		—		4,131
Net issuance under employee stock plans	(28)		—		(1,513)		—		—		(1,513)
Balance at September 30, 2021	50,321	$	503	$	1,122,526	$	(689,486)	$	1,770	$	435,313

Accumulated Other Comprehensive Income (“AOCI”)

The following table presents the changes in the balances of each component of AOCI, net of tax:

			Unrealized
			Gains (Losses)
	Foreign		on Available
	Currency		for Sale
	Translation		Securities		Total
	(in thousands)
Balance - December 31, 2021	$	1,814	$	(331)	$	1,483
Other comprehensive income (loss)		(108)		(1,156)		(1,264)
Balance - September 30, 2022	$	1,706	$	(1,487)	$	219

There were minimal reclassifications from AOCI into net income for the three and nine months ended September 30, 2022 and 2021.

XML

Share-based Compensation

9 Months Ended

Sep. 30, 2022

Share-based Compensation

Share-based compensation

Note 8 — Share-based Compensation

Restricted share awards are issued to employees and board of directors that are subject to specified restrictions and a risk of forfeiture. The restrictions typically lapse over one to four years and may entitle holders to dividends and voting rights. Other types of share-based compensation include performance share awards, performance share units, and restricted share units (collectively with restricted share awards, “restricted shares”), as well as options to purchase common stock.

Share-based compensation expense was recognized in the following line items in the Consolidated Statements of Operations for the three and nine months ended September 30, 2022 and 2021:

	Three months ended September 30,				Nine months ended September 30,
	2022		2021		2022		2021
	(in thousands)
Cost of sales	$	1,195	$	620	$	3,384	$	1,765
Research and development		1,819		1,007		4,939		2,957
Selling, general, and administrative		3,196		2,504		8,646		7,013
Total	$	6,210	$	4,131	$	16,969	$	11,735

For the nine months ended September 30, 2022, equity activity related to stock options was as follows:

		Weighted
	Number of	Average
	Shares	Exercise Price
	(in thousands)
Balance - December 31, 2021	443	$	32.15
Expired	(266)		32.95
Balance - September 30, 2022	177		30.94

For the nine months ended September 30, 2022, equity activity related to non-vested restricted shares and performance shares was as follows:

		Weighted
		Average
	Number of	Grant Date
	Shares	Fair Value
	(in thousands)
Balance - December 31, 2021	2,083	$	17.33
Granted	1,060		30.84
Performance award adjustments	85		14.03
Vested	(787)		15.21
Forfeited	(73)		19.85
Balance - September 30, 2022	2,368		23.88

XML

Income Taxes

9 Months Ended

Sep. 30, 2022

Income Taxes

Income Taxes

Note 9 — Income Taxes

Income taxes are estimated for each of the jurisdictions in which the Company operates. Deferred income taxes reflect the net tax effect of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes, as well as the tax effect of carryforwards. Realization of net deferred tax assets is dependent on future taxable income. At September 30, 2022, the Company’s U.S. deferred tax assets are fully offset by a valuation allowance since the Company cannot conclude that it is more likely than not that these future benefits will be realized. The Company will maintain this valuation allowance until there is sufficient positive evidence to support its reversal. The Company believes there is a reasonable possibility within the next twelve months that sufficient positive evidence may become available to allow management to reach a conclusion that a significant portion of the valuation allowance will no longer be needed. Release of the valuation allowance would result in the recognition of certain deferred tax assets with a corresponding decrease to income tax expense for the period the release is recorded. Additionally, if the valuation allowance is released and the Company continues to earn profits, the Company’s effective tax rate would likely increase in future periods compared to its current rates.

At the end of each interim reporting period, the effective tax rate is aligned with expectations for the full year. This estimate is used to determine the income tax provision on a year-to-date basis and may change in subsequent interim periods.

Income before income taxes and income tax expense (benefit) for the three and nine months ended September 30, 2022 and 2021 were as follows:

	Three months ended September 30,				Nine months ended September 30,
	2022		2021		2022		2021
	(in thousands)
Income before income taxes	$	15,249	$	9,404	$	39,151	$	18,864
Income tax expense (benefit)	$	208	$	411	$	1,125	$	1,029

The Company’s tax expense for the three months ended September 30, 2022 was $0.2 million, compared to $0.4 million for the comparable prior period. The 2022 tax expense included an expense of $0.1 million related to the Company’s non-U.S. operations and $0.1 million related to the Company’s domestic operations. The 2021 tax expense included an expense of $0.4 million related to the Company’s non-U.S. operations and minimal expense related to the Company’s domestic operations. For the three months ended September 30, 2022 and 2021, the Company’s U.S. deferred tax assets are fully offset by a valuation allowance since the Company cannot conclude that it is more likely than not that these future benefits will be realized. The domestic tax expense for both periods is primarily attributable to state income taxes and the tax amortization of indefinite lived intangible assets that is not available to offset U.S. deferred tax assets. The

foreign tax expense for both periods is primarily attributable to non-US operations profits and foreign withholding taxes on unremitted earnings, offset by the amortization of intangible assets.

The Company’s tax expense for the nine months ended September 30, 2022 was $1.1 million, compared to $1.0 million for the comparable prior period. The 2022 tax expense included an expense of $0.8 million related to the Company’s non-U.S. operations and $0.3 million related to the Company’s domestic operations. The 2021 tax expense included an expense of $0.8 million related to the Company’s non-U.S. operations and $0.2 million related to the Company’s domestic operations. For the nine months ended September 30, 2022 and 2021, the Company’s U.S. deferred tax assets are fully offset by a valuation allowance since the Company cannot conclude that it is more likely than not that these future benefits will be realized. The domestic tax expense for both periods is primarily attributable to state income taxes and the tax amortization of indefinite lived intangible assets that is not available to offset U.S. deferred tax assets. The foreign tax expense for both periods is primarily attributable to non-US operations profits and foreign withholding taxes on unremitted earnings, offset by the amortization of intangible assets.

Inflation Reduction Act and CHIP Act

The Inflation Reduction Act of 2022 (the “IRA Act”) was signed into U.S. law on August 16, 2022. The Act includes various tax provisions, including an excise tax on stock repurchases, expanded tax credits for clean energy incentives, and a corporate alternative minimum tax that generally applies to U.S. corporations with average adjusted financial statement income over a three year period in excess of $1 billion. The Company does not expect the IRA Act to materially impact its financial statements.

The CHIPS and Science Act of 2022 (the “CHIP Act”) was signed into U.S. law on August 9, 2022. The Act includes a 25% advanced investment tax credit for certain investments in semiconductor manufacturing. While the Company is still evaluating the impact of this act, the CHIP Act may benefit the Company for qualified investments placed in service after December 31, 2022.

XML

Segment Reporting and Geographic Information

9 Months Ended

Sep. 30, 2022

Segment Reporting and Geographic Information

Segment Reporting and Geographic Information

Note 10 — Segment Reporting and Geographic Information

Veeco operates and measures its results in one operating segment and therefore has one reportable segment: the development, manufacture, sales, and support of semiconductor and thin film process equipment primarily sold to make electronic devices.

Veeco serves the following four end-markets:

Semiconductor

The Semiconductor market refers to early process steps in logic and memory applications where silicon wafers are processed. There are many different process steps in forming patterned wafers, such as deposition, etching, masking, and doping, where the microchips are created but remain on the silicon wafer. This market includes mask blank production for extreme ultraviolet (“EUV”) lithography. This market also includes Advanced Packaging which refers to a portfolio of wafer-level assembly technologies that enable improved performance of electronic products, such as smartphones, high-end servers, and graphical processors.

Compound Semiconductor

The Compound Semiconductor market includes Photonics, Power Electronics, RF Filters and Amplifiers, and Solar applications. Photonics refers to light source technologies and laser-based solutions for 3D sensing, datacom and telecom applications. This includes micro-LED, laser diodes, edge emitting lasers and vertical cavity surface emitting lasers (“VCSELs”). Power Electronics refers to semiconductor devices such as rectifiers, inverters and converters for the

control and conversion of electric power in applications such as fast or wireless charging of consumer electronics and automotive applications. RF power amplifiers and filters (including surface acoustic wave (“SAW”) and bulk acoustic wave (“BAW”) filters) are used in 5G communications infrastructure, smartphones, tablets, and mobile devices. They make use of radio waves for wireless broadcasting and/or communications. Solar refers to power obtained by harnessing the energy of the sun through the use of compound semiconductor devices such as photovoltaics.

Data Storage

Data Storage refers to the Hard Disk Drive (“HDD”) market, for which our systems enable customers to manufacture thin film magnetic heads for hard disk drives as part of large capacity storage applications.

Scientific & Other

Scientific & Other refers to advanced materials research and a range of manufacturing applications including optical coatings (laser mirrors, optical filters, and anti-reflective coatings).

Sales by end-market and geographic region for the three and nine months ended September 30, 2022 and 2021 were as follows:

	Three months ended September 30,				Nine months ended September 30,
	2022		2021		2022		2021
	(in thousands)
Sales by end-market
Semiconductor	$	100,387	$	76,320	$	275,528	$	181,641
Compound Semiconductor		28,094		23,273		96,325		72,255
Data Storage		27,702		39,256		70,845		132,261
Scientific & Other		15,730		11,397		49,640		44,148
Total	$	171,913	$	150,246	$	492,338	$	430,305
Sales by geographic region
United States	$	53,747	$	48,776	$	159,157	$	160,908
EMEA(1)		17,562		13,564		66,221		36,128
China		36,193		27,261		95,071		68,148
Rest of APAC		64,259		60,589		170,526		164,926
Rest of World		152		56		1,363		195
Total	$	171,913	$	150,246	$	492,338	$	430,305

(1) EMEA consists of Europe, the Middle East, and Africa

For geographic reporting, sales are attributed to the location in which the customer facility is located.

XML

Basis of Presentation (Policies)

9 Months Ended

Sep. 30, 2022

Significant Accounting Policies

Basis of Presentation

The accompanying unaudited Consolidated Financial Statements of Veeco have been prepared in accordance with U.S. GAAP as defined in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification 270 for interim financial information and with the instructions to Rule 10-01 of Securities and Exchange Commission Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements as the interim information is an update of the information that was presented in Veeco’s most recent annual financial statements. For further information, refer to Veeco’s Consolidated Financial Statements and Notes thereto included in the Annual Report on Form 10-K for the year ended December 31, 2021 (“2021 Form 10-K”). In the opinion of management, all adjustments considered necessary for a fair presentation have been included. All such adjustments are of a normal, recurring nature.

Fiscal Period

Veeco reports interim quarters on a 13-week basis ending on the last Sunday of each quarter. The fourth quarter always ends on the last day of the calendar year, December 31. The 2022 interim quarters end on April 3, July 3, and October 2, and the 2021 interim quarters ended on April 4, July 4, and October 3. These interim quarters are reported as March 31, June 30, and September 30 in Veeco’s interim consolidated financial statements.

Use of Estimates

The preparation of financial statements in conformity with U.S GAAP requires the Company’s management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Although these estimates are based on management’s knowledge of current events and actions it may undertake in the future, actual results may differ from these estimates. In particular, the COVID-19 pandemic has adversely impacted and is likely to further adversely impact the Company’s business and markets, including the Company’s workforce and operations and the operations of the Company’s customers, suppliers, and business partners. The full extent to which the pandemic will directly or indirectly impact the Company's business, results of operations and financial condition, including sales, expenses, manufacturing, research and development costs, reserves and allowances, fair value measurements, and asset impairment charges, will depend on future developments that are highly uncertain and difficult to predict. These developments include, but are not limited to, the duration and spread of the outbreak, its severity, the actions to contain the virus or address its impact, governmental actions to contain the spread of the pandemic and respond to the reduction in global economic activity, and how quickly and to what extent normal economic and operating conditions can resume.

Revenue Recognition

Revenue Recognition

Revenue is recognized upon the transfer of control of the promised product or service to the customer in an amount that reflects the consideration the Company expects to receive in exchange for such product or service. The Company’s contracts with customers generally do not contain variable consideration. In the rare instances where variable consideration is included, the Company estimates the amount of variable consideration and determines what portion of that, if any, has a high probability of significant subsequent revenue reversal, and if so, that amount is excluded from the transaction price. The Company’s contracts with customers frequently contain multiple deliverables, such as systems, upgrades, components, spare parts, installation, maintenance, and service plans. Judgment is required to properly identify the performance obligations within a contract and to determine how the revenue should be allocated among the performance obligations. The Company also evaluates whether multiple transactions with the same customer or related parties should be considered part of a single contract based on an assessment of whether the contracts or agreements are negotiated or executed within a short time frame of each other or if there are indicators that the contracts are negotiated in contemplation of one another.

When there are separate units of accounting, the Company allocates revenue to each performance obligation on a relative stand-alone selling price basis. The stand-alone selling prices are determined based on the prices at which the Company separately sells the systems, upgrades, components, spare parts, installation, maintenance, and service plans. For items

that are not sold separately, the Company estimates stand-alone selling prices generally using an expected cost plus margin approach.

Most of the Company’s revenue is recognized at a point in time when the performance obligation is satisfied. The Company considers many facts when evaluating each of its sales arrangements to determine the timing of revenue recognition, including its contractual obligations and the nature of the customer’s post-delivery acceptance provisions. The Company’s system sales arrangements, including certain upgrades, generally include field acceptance provisions that may include functional or mechanical test procedures. For many of these arrangements, a customer source inspection of the system is performed in the Company’s facility, test data is sent to the customer documenting that the system is functioning to the agreed upon specifications prior to delivery, or other quality assurance testing is performed internally to ensure system functionality prior to shipment. Historically, such source inspection or test data replicates the field acceptance provisions that are performed at the customer’s site prior to final acceptance of the system. When the Company objectively demonstrates that the criteria specified in the contractual acceptance provisions are achieved prior to delivery either through customer testing or the Company’s historical experience of its tools meeting specifications, transfer of control of the product to the customer is considered to have occurred and revenue is recognized upon system delivery since there is no substantive contingency remaining related to the acceptance provisions at that date. For new products, new applications of existing products, or for products with substantive customer acceptance provisions where the Company cannot objectively demonstrate that the criteria specified in the contractual acceptance provisions have been achieved prior to delivery, revenue and the associated costs are deferred. The Company recognizes such revenue and costs upon obtaining objective evidence that the acceptance provisions can be achieved, assuming all other revenue recognition criteria have been met.

In certain cases the Company’s contracts with customers contain a billing retention, which is billed by the Company and payable by the customer when field acceptance provisions are completed. Revenue recognized in advance of the amount that has been billed is recorded as a contract asset on the Consolidated Balance Sheets.

The Company recognizes revenue related to maintenance and service contracts over time based upon the respective contract term. Installation revenue is recognized over time as the installation services are performed. The Company recognizes revenue from the sales of components, spare parts, and specified service engagements at a point in time, which is typically consistent with the time of delivery in accordance with the terms of the applicable sales arrangement.

The Company may receive customer deposits on system transactions. The timing of the transfer of goods or services related to the deposits is either at the discretion of the customer or generally expected to be within one year from the deposit receipt. As such, the Company does not adjust transaction prices for the time value of money. Incremental direct costs incurred related to the acquisition of a customer contract, such as sales commissions, are expensed as incurred since the expected amortization period is one year or less.

The Company has elected to treat shipping and handling costs as a fulfillment activity, and the Company includes such costs in cost of sales when the Company recognizes revenue for the related goods. Taxes assessed by governmental authorities that are collected by the Company from a customer are excluded from revenue.

Inventories

Inventories

Inventories are stated at the lower of cost or net realizable value, with cost determined on a first-in, first-out basis. Each quarter the Company assesses the valuation and recoverability of all inventories: materials (raw materials, spare parts, and service inventory); work-in-process; and finished goods. Obsolete inventory or inventory in excess of management’s estimated usage requirement is written down to its estimated net realizable value if less than cost. The Company evaluates usage requirements by analyzing historical usage, anticipated demand, alternative uses of materials, and other qualitative factors. Unanticipated changes in demand for the Company’s products may require a write down of

inventory, which would be reflected in cost of sales in the period the revision is made. Inventory acquired as part of a business combination is recorded at fair value on the date of acquisition.

Recently Adopted Accounting Standards

Recently Adopted Accounting Standards

The Company adopted ASU 2020-06: Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity on January 1, 2022, using the modified retrospective method for all financial instruments that are outstanding as of the adoption date. This standard simplifies the accounting for convertible debt instruments by removing the separation models for convertible debt with a cash conversion feature, as well as convertible instruments with a beneficial conversion feature. As a result, entities will account for a convertible debt instrument wholly as debt, unless certain other conditions are met. The elimination of these models will reduce non-cash interest expense for entities that have issued a convertible instrument that was within the scope of those models before the adoption of ASU 2020-06, such as the Company’s 2023 Notes, 2025 Notes, and 2027 Notes. Additionally, ASU 2020-06 requires the application of the if-converted method for calculating diluted earnings per share, and precludes the use of the treasury stock method for certain debt instruments, such as the Company’s 2023 Notes, 2025 Notes, and 2027 Notes.

The adoption of ASU 2020-06 resulted in the following adjustments to the Consolidated Balance Sheets:

	December 31, 2021		Adoption of ASU 2020-06		January 1, 2022
	(in thousands)
Balance Sheet line item:
Long-term debt	$	229,438	$	44,260	$	273,698
Additional paid-in capital		1,116,921		(56,801)		1,060,120
Accumulated deficit		(681,283)		12,541		(668,742)

The adoption of ASU 2020-06 resulted in the following adjustments to the Company’s calculations of basic and diluted income per share for the three and nine months ended September 30, 2022:

	Three months ended September 30, 2022						Nine months ended September 30, 2022
	Under		Under				Under		Under
	ASU 2020-06		legacy accounting		Difference		ASU 2020-06		legacy accounting		Difference
Income per common share:
Basic income per common share	$	0.30	$	0.25	$	0.05	$	0.76	$	0.62	$	0.14
Diluted income per common share		0.27		0.24		0.03		0.70		0.57		0.13

The adoption of ASU 2020-06 did not materially impact the Company’s cash flows or compliance with debt covenants.

XML

Basis of Presentation (Tables)

9 Months Ended

Sep. 30, 2022

Significant Accounting Policies

Schedule of adjustments to Consolidated Balance Sheets and adjustments to calculations of basic and diluted income per share

	December 31, 2021		Adoption of ASU 2020-06		January 1, 2022
	(in thousands)
Balance Sheet line item:
Long-term debt	$	229,438	$	44,260	$	273,698
Additional paid-in capital		1,116,921		(56,801)		1,060,120
Accumulated deficit		(681,283)		12,541		(668,742)

	Three months ended September 30, 2022						Nine months ended September 30, 2022
	Under		Under				Under		Under
	ASU 2020-06		legacy accounting		Difference		ASU 2020-06		legacy accounting		Difference
Income per common share:
Basic income per common share	$	0.30	$	0.25	$	0.05	$	0.76	$	0.62	$	0.14
Diluted income per common share		0.27		0.24		0.03		0.70		0.57		0.13

XML

Income Per Common Share (Tables)

9 Months Ended

Sep. 30, 2022

Income Per Common Share

Schedule of computations of basic and diluted income per share

	Three months ended September 30,				Nine months ended September 30,
	2022		2021		2022		2021
	(in thousands, except per share amounts)
Numerator:
Net income	$	15,041	$	8,993	$	38,026	$	17,835
Interest expense associated with convertible notes		2,549		—		7,639		—
Net income available to common shareholders	$	17,590	$	8,993	$	45,665	$	17,835
Denominator:
Basic weighted average shares outstanding		49,887		49,021		49,831		48,968
Effect of potentially dilutive share-based awards		801		1,507		796		1,377
Dilutive effect of convertible notes		14,463		3,321		14,463		3,261
Diluted weighted average shares outstanding		65,151		53,849		65,090		53,606
Net income per common share:
Basic	$	0.30	$	0.18	$	0.76	$	0.36
Diluted	$	0.27	$	0.17	$	0.70	$	0.33
Potentially dilutive shares excluded from the diluted calculation as their effect would be antidilutive		1,016		451		751		447
Maximum potential shares to be issued for settlement of the convertible notes excluded from the diluted calculation as their effect would be antidilutive		504		8,811		504		8,811

XML

Assets (Tables)

9 Months Ended

Sep. 30, 2022

Assets

Schedule of portion of Veeco's assets (excluding cash balances) that are measured at fair value on a recurring basis

	Level 1		Level 2		Level 3		Total
	(in thousands)
September 30, 2022
Cash equivalents
Certificate of deposits and time deposits	$	63,527	$	—	$	—	$	63,527
Commercial paper		—		4,959		—		4,959
Money market cash		15,066		—		—		15,066
Total	$	78,593	$	4,959	$	—	$	83,552
Short-term investments
U.S. treasuries	$	46,353	$	—	$	—	$	46,353
Government agency securities		—		12,879		—		12,879
Corporate debt		—		36,745		—		36,745
Commercial paper		—		5,885		—		5,885
Total	$	46,353	$	55,509	$	—	$	101,862
December 31, 2021
Cash equivalents
Certificate of deposits and time deposits	$	41,544	$	—	$	—	$	41,544
Money market cash		121		—		—		121
Total	$	41,665	$	—	$	—	$	41,665
Short-term investments
U.S. treasuries	$	51,095	$	—	$	—	$	51,095
Government agency securities		—		12,052		—		12,052
Corporate debt		—		40,035		—		40,035
Commercial paper		—		999		—		999
Total	$	51,095	$	53,086	$	—	$	104,181

Schedule of amortized cost and fair value of available-for-sale securities

			Gross		Gross
	Amortized		Unrealized		Unrealized		Estimated
	Cost		Gains		Losses		Fair Value
	(in thousands)
September 30, 2022
U.S. treasuries	$	47,084	$	—	$	(732)	$	46,352
Government agency securities		12,991		—		(112)		12,879
Corporate debt		37,389		—		(643)		36,746
Commercial paper		5,885		—		—		5,885
Total	$	103,349	$	—	$	(1,487)	$	101,862
December 31, 2021
U.S. treasuries	$	51,269	$	—	$	(174)	$	51,095
Government agency securities		12,075		—		(23)		12,052
Corporate debt		40,169		—		(134)		40,035
Commercial paper		999		—		—		999
Total	$	104,512	$	—	$	(331)	$	104,181

Schedule of fair value and unrealized losses of available-for-sale securities in a loss position

	September 30, 2022								December 31, 2021
	Continuous Loss Position				Continuous Loss Position				Continuous Loss Position
	for Less than 12 Months				for 12 Months or More				for Less than 12 Months
			Gross				Gross				Gross
	Estimated		Unrealized		Estimated		Unrealized		Estimated		Unrealized
	Fair Value		Losses		Fair Value		Losses		Fair Value		Losses
		(in thousands)
U.S. treasuries	$	16,973	$	(122)	$	29,379	$	(610)	$	51,095	$	(174)
Government agency securities		8,082		(59)		4,797		(53)		12,052		(23)
Corporate debt		25,980		(423)		10,766		(220)		40,035		(134)
Total	$	51,035	$	(604)	$	44,942	$	(883)	$	103,182	$	(331)

Schedule of contractual maturities of securities classified as available-for-sale

	September 30, 2022
	Amortized		Estimated
	Cost		Fair Value
		(in thousands)
Due in one year or less	$	97,762	$	96,468
Due after one year through two years		5,587		5,394
Total	$	103,349	$	101,862

Schedule of inventories

	September 30,		December 31,
	2022		2021
	(in thousands)
Materials	$	120,021	$	96,027
Work-in-process		61,052		54,128
Finished goods		6,664		20,703
Total	$	187,737	$	170,858

Schedule of property, plant, and equipment

	September 30,		December 31,
	2022		2021
	(in thousands)
Land	$	5,061	$	5,061
Building and improvements		64,198		63,946
Machinery and equipment (1)		160,365		145,656
Leasehold improvements		50,404		45,979
Gross property, plant, and equipment		280,028		260,642
Less: accumulated depreciation and amortization		171,612		160,899
Net property, plant, and equipment	$	108,416	$	99,743

(1) Machinery and equipment also includes software, furniture and fixtures

Schedule of intangible assets excluding goodwill

	September 30, 2022						December 31, 2021
			Accumulated						Accumulated
	Gross		Amortization				Gross		Amortization
	Carrying		and		Net		Carrying		and		Net
	Amount		Impairment		Amount		Amount		Impairment		Amount
	(in thousands)
Technology	$	327,908	$	315,327	$	12,581	$	327,908	$	310,551	$	17,357
Customer relationships		146,465		134,803		11,662		146,465		132,970		13,495
Trademarks and tradenames		30,910		28,762		2,148		30,910		27,857		3,053
Other		3,686		3,686		—		3,686		3,686		—
Total	$	508,969	$	482,578	$	26,391	$	508,969	$	475,064	$	33,905

XML

Liabilities (Tables)

9 Months Ended

Sep. 30, 2022

Liabilities

Schedule of accrued expenses and other current liabilities

	September 30,		December 31,
	2022		2021
	(in thousands)
Payroll and related benefits	$	33,920	$	35,712
Warranty		8,716		7,878
Operating lease liabilities		3,802		4,437
Interest		2,732		2,757
Professional fees		1,865		1,467
Legal settlement		300		15,000
Sales, use, and other taxes		5,317		4,889
Other		8,410		7,612
Total	$	65,062	$	79,752

Schedule of changes in product warranty reserves

		(in thousands)
Balance - December 31, 2021	$	7,878
Warranties issued		6,195
Consumption of reserves		(5,734)
Changes in estimate		377
Balance - September 30, 2022	$	8,716

Schedule of changes in deferred revenue

	(in thousands)
Balance - December 31, 2021	$	16,276
Deferral of revenue		2,908
Recognition of unearned revenue		(5,836)
Balance - September 30, 2022	$	13,348

Schedule of carrying value of Convertible Senior Notes

		September 30, 2022						December 31, 2021
		Principal Amount		Unamortized transaction costs		Net carrying value		Principal Amount		Unamortized debt discount/ transaction costs		Net carrying value
		(in thousands)
2023 Notes	$	20,173	$	(29)	$	20,144	$	20,173	$	(967)	$	19,206
2025 Notes		132,500		(1,105)		131,395		132,500		(17,302)		115,198
2027 Notes		125,000		(2,123)		122,877		125,000		(29,966)		95,034
Net carrying value	$	277,673	$	(3,257)	$	274,416	$	277,673	$	(48,235)	$	229,438

Schedule of interest expense related to Convertible Senior Notes

	Three months ended September 30,				Nine months ended September 30,
	2022		2021		2022		2021
	(in thousands)
Cash Interest Expense
Coupon interest expense - 2023 Notes	$	136	$	889	$	409	$	2,667
Coupon interest expense - 2025 Notes		1,159		1,159		3,478		3,478
Coupon interest expense - 2027 Notes		1,172		1,172		3,516		3,516
Non-cash Interest Expense
Amortization of debt discount/transaction costs- 2023 Notes		24		1,417		73		4,171
Amortization of debt discount/transaction costs- 2025 Notes		115		1,211		341		3,558
Amortization of debt discount/transaction costs- 2027 Notes		103		1,035		305		3,033
Total Interest Expense	$	2,709	$	6,883	$	8,122	$	20,423

XML

Commitments and Contingencies (Tables)

9 Months Ended

Sep. 30, 2022

Commitments and Contingencies

Schedule of maturities of lease liabilities 2020

The following table provides the maturities of lease liabilities at September 30, 2022:

	Operating
	Leases
	(in thousands)
Payments due by period:
2022	$	952
2023		4,097
2024		3,877
2025		3,292
2026		3,480
Thereafter		35,961
Total future minimum lease payments		51,659
Less: Imputed interest		(16,591)
Total	$	35,068
Reported as of September 30, 2022
Accrued expenses and other current liabilities	$	3,802
Long-term operating lease liabilities		31,266
Total	$	35,068

XML

Equity (Tables)

9 Months Ended

Sep. 30, 2022

Stockholders' Equity

Schedule of Stockholders' Equity

								Accumulated
				Additional				Other
	Common Stock			Paid-in		Accumulated		Comprehensive
	Shares	Amount		Capital		Deficit		Income		Total
	(in thousands)
Balance at December 31, 2021	50,653	$	507	$	1,116,921	$	(681,283)	$	1,483	$	437,628
Cumulative effect of change in accounting principle - adoption of ASU 2020-06	—		—		(56,801)		12,541		—		(44,260)
Net income	—		—		—		13,330		—		13,330
Other comprehensive income (loss), net of tax	—		—		—		—		(822)		(822)
Share-based compensation expense	—		—		4,481		—		—		4,481
Net issuance under employee stock plans	590		6		(6,793)		—		—		(6,787)
Balance at March 31, 2022	51,243	$	513	$	1,057,808	$	(655,412)	$	661	$	403,570
Net income	—		—		—		9,655		—		9,655
Other comprehensive income (loss), net of tax	—		—		—		—		(272)		(272)
Share-based compensation expense	—		—		6,278		—		—		6,278
Net issuance under employee stock plans	182		2		1,504		—		—		1,506
Balance at June 30, 2022	51,425	$	515	$	1,065,590	$	(645,757)	$	389	$	420,737
Net income (loss)	—		—		—		15,041		—		15,041
Other comprehensive income (loss), net of tax	—		—		—		—		(170)		(170)
Share-based compensation expense	—		—		6,210		—		—		6,210
Net issuance under employee stock plans	(5)		—		(703)		—		—		(703)
Balance at September 30, 2022	51,420	$	515	$	1,071,097	$	(630,716)	$	219	$	441,115

								Accumulated
				Additional				Other
	Common Stock			Paid-in		Accumulated		Comprehensive
	Shares	Amount		Capital		Deficit		Income		Total
	(in thousands)
Balance at December 31, 2020	49,724	$	497	$	1,113,352	$	(707,321)	$	1,846	$	408,374
Net income	—		—		—		2,494		—		2,494
Other comprehensive income (loss), net of tax	—		—		—		—		(19)		(19)
Share-based compensation expense	—		—		3,237		—		—		3,237
Net issuance under employee stock plans	459		5		(1,630)		—		—		(1,625)
Balance at March 31, 2021	50,183	$	502	$	1,114,959	$	(704,827)	$	1,827	$	412,461
Net income	—		—		—		6,348		—		6,348
Other comprehensive income (loss), net of tax	—		—		—		—		(24)		(24)
Share-based compensation expense	—		—		4,367		—		—		4,367
Net issuance under employee stock plans	166		1		582		—		—		583
Balance at June 30, 2021	50,349	$	503	$	1,119,908	$	(698,479)	$	1,803	$	423,735
Net income (loss)	—		—		—		8,993		—		8,993
Other comprehensive income (loss), net of tax	—		—		—		—		(33)		(33)
Share-based compensation expense	—		—		4,131		—		—		4,131
Net issuance under employee stock plans	(28)		—		(1,513)		—		—		(1,513)
Balance at September 30, 2021	50,321	$	503	$	1,122,526	$	(689,486)	$	1,770	$	435,313

Schedule of the changes in the balances of each component of AOCI, net of tax

			Unrealized
			Gains (Losses)
	Foreign		on Available
	Currency		for Sale
	Translation		Securities		Total
	(in thousands)
Balance - December 31, 2021	$	1,814	$	(331)	$	1,483
Other comprehensive income (loss)		(108)		(1,156)		(1,264)
Balance - September 30, 2022	$	1,706	$	(1,487)	$	219

XML

Share-based Compensation (Tables)

9 Months Ended

Sep. 30, 2022

Share-based Compensation

Schedule of share-based compensation expense

	Three months ended September 30,				Nine months ended September 30,
	2022		2021		2022		2021
	(in thousands)
Cost of sales	$	1,195	$	620	$	3,384	$	1,765
Research and development		1,819		1,007		4,939		2,957
Selling, general, and administrative		3,196		2,504		8,646		7,013
Total	$	6,210	$	4,131	$	16,969	$	11,735

Summary of stock option activity

		Weighted
	Number of	Average
	Shares	Exercise Price
	(in thousands)
Balance - December 31, 2021	443	$	32.15
Expired	(266)		32.95
Balance - September 30, 2022	177		30.94

Summary of non-vested restricted and performance shares activity

		Weighted
		Average
	Number of	Grant Date
	Shares	Fair Value
	(in thousands)
Balance - December 31, 2021	2,083	$	17.33
Granted	1,060		30.84
Performance award adjustments	85		14.03
Vested	(787)		15.21
Forfeited	(73)		19.85
Balance - September 30, 2022	2,368		23.88

XML

Income Taxes (Tables)

9 Months Ended

Sep. 30, 2022

Income Taxes

Schedule of income before income taxes and income tax expense (benefit)

	Three months ended September 30,				Nine months ended September 30,
	2022		2021		2022		2021
	(in thousands)
Income before income taxes	$	15,249	$	9,404	$	39,151	$	18,864
Income tax expense (benefit)	$	208	$	411	$	1,125	$	1,029

XML

Segment Reporting and Geographic Information (Tables)

9 Months Ended

Sep. 30, 2022

Segment Reporting and Geographic Information

Schedule of sales by end-market

	Three months ended September 30,				Nine months ended September 30,
	2022		2021		2022		2021
	(in thousands)
Sales by end-market
Semiconductor	$	100,387	$	76,320	$	275,528	$	181,641
Compound Semiconductor		28,094		23,273		96,325		72,255
Data Storage		27,702		39,256		70,845		132,261
Scientific & Other		15,730		11,397		49,640		44,148
Total	$	171,913	$	150,246	$	492,338	$	430,305
Sales by geographic region
United States	$	53,747	$	48,776	$	159,157	$	160,908
EMEA(1)		17,562		13,564		66,221		36,128
China		36,193		27,261		95,071		68,148
Rest of APAC		64,259		60,589		170,526		164,926
Rest of World		152		56		1,363		195
Total	$	171,913	$	150,246	$	492,338	$	430,305

(1) EMEA consists of Europe, the Middle East, and Africa

Schedule of sales by geographic region

	Three months ended September 30,				Nine months ended September 30,
	2022		2021		2022		2021
	(in thousands)
Sales by end-market
Semiconductor	$	100,387	$	76,320	$	275,528	$	181,641
Compound Semiconductor		28,094		23,273		96,325		72,255
Data Storage		27,702		39,256		70,845		132,261
Scientific & Other		15,730		11,397		49,640		44,148
Total	$	171,913	$	150,246	$	492,338	$	430,305
Sales by geographic region
United States	$	53,747	$	48,776	$	159,157	$	160,908
EMEA(1)		17,562		13,564		66,221		36,128
China		36,193		27,261		95,071		68,148
Rest of APAC		64,259		60,589		170,526		164,926
Rest of World		152		56		1,363		195
Total	$	171,913	$	150,246	$	492,338	$	430,305

(1) EMEA consists of Europe, the Middle East, and Africa

XML

Basis of Presentation - Fiscal Period (Details)	9 Months Ended
	Sep. 30, 2022
Significant Accounting Policies
Fiscal period duration (in days)	91 days

XML

Basis of Presentation - Revenue Recognition (Details)	9 Months Ended
	Sep. 30, 2022
Significant Accounting Policies
Revenue, practical expedient, incremental cost of obtaining contract	true

XML

Basis of Presentation - Recently Adopted Accounting Standards (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended		9 Months Ended
	Jan. 01, 2022	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Balance Sheet line item:
Long-term debt		$ 254,272		$ 254,272		$ 229,438
Additional paid-in capital		1,071,097		1,071,097		1,116,921
Accumulated deficit		$ (630,716)		$ (630,716)		(681,283)
Income per common share:
Basic income per common share (in dollars per share)		$ 0.30	$ 0.18	$ 0.76	$ 0.36
Diluted earnings per share (in dollars per share)		0.27	$ 0.17	0.70	$ 0.33
ASU 2020-06: Debt
Accounting Changes
Change in Accounting Principle, Accounting Standards Update, Adopted	true
Change in Accounting Principle, Accounting Standards Update, Transition Option Elected	us-gaap:AccountingStandardsUpdate202006CumulativeEffectPeriodOfAdoptionMember
ASU 2020-06: Debt | Cumulative Effect, Period of Adoption, Adjustment
Balance Sheet line item:
Long-term debt						44,260
Additional paid-in capital						(56,801)
Accumulated deficit						12,541
ASU 2020-06: Debt | Cumulative Effect, Period of Adoption, Adjusted Balance
Balance Sheet line item:
Long-term debt						273,698
Additional paid-in capital						1,060,120
Accumulated deficit						$ (668,742)
Income per common share:
Basic income per common share (in dollars per share)		0.30		0.76
Diluted earnings per share (in dollars per share)		0.27		0.70
Under legacy accounting
Income per common share:
Basic income per common share (in dollars per share)		0.25		0.62
Diluted earnings per share (in dollars per share)		0.24		0.57
Difference between adoption of ASU 2020-06 and legacy accounting | ASU 2020-06: Debt
Income per common share:
Basic income per common share (in dollars per share)		0.05		0.14
Diluted earnings per share (in dollars per share)		$ 0.03		$ 0.13

XML

Income Per Common Share - Basic and Diluted (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Numerator:
Net income	$ 15,041	$ 8,993	$ 38,026	$ 17,835
Interest expense associated with convertible notes	2,549		7,639
Net income available to common shareholders	$ 17,590	$ 8,993	$ 45,665	$ 17,835
Denominator:
Basic weighted average shares outstanding	49,887	49,021	49,831	48,968
Effect of potentially dilutive share-based awards	801	1,507	796	1,377
Dilutive effect of convertible notes	14,463	3,321	14,463	3,261
Diluted weighted average shares outstanding	65,151	53,849	65,090	53,606
Net income (loss) per common share:
Basic (in dollars per share)	$ 0.30	$ 0.18	$ 0.76	$ 0.36
Diluted (in dollars per share)	$ 0.27	$ 0.17	$ 0.70	$ 0.33

XML

Income Per Common Share - Shares Excluded from EPS (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Potentially dilutive shares
Diluted income (loss) per share
Securities excluded from the diluted calculation as their effect would be antidilutive	1,016	451	751	447
Convertible Notes
Diluted income (loss) per share
Securities excluded from the diluted calculation as their effect would be antidilutive	504	8,811	504	8,811

XML

Assets - Fair Value (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Short-term investments
Transfer of assets from Level 1 to Level 2	$ 0
Transfer of assets from Level 2 to Level 1	0
Transfer of Liabilities from Level 1 to Level 2	0
Transfer of Liabilities from Level 2 to Level 1	0
Measured on a recurring basis
Cash equivalents
Total Cash equivalents	83,552	$ 41,665
Short-term investments
Total Short-term investments	101,862	104,181
Measured on a recurring basis | U.S. treasuries
Short-term investments
Total Short-term investments	46,353	51,095
Measured on a recurring basis | Government agency securities
Short-term investments
Total Short-term investments	12,879	12,052
Measured on a recurring basis | Corporate debt
Short-term investments
Total Short-term investments	36,745	40,035
Measured on a recurring basis | Commercial paper
Short-term investments
Total Short-term investments	5,885	999
Measured on a recurring basis | Certificate of deposits and time deposits
Cash equivalents
Total Cash equivalents	63,527	41,544
Measured on a recurring basis | Commercial paper
Cash equivalents
Total Cash equivalents	4,959
Measured on a recurring basis | Money market cash
Cash equivalents
Total Cash equivalents	15,066	121
Measured on a recurring basis | Level 1
Cash equivalents
Total Cash equivalents	78,593	41,665
Short-term investments
Total Short-term investments	46,353	51,095
Measured on a recurring basis | Level 1 | U.S. treasuries
Short-term investments
Total Short-term investments	46,353	51,095
Measured on a recurring basis | Level 1 | Certificate of deposits and time deposits
Cash equivalents
Total Cash equivalents	63,527	41,544
Measured on a recurring basis | Level 1 | Money market cash
Cash equivalents
Total Cash equivalents	15,066	121
Measured on a recurring basis | Level 2
Cash equivalents
Total Cash equivalents	4,959
Short-term investments
Total Short-term investments	55,509	53,086
Measured on a recurring basis | Level 2 | Government agency securities
Short-term investments
Total Short-term investments	12,879	12,052
Measured on a recurring basis | Level 2 | Corporate debt
Short-term investments
Total Short-term investments	36,745	40,035
Measured on a recurring basis | Level 2 | Commercial paper
Short-term investments
Total Short-term investments	5,885	$ 999
Measured on a recurring basis | Level 2 | Commercial paper
Cash equivalents
Total Cash equivalents	$ 4,959

XML

Assets - Available-For-Sale Securities (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Total available-for-sale securities
Amortized Cost	$ 103,349		$ 104,512
Gross Unrealized Losses	(1,487)		(331)
Estimated Fair Value	101,862		104,181
Available-for-sale securities in a loss position
Investments, Continuous loss position for less than 12 months, Estimated Fair Value	51,035		103,182
Investments, Continuous loss position for less than 12 months, Gross Unrealized Losses	(604)		(331)
Investments, Continuous loss position for 12 months or more, Estimated Fair Value	44,942		0
Investments, Continuous loss position for 12 months or more, Gross Unrealized Losses	(883)
Contractual maturities - Amortized Cost
Amortized Cost, Due in one year or less	97,762
Amortized Cost, Due after one year through two years	5,587
Amortized Cost	103,349		104,512
Contractual maturities - Estimated Fair Value
Estimated Fair Value, Due in one year or less	96,468
Estimated Fair Value, Due after one year through two years	5,394
Available-for-sale Securities, Debt Securities, Total	101,862		104,181
Realized gains or losses
Realized gains or losses	0	$ 0
U.S. treasuries
Total available-for-sale securities
Amortized Cost	47,084		51,269
Gross Unrealized Losses	(732)		(174)
Estimated Fair Value	46,352		51,095
Available-for-sale securities in a loss position
Investments, Continuous loss position for less than 12 months, Estimated Fair Value	16,973		51,095
Investments, Continuous loss position for less than 12 months, Gross Unrealized Losses	(122)		(174)
Investments, Continuous loss position for 12 months or more, Estimated Fair Value	29,379
Investments, Continuous loss position for 12 months or more, Gross Unrealized Losses	(610)
Contractual maturities - Amortized Cost
Amortized Cost	47,084		51,269
Contractual maturities - Estimated Fair Value
Available-for-sale Securities, Debt Securities, Total	46,352		51,095
Government agency securities
Total available-for-sale securities
Amortized Cost	12,991		12,075
Gross Unrealized Losses	(112)		(23)
Estimated Fair Value	12,879		12,052
Available-for-sale securities in a loss position
Investments, Continuous loss position for less than 12 months, Estimated Fair Value	8,082		12,052
Investments, Continuous loss position for less than 12 months, Gross Unrealized Losses	(59)		(23)
Investments, Continuous loss position for 12 months or more, Estimated Fair Value	4,797
Investments, Continuous loss position for 12 months or more, Gross Unrealized Losses	(53)
Contractual maturities - Amortized Cost
Amortized Cost	12,991		12,075
Contractual maturities - Estimated Fair Value
Available-for-sale Securities, Debt Securities, Total	12,879		12,052
Corporate debt
Total available-for-sale securities
Amortized Cost	37,389		40,169
Gross Unrealized Losses	(643)		(134)
Estimated Fair Value	36,746		40,035
Available-for-sale securities in a loss position
Investments, Continuous loss position for less than 12 months, Estimated Fair Value	25,980		40,035
Investments, Continuous loss position for less than 12 months, Gross Unrealized Losses	(423)		(134)
Investments, Continuous loss position for 12 months or more, Estimated Fair Value	10,766
Investments, Continuous loss position for 12 months or more, Gross Unrealized Losses	(220)
Contractual maturities - Amortized Cost
Amortized Cost	37,389		40,169
Contractual maturities - Estimated Fair Value
Available-for-sale Securities, Debt Securities, Total	36,746		40,035
Commercial paper
Total available-for-sale securities
Amortized Cost	5,885		999
Estimated Fair Value	5,885		999
Contractual maturities - Amortized Cost
Amortized Cost	5,885		999
Contractual maturities - Estimated Fair Value
Available-for-sale Securities, Debt Securities, Total	$ 5,885		$ 999

XML

Assets - Accounts Receivable (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Assets
Allowance for doubtful accounts receivable	$ 0.7	$ 0.7

XML

Assets - Inventories (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Inventories
Materials	$ 120,021	$ 96,027
Work-in-process	61,052	54,128
Finished goods	6,664	20,703
Total	$ 187,737	$ 170,858

XML

Assets - Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Prepaid expenses and other current assets
Deposits with suppliers	$ 7.1	$ 3.9

XML

Assets - Property, Plant, and Equipment (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Property, plant, and equipment
Gross property, plant and equipment	$ 280,028		$ 280,028		$ 260,642
Less: accumulated depreciation and amortization	171,612		171,612		160,899
Net property, plant, and equipment	108,416		108,416		99,743
Depreciation expense	3,800	$ 3,500	11,600	$ 10,300
Land
Property, plant, and equipment
Gross property, plant and equipment	5,061		5,061		5,061
Building and improvements
Property, plant, and equipment
Gross property, plant and equipment	64,198		64,198		63,946
Machinery and equipment
Property, plant, and equipment
Gross property, plant and equipment	160,365		160,365		145,656
Leaseholds improvements
Property, plant, and equipment
Gross property, plant and equipment	$ 50,404		$ 50,404		$ 45,979

XML

Assets - Intangible Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Intangible assets
Total Gross Intangible Assets	$ 508,969	$ 508,969
Accumulated Amortization and Impairment	482,578	475,064
Total Net Intangible Assets	26,391	33,905
Technology
Intangible assets
Gross Carrying Amount, Definite-lived intangible assets	327,908	327,908
Accumulated Amortization and Impairment, Definite-lived intangible assets	315,327	310,551
Total definite-lived intangible assets	12,581	17,357
Customer relationship
Intangible assets
Gross Carrying Amount, Definite-lived intangible assets	146,465	146,465
Accumulated Amortization and Impairment, Definite-lived intangible assets	134,803	132,970
Total definite-lived intangible assets	11,662	13,495
Trademarks and tradenames
Intangible assets
Gross Carrying Amount, Definite-lived intangible assets	30,910	30,910
Accumulated Amortization and Impairment, Definite-lived intangible assets	28,762	27,857
Total definite-lived intangible assets	2,148	3,053
Other Intangible Assets
Intangible assets
Gross Carrying Amount, Definite-lived intangible assets	3,686	3,686
Accumulated Amortization and Impairment, Definite-lived intangible assets	$ 3,686	$ 3,686

XML

Liabilities - Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Accrued expenses and other current liabilities
Payroll and related benefits	$ 33,920	$ 35,712
Warranty	8,716	7,878
Operating lease liabilities	3,802	4,437
Interest	2,732	2,757
Professional fees	1,865	1,467
Legal settlement	300	15,000
Sales, use, and other taxes	5,317	4,889
Other	8,410	7,612
Total	$ 65,062	$ 79,752

XML

Liabilities - Warranty (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2022 USD ($)
Warranty
Warranty period	1 year
Balance, beginning of the period	$ 7,878
Warranties issued	6,195
Consumption of reserves	(5,734)
Changes in estimate	377
Balance, end of the period	$ 8,716

XML

Liabilities - Customer Deposits and Deferred Revenue (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Liabilities
Customer deposits and deferred revenue	$ 108,900	$ 46,900
Changes in deferred revenue
Beginning balance	16,276
Deferral of revenue	2,908
Recognition of unearned revenue	(5,836)
Ending balance	$ 13,348

XML

Liabilities - Performance Obligations Amount (Details) $ in Millions	9 Months Ended
	Sep. 30, 2022 USD ($)
Performance obligations
Remaining performance obligations	$ 142.5
Minimum
Performance obligations
Performance obligation at time of contract origination	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-07-01
Performance obligations
Percentage of remaining performance obligation expected to be recognized	24.00%

XML

Liabilities - Performance Obligations Timing (Details)	9 Months Ended
	Sep. 30, 2022
Liabilities
Revenue, Practical Expedient, Remaining Performance Obligation	true
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-07-01
Performance obligations
Remaining performance obligations, expected timing of satisfaction	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-07-01
Performance obligations
Remaining performance obligations, expected timing of satisfaction	2 years

XML

Liabilities - 2023, 2025 and 2027 Convertible Senior Notes (Details) - USD ($) $ in Thousands	Nov. 05, 2021	Nov. 11, 2020	May 18, 2020	Jan. 10, 2017	Sep. 30, 2022	Dec. 31, 2021	Nov. 17, 2020
Debt
Principal amount					$ 277,673	$ 277,673
2023 Notes
Debt
Principal amount				$ 345,000	20,173	20,173
Interest rate (as a percent)				2.70%
Proceeds, net of issuance costs				$ 335,800
Repurchased and retired amount	$ 111,500	$ 125,000	$ 88,300
Carrying amount of debt extinguished	105,500	$ 113,100	78,100
Cash paid for repurchase of notes	115,600		81,200
Accrued and unpaid interest	$ 1,000
2025 Notes
Debt
Principal amount					132,500	132,500	$ 132,500
Interest rate (as a percent)							3.50%
2027 Notes
Debt
Principal amount			$ 125,000		$ 125,000	$ 125,000
Interest rate (as a percent)			3.75%
Proceeds, net of issuance costs			$ 121,900
Purchase of capped calls			$ 10,300

XML

Liabilities - Convertible Senior Notes (Details)				3 Months Ended	9 Months Ended
	Nov. 17, 2020 USD ($) $ / shares	May 18, 2020 USD ($) $ / shares	Jan. 10, 2017 USD ($) $ / shares	Sep. 30, 2022 D	Sep. 30, 2022 USD ($) D
Convertible Notes
Debt
Multiples of principal holders may convert					1,000
Minimum threshold period | D					20
Consecutive trading days | D				30	30
Stock price trigger (as a percent)				130.00%	130.00%
Trading days | D					5
Number of consecutive business days					5 days
Maximum percentage of common stock conversion					98.00%
2023 Notes
Debt
Conversion rate			0.0249800
Conversion price (in dollars per share) | $ / shares			$ 40.03
Measurement input			0.070
Long-term Debt, Measurement Input			us-gaap:MeasurementInputDiscountRateMember
Debt discount			$ 72,500,000
Transaction costs			9,200,000
Transaction costs allocated to the equity component			$ 1,900,000
2025 Notes
Debt
Conversion rate	0.0416667
Conversion price (in dollars per share) | $ / shares	$ 24.00
Measurement input	0.080
Long-term Debt, Measurement Input	us-gaap:MeasurementInputDiscountRateMember
Debt discount	$ 21,000,000.0
Transaction costs	1,900,000
Transaction costs allocated to the equity component	$ 300,000
2027 Notes
Debt
Conversion rate		0.0715372
Conversion price (in dollars per share) | $ / shares		$ 13.98
Measurement input		0.091
Long-term Debt, Measurement Input		us-gaap:MeasurementInputDiscountRateMember
Debt discount		$ 34,200,000
Transaction costs		3,100,000
Transaction costs allocated to the equity component		$ 800,000

XML

Liabilities - Convertible Senior Notes Carrying Value (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021	Nov. 17, 2020	May 18, 2020	Jan. 10, 2017
Debt
Principal amount	$ 277,673	$ 277,673
Unamortized debt discount/transaction costs	(3,257)	(48,235)
Net carrying value	274,416	229,438
2023 Notes
Debt
Principal amount	20,173	20,173			$ 345,000
Unamortized debt discount/transaction costs	(29)	(967)
Net carrying value	20,144	19,206
2025 Notes
Debt
Principal amount	132,500	132,500	$ 132,500
Unamortized debt discount/transaction costs	(1,105)	(17,302)
Net carrying value	131,395	115,198
2027 Notes
Debt
Principal amount	125,000	125,000		$ 125,000
Unamortized debt discount/transaction costs	(2,123)	(29,966)
Net carrying value	$ 122,877	$ 95,034

XML

Liabilities - Convertible Senior Notes - Interest Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Non-Cash Interest Expense
Amortization of debt discount/transaction costs			$ 719	$ 10,762
Total Interest Expense	$ 2,709	$ 6,883	8,122	20,423
2023 Notes
Cash Interest Expense
Coupon interest expense	136	889	409	2,667
Non-Cash Interest Expense
Amortization of debt discount/transaction costs	$ 24	1,417	$ 73	4,171
Convertible Debt, Fair Value by Fair Value Hierarchy Level	Level 2		Level 2
Estimated fair value	$ 19,500		$ 19,500
2025 Notes
Cash Interest Expense
Coupon interest expense	1,159	1,159	3,478	3,478
Non-Cash Interest Expense
Amortization of debt discount/transaction costs	$ 115	1,211	$ 341	3,558
Convertible Debt, Fair Value by Fair Value Hierarchy Level	Level 2		Level 2
Estimated fair value	$ 144,300		$ 144,300
2027 Notes
Cash Interest Expense
Coupon interest expense	1,172	1,172	3,516	3,516
Non-Cash Interest Expense
Amortization of debt discount/transaction costs	$ 103	$ 1,035	$ 305	$ 3,033
Convertible Debt, Fair Value by Fair Value Hierarchy Level	Level 2		Level 2
Estimated fair value	$ 191,900		$ 191,900

XML

Liabilities - Capped Call Transactions (Details) - Capped Call Transactions $ / shares in Units, $ in Millions	May 13, 2020 USD ($) $ / shares
Debt
Aggregate price of capped call transaction | $	$ 10.3
Cap price of the capped call transactions (in dollars per share) | $ / shares	$ 18.46

XML

Liabilities - Revolving Credit Facility (Details) - USD ($) $ in Millions		9 Months Ended	12 Months Ended
	Dec. 16, 2021	Sep. 30, 2022	Dec. 31, 2021
Credit Facility
Debt
Borrowing capacity	$ 150
Debt instrument term	5 years
Additional increase in borrowing subject to certain conditions	$ 75
Outstanding amount		$ 0	$ 0
Credit Facility | Minimum
Debt
Unused commitment fee percentage (as a percent)	0.25%
Interest coverage ratio	3.00
Credit Facility | Maximum
Debt
Unused commitment fee percentage (as a percent)	0.35%
Total net leverage ratio	4.50
Secured net leverage ratio	2.50
Credit Facility | Base rate | Minimum
Debt
Basis spread on base rate (as a percent)	0.50%
Credit Facility | Base rate | Maximum
Debt
Basis spread on base rate (as a percent)	1.25%
Credit Facility | SOFR
Debt
Floor rate on debt instrument (as a percent)	0.00%
Credit Facility | SOFR | Minimum
Debt
Basis spread on base rate (as a percent)	1.50%
Credit Facility | SOFR | Maximum
Debt
Basis spread on base rate (as a percent)	2.25%
Credit Facility, Letter of Credit
Debt
Borrowing capacity	$ 15

XML

Liabilities - Other Liabilities (Details) - Other Liabilities - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Other liabilities
Medical and dental benefits	$ 1.8	$ 1.8
Asset retirement obligations	2.8	2.8
Income taxes payable	$ 0.4	$ 0.4

XML

Commitments and Contingencies - Lease terms (Details)	Sep. 30, 2022
Leases
Lease renewal term	5 years
Remaining lease term	12 years
Weighted average discount rate (as a percent)	5.60%

XML

Commitments and Contingencies - Minimum lease commitments (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Minimum lease commitments, Payments due by period:
2022	$ 952
2023	4,097
2024	3,877
2025	3,292
2026	3,480
Thereafter	35,961
Total future minimum lease payments	51,659
Less: Imputed interest	(16,591)
Total operating lease liabilities	35,068
Operating lease liability, current	$ 3,802	$ 4,437
Operating Lease, Liability, Current, Statement of Financial Position	Accrued expenses and other current liabilities
Long-term operating lease liabilities	$ 31,266	$ 32,834
Total operating lease liabilities	$ 35,068
Operating Lease, Liability, Statement of Financial Position	Long-term operating lease liabilities, Accrued expenses and other current liabilities

XML

Commitments and Contingencies - Lease costs (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Lease cost
Operating lease cost	$ 1.8	$ 1.8	$ 5.5	$ 4.8
Variable lease cost	$ 0.5	$ 0.4	1.5	1.3
Operating cash flows from operating leases			$ 5.7	$ 4.9

XML

Commitments and Contingencies - Receivable Purchase Agreement (Details) - USD ($) $ in Millions	3 Months Ended
	Sep. 30, 2022	Dec. 31, 2020
Commitments and Contingencies
Maximum amount of trade receivables to be sold under agreement		$ 15.0
Receivables sold	$ 7.8
Receivables sold remaining outstanding	$ 7.2

XML

Commitments and Contingencies - Purchase Commitments and Bank Guarantees (Details) $ in Millions	Sep. 30, 2022 USD ($)
Purchase commitments
Purchase commitments due within one year	$ 299.4
Bank guarantees
Bank guarantees and letters of credit outstanding	7.0
Unused bank guarantees and letters of credit	$ 14.7

XML

Commitments and Contingencies - Legal Proceedings (Details) $ in Millions		1 Months Ended
	Aug. 08, 2018 case	Oct. 31, 2021 USD ($)	Apr. 30, 2022 USD ($)
Ultratech acquisition litigation
Legal Proceedings
Number of purported class action complaints filed | case	2
Amount plaintiff will receive for fees and expenses			$ 0.3
Wolther Action
Legal Proceedings
Settlement amount		$ 15.0

XML

Derivative Financial Instruments (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Not Designated as Hedges | Foreign currency exchange forwards
Derivative Financial Instruments
Gains (losses)	$ 0	$ 0

XML

Equity - Statement of Stockholders' Equity (Details) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2022	Sep. 30, 2021
Increase (Decrease) in Stockholders' Equity
Balance at the beginning of the period	$ 420,737	$ 403,570	$ 437,628	$ 423,735	$ 412,461	$ 408,374	$ 437,628	$ 408,374
Net income	15,041	9,655	13,330	8,993	6,348	2,494	38,026	17,835
Other comprehensive income (loss), net of tax	(170)	(272)	(822)	(33)	(24)	(19)
Share-based compensation expense	6,210	6,278	4,481	4,131	4,367	3,237
Net issuance under employee stock plans	(703)	1,506	(6,787)	(1,513)	583	(1,625)
Balance at the end of the period	441,115	420,737	403,570	435,313	423,735	412,461	441,115	435,313
Cumulative Effect, Period of Adoption, Adjustment
Increase (Decrease) in Stockholders' Equity
Balance at the beginning of the period			(44,260)				(44,260)
Common Stock
Increase (Decrease) in Stockholders' Equity
Balance at the beginning of the period	$ 515	$ 513	$ 507	$ 503	$ 502	$ 497	$ 507	$ 497
Balance (in shares)	51,425	51,243	50,653	50,349	50,183	49,724	50,653	49,724
Net issuance under employee stock plans		$ 2	$ 6		$ 1	$ 5
Net issuance under employee stock plans (in shares)	(5)	182	590	(28)	166	459
Balance at the end of the period	$ 515	$ 515	$ 513	$ 503	$ 503	$ 502	$ 515	$ 503
Balance (in shares)	51,420	51,425	51,243	50,321	50,349	50,183	51,420	50,321
Additional Paid-in Capital
Increase (Decrease) in Stockholders' Equity
Balance at the beginning of the period	$ 1,065,590	$ 1,057,808	$ 1,116,921	$ 1,119,908	$ 1,114,959	$ 1,113,352	$ 1,116,921	$ 1,113,352
Share-based compensation expense	6,210	6,278	4,481	4,131	4,367	3,237
Net issuance under employee stock plans	(703)	1,504	(6,793)	(1,513)	582	(1,630)
Balance at the end of the period	1,071,097	1,065,590	1,057,808	1,122,526	1,119,908	1,114,959	1,071,097	1,122,526
Additional Paid-in Capital | Cumulative Effect, Period of Adoption, Adjustment
Increase (Decrease) in Stockholders' Equity
Balance at the beginning of the period			(56,801)				(56,801)
Accumulated Deficit
Increase (Decrease) in Stockholders' Equity
Balance at the beginning of the period	(645,757)	(655,412)	(681,283)	(698,479)	(704,827)	(707,321)	(681,283)	(707,321)
Net income	15,041	9,655	13,330	8,993	6,348	2,494
Balance at the end of the period	(630,716)	(645,757)	(655,412)	(689,486)	(698,479)	(704,827)	(630,716)	(689,486)
Accumulated Deficit | Cumulative Effect, Period of Adoption, Adjustment
Increase (Decrease) in Stockholders' Equity
Balance at the beginning of the period			12,541				12,541
Accumulated Other Comprehensive Income
Increase (Decrease) in Stockholders' Equity
Balance at the beginning of the period	389	661	1,483	1,803	1,827	1,846	1,483	1,846
Other comprehensive income (loss), net of tax	(170)	(272)	(822)	(33)	(24)	(19)
Balance at the end of the period	$ 219	$ 389	$ 661	$ 1,770	$ 1,803	$ 1,827	$ 219	$ 1,770

XML

Equity - AOCI Rollforward (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Changes in the balances of each component of AOCI
Balance at the beginning of the period	$ 420,737	$ 423,735	$ 437,628	$ 408,374
Other comprehensive income (loss)	(170)	(33)	(1,264)	(76)
Balance at the end of the period	441,115	435,313	441,115	435,313
Accumulated Other Comprehensive Income
Changes in the balances of each component of AOCI
Balance at the beginning of the period	389	1,803	1,483	1,846
Other comprehensive income (loss)			(1,264)
Balance at the end of the period	219	$ 1,770	219	$ 1,770
Translation adjustment
Changes in the balances of each component of AOCI
Balance at the beginning of the period			1,814
Other comprehensive income (loss)			(108)
Balance at the end of the period	1,706		1,706
Unrealized gain on available for sale securities
Changes in the balances of each component of AOCI
Balance at the beginning of the period			(331)
Other comprehensive income (loss)			(1,156)
Balance at the end of the period	$ (1,487)		$ (1,487)

XML

Share-based Compensations - Recognized Share-based Compensation (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Recognized share-based compensation
Total share-based compensation expense	$ 6,210	$ 4,131	$ 16,969	$ 11,735
Cost of sales
Recognized share-based compensation
Total share-based compensation expense	1,195	620	3,384	1,765
Research and development
Recognized share-based compensation
Total share-based compensation expense	1,819	1,007	4,939	2,957
Selling, general and administrative
Recognized share-based compensation
Total share-based compensation expense	$ 3,196	$ 2,504	$ 8,646	$ 7,013
Restricted Stock Awards | Minimum
Recognized share-based compensation
Expiration term			1 year
Restricted Stock Awards | Maximum
Recognized share-based compensation
Expiration term			4 years

XML

Share-based Compensations - Stock Option Activity (Details) shares in Thousands	9 Months Ended
	Sep. 30, 2022 $ / shares shares
Number of Shares
Outstanding at the beginning of the period (in shares) | shares	443
Expired (in shares) | shares	(266)
Outstanding at the end of the period (in shares) | shares	177
Weighted Average Exercise Price
Outstanding at the beginning of the period (in dollars per share) | $ / shares	$ 32.15
Expired or forfeited (in dollars per share) | $ / shares	32.95
Outstanding at the end of the period (in dollars per share) | $ / shares	$ 30.94

XML

Share-based Compensation - Restricted shares and performance shares (Details) - Non-vested restricted shares and performance shares shares in Thousands	9 Months Ended
	Sep. 30, 2022 $ / shares shares
Number of Shares
Outstanding at the beginning of the period (in shares) | shares	2,083
Granted (in shares) | shares	1,060
Performance award adjustments (in shares) | shares	85
Vested (in shares) | shares	(787)
Forfeited (in shares) | shares	(73)
Outstanding at the end of the period (in shares) | shares	2,368
Weighted Average Grant Date Fair Value
Outstanding at the beginning of the period (in dollars per share) | $ / shares	$ 17.33
Granted (in dollars per share) | $ / shares	30.84
Performance award adjustments (in dollars per share) | $ / shares	14.03
Vested (in dollars per share) | $ / shares	15.21
Forfeited (in dollars per share) | $ / shares	19.85
Outstanding at the end of the period (in dollars per share) | $ / shares	$ 23.88

XML

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Tax reconciliation disclosures
Income before income taxes	$ 15,249	$ 9,404	$ 39,151	$ 18,864
Income tax expense (benefit)	208	411	1,125	1,029
Federal
Tax reconciliation disclosures
Income tax expense (benefit)	100		300	200
Foreign tax
Tax reconciliation disclosures
Income tax expense (benefit)	$ 100	$ 400	$ 800	$ 800

XML

Segment Reporting and Geographic Information (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	Sep. 30, 2022 USD ($) item segment	Sep. 30, 2021 USD ($)
Revenue reporting by end-market and geographic region
Number of operating segments | segment			1
Number of reportable segments | segment			1
Number of key markets | item			4
Sales	$ 171,913	$ 150,246	$ 492,338	$ 430,305
United States
Revenue reporting by end-market and geographic region
Sales	53,747	48,776	159,157	160,908
EMEA
Revenue reporting by end-market and geographic region
Sales	17,562	13,564	66,221	36,128
China
Revenue reporting by end-market and geographic region
Sales	36,193	27,261	95,071	68,148
Rest of APAC
Revenue reporting by end-market and geographic region
Sales	64,259	60,589	170,526	164,926
Rest Of World
Revenue reporting by end-market and geographic region
Sales	152	56	1,363	195
Semiconductor
Revenue reporting by end-market and geographic region
Sales	100,387	76,320	275,528	181,641
Compound Semiconductor
Revenue reporting by end-market and geographic region
Sales	28,094	23,273	96,325	72,255
Data Storage
Revenue reporting by end-market and geographic region
Sales	27,702	39,256	70,845	132,261
Scientific & Other
Revenue reporting by end-market and geographic region
Sales	$ 15,730	$ 11,397	$ 49,640	$ 44,148